Any compound that can be used for the treatment of neurodegenerative disorders.
| Member | Definition | Class |
|---|
| ((5z)5-(1,3-benzodioxol-5-yl)methylene-2-phenylamino-3,5-dihydro-4h-imidazol-4-one) | A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a (2-anilino-5-oxo-1,5-dihydro-4H-imidazol-4-ylidene)methyl group at position 5. It is an inhibitor of DYRK1A, DYRK2, CLK1, and CLK3 (IC50s = 0.04, 0.035, 0.015, and 4.5 muM, respectively). | leucettine L41 |
| (3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone | A organic heterotricyclic compound that is 5-methyl-3-(morpholin-4-ylmethyl)-2,3-dihydro[1,4]oxazino[2,3,4-hi]indole substituted at position 6 by a 1-naphthylcarbonyl group. | WIN 55212-2 |
| 27-hydroxycholesterol | A 26-hydroxycholesterol in which the 25-position has R-configuration. | (25R)-cholest-5-ene-3beta,26-diol |
| 3-(2,2,2-trimethylhydrazine)propionate | An ammonium betaine that is beta-alaninate in which one of the amino hydrogens is replaced by a trimethylamino group. A clinically used cardioprotective drug that is used for treatment of heart failure, myocardial infarction, arrhythmia, atherosclerosis and diabetes. | meldonium |
| 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione | A member of the class of thiadiazolidines that is 1,2,4-thiadiazolidine-3,5-dione which is substituted by a methyl group at position 2 and by a benzyl group at position 4. It is a non-ATP competitive inhibitor of glycogen synthase kinase 3beta (GSK3beta). An experimental compound which was being developed for the potential treatment of Alzheimer's disease. | TDZD-8 |
| 4-phenylbutyric acid, sodium salt | The organic sodium salt of 4-phenylbutyric acid. A prodrug for phenylacetate, it is used to treat urea cycle disorders. | sodium phenylbutyrate |
| 5-methoxytryptamine | A member of the class of tryptamines that is the methyl ether derivative of serotonin. | 5-methoxytryptamine |
| 5,11-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol | A carbotetracyclic compound that is 5,6,11,12-tetrahydrochrysene substituted by hydroxy groups at positions 2 and 8 and by ethyl groups at positions 5 and 11 (the 5R,11R-stereoisomer). It is an agonist of ER-alpha and antagonist of ER-beta receptors. | (R,R)-5,11-diethyl-5,6,11,12-tetrahydro-2,8-chrysenediol |
| 5,5-dimethyl-1-pyrroline-1-oxide | A member of the class of 1-pyrroline nitrones (1-pyrroline N-oxides) resulting from the formal N-oxidation of 5,5-dimethyl-1-pyrroline. Used as a spin trap for the study of radicals formed by enzymatic acetaldehyde oxidation. | 5,5-dimethyl-1-pyrroline N-oxide |
| 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | A chromanol that is 6-hydroxychromane which is substituted by a carboxy group at position 2 and by methyl groups at positions 2, 5, 7, and 8. A cell-permeable, water-soluble analogue of vitamin E, it is used as a standard for measuring the antioxidant capacity of complex mixtures. | Trolox |
| 6-methylthiohexyl isothiocyanate | A isothiocyanate that is hexane in which two of the terminal methyl hydrogens at positions 1 and 6 have been replaced by isothiocyanato and methylsulfanyl groups. | 1-isothiocyanato-6-(methylsulfanyl)hexane |
| 7-chlorokynurenic acid | A quinolinemonocarboxylic acid that is quinaldic acid which is substituted by a hydroxy group at position 4 and by a chlorine at position 7. It is a potent NMDA glutamate receptor antagonist which antagonizes the strychnine-insensitive glycine site of the NMDA receptor. It also prevents neurodegeneration produced by quinolinic acid. | 7-chlorokynurenic acid |
| 7-ketocholesterol | A cholestanoid that consists of cholesterol bearing an oxo substituent at position 7. | 7-ketocholesterol |
| acteoside | A glycoside that is the alpha-L-rhamnosyl-(1->3)-beta-D-glucoside of hydroxytyrosol in which the hydroxy group at position 4 of the glucopyranosyl moiety has undergone esterification by formal condensation with trans-caffeic acid. | acteoside |
| albiflorin | A monoterpene glycoside with formula C23H28O11, originally isolated from the roots of Paeonia lactiflora. | albiflorin |
| amn082 | A diamine that is ethane-1,2-diamine in which both amino groups are substituted by diphenylmethyl groups. It is an allosteric agonist of the metabotropic glutamate receptor 7 (mGluR7). | N,N'-bis(diphenylmethyl)ethane-1,2-diamine |
| anacardic acid | A hydroxybenzoic acid that is salicylic acid substituted by a pentadecyl group at position 6. It is a major component of cashew nut shell liquid and exhibits an extensive range of bioactivities. | anacardic acid |
| apelin-12 peptide | A 12 amino acid oligopeptide fragment of apelin-13 lacking the terminal L-phenylalanine residue. | apelin-12 |
| apelin-13 peptide | A 13 amino acid oligopeptide which is the ligand for the apelin receptor (also known as the APJ receptor). It exhibits hypotensive and neuroprotective effects, and may be a potential prognostic biomarker for acute ischemic stroke and multiple sclerosis. | apelin-13 |
| arachidonyl-2-chloroethylamide | A fatty amide obtained by the formal condensation of arachidonic acid with 2-chloroethanamine. It is a potent agonist of the CB1 receptor (Ki = 1.4 nM) and also has a low affinity for the CB2 receptor (Ki = 3100 nM). | arachidonyl-2'-chloroethylamide |
| argon | | argon atom; argon(0) |
| astragaloside IV | A pentacyclic triterpenoid that is cycloastragenol having beta-D-xylopyranosyl and beta-D-glucopyranosyl residues attached at positions O-3 and O-6 respectively. It is isolated from Astragalus membranaceus var mongholicus. | astragaloside IV |
| astressin | A 30-membered homodetic cyclic peptide comprising the sequence D-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Nle-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Glu-Ala-His-Lys-Asn-Arg-Lys-Leu-Nle-Glu-Ile-Ile-NH2 cyclised by an amide bridge, formed by condensation of the side-chain carboxy group of the Glu residue at position 19 and the side-chain amino group of the Lys residue at position 22. | astressin |
| aurapten | A member of the class of coumarins that is umbelliferone in which the phenolic hydrogen has been replaced by a geranyl group. Ii is isolated from several edible fruits and vegetables and exhibits a variety of therapeutic properties. | auraptene |
| baicalin | The glycosyloxyflavone which is the 7-O-glucuronide of baicalein. It is an active ingredient of Chinese herbal medicine Scutellaria baicalensis. | baicalin |
| bis(7)-tacrine | A secondary amino compound consisting of two molecules of tacrine that are linked together through their exocyclic amino groups by a heptane-1,7-diyl chain. Bis(7)-tacrine is an acetylcholinesterase (AChE)inhibitor (IC50 0.40 nM, >1,000 times more potent than tacrine). It has also been found to protect against H2O2 -induced apoptosis in rat pheochromocytoma cells. | bis(7)-tacrine |
| caffeic acid phenethyl ester | An alkyl caffeate ester in which 2-phenylethyl is the alkyl component. | phenethyl caffeate |
| cannabigerol | A member of the class of resorcinols that is resorcinol which is substituted by a (2E)-3,7-dimethylocta-2,6-dien-1-yl group at position 2 and by a pentyl group at position 5. It is a natural product found in Cannabis sativa and Helichrysum species. | cannabigerol |
| carnosine | A dipeptide that is the N-(beta-alanyl) derivative of L-histidine. | carnosine zwitterion; carnosine |
| cgp 42112a | A hexapeptide consisting of L-tyrosine, L-lysine, L-histidine, L-proline and L-isoleucine amino acid residues coupled in sequence and in which the amino group of the L-tyrosyl residue is substituted by a (pyridin-3-ylcarbonyl)nitrilo group and in which the L-lysyl side chain amino group is substituted by a {N(2)-[(benzyloxy)carbonyl]-L-arginyl}nitrilo group. It is a potent angiotensin II receptor type 2 (AT2 receptor) agonist. | CGP-42112A |
| cilostazol | A lactam that is 3,4-dihydroquinolin-2(1H)-one in which the hydrogen at position 6 is substituted by a 4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy group. | cilostazol |
| creatine | A glycine derivative having methyl and amidino groups attached to the nitrogen. | creatine zwitterion; creatine |
| curcumin | A beta-diketone that is methane in which two of the hydrogens are substituted by feruloyl groups. A natural dyestuff found in the root of Curcuma longa. | curcumin |
| cyanidin | An anthocyanidin cation that is flavylium substituted at positions 3, 3', 4', 5 and 7 by hydroxy groups. | cyanidin cation |
| cycloheximide | A dicarboximide that is 4-(2-hydroxyethyl)piperidine-2,6-dione in which one of the hydrogens attached to the carbon bearing the hydroxy group is replaced by a 3,5-dimethyl-2-oxocyclohexyl group. It is an antibiotic produced by the bacterium Streptomyces griseus. | cycloheximide |
| cytidine diphosphate choline | A member of the class of phosphocholines that is the chloine ester of CDP. It is an intermediate obtained in the biosynthetic pathway of structural phospholipids in cell membranes. | CDP-choline |
| cytidine diphosphate choline | A member of the class of phosphocholines that is the chloine ester of CDP. It is an intermediate obtained in the biosynthetic pathway of structural phospholipids in cell membranes. | CDP-choline |
| dantrolene | The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia. | dantrolene |
| delta(9)-tetrahydrocannabinolic acid | A diterpenoid that is 6a,7,8,10a-tetrahydro-6H-benzo[c]chromene substituted at position 1 by a hydroxy group, positions 6, 6 and 9 by methyl groups and at position 3 by a pentyl group. A biosynthetic precursor to Delta(9)-tetrahydrocannabinol, the principal psychoactive constituent of the cannabis plant. | Delta(9)-tetrahydrocannabinolic acid |
| dihydrolipoic acid | A thio-fatty acid that is reduced form of lipoic acid. A potent antioxidant shown to directly destroy superoxide, hydroperoxy and hydroxyl radicals; also has neuroprotective and anti-tumour effects. | dihydrolipoic acid |
| dimethyloxalylglycine | A glycine derivative that is the diester obtained by formal condensation of the carboxy groups of N-oxalylglycine with two molecules of methanol. | dimethyloxalylglycine |
| dizocilpine | An organic heterotetracyclic compound that is 1-methyl-8-azabicyclo[3.2.1]octane ortho-fused to two benzene rings at positions 2-3 and 6-7 (the 5S,10R-stereoisomer). It is a non-competitive antagonist of the N-methyl-D-aspartate (NMDA) receptor and affects cognitive function, learning, and memory. | dizocilpine |
| dizocilpine maleate | A maleate salt obtained by reaction of dizocilpine with one equivalent of maleic acid. | dizocilpine maleate |
| ebselen | A benzoselenazole that is 1,2-benzoselenazol-3-one carrying an additional phenyl substituent at position 2. Acts as a mimic of glutathione peroxidase. | ebselen |
| epigallocatechin gallate | A gallate ester obtained by the formal condensation of gallic acid with the (3R)-hydroxy group of (-)-epigallocatechin. | (-)-epigallocatechin 3-gallate |
| etazolate | A pyrazolopyridine that is 1H-pyrazolo[3,4-b]pyridine which is substituted at positions 1, 4, and 5 by ethyl, 2-isopropylidenehydrazino, and ethoxycarbonyl groups, respectively. A phosphodiesterase IV inhibitor with antidepressant and anxiolytic properties. | etazolate |
| ethoxyquin | A quinoline that is 1,2-dihydroquinoline bearing three methyl substituents at position 2, 2 and 4 as well as an ethoxy substituent at position 6. | ethoxyquin |
| ethylisopropylamiloride | A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group. | ethylisopropylamiloride |
| fangchinoline | A bisbenzylisoquinoline alkaloid that is (1beta)- berbaman which has been substituted by methyl groups at the 2 and 2' positions, by methoxy groups at the 6, 6', and 12 positions, and by a hydroxy group at position 7. Isolated from Stephania tetrandra, it has been found to possess neuroprotective and anti-tumour activity. | fangchinoline |
| fasudil | An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia. | fasudil |
| fasudil hydrochloride | A hydrochloride obtained by reaction of fasudil with one equivalent of hydrochloric acid. | fasudil hydrochloride |
| felbamate | The bis(carbamate ester) of 2-phenylpropane-1,3-diol. An anticonvulsant, it is used in the treatment of epilepsy. | felbamate |
| ferrostatin-1 | An ethyl ester resulting from the formal condensation of the carboxy group of 3-amino-4-(cyclohexylamino)benzoic acid with ethanol. It is a potent inhibitor of ferroptosis, a distinct non-apoptotic form of cell death caused by lipid peroxidation. It is also a radical-trapping antioxidant and has the ability to reduce the accumulation of lipid peroxides and chain-carrying peroxyl radicals. | ferrostatin-1 |
| forapin | A 26-membered polypeptide consisting of Gly, Ile, Gly, Ala, Val, Leu, Lys, Val, Leu, Thr, Thr, Gly, Leu, Pro, Ala, Leu, Ile, Ser, Trp, Ile, Lys, Arg, Lys, Arg, Gln and Gln-NH2 residues joined in sequence. It is the principal active component of bee venom. | melittin |
| galgravin | A member of the class of aryltetrahydrofurans carrying two 3,4-dimethoxyphenyl substituents at positions 2 and 5 as well as two methyl groups at positions 3 and 4. | galgravin |
| germacrone | A germacrane sesquiterpenoid that has formula C15H22O. It is a natural product found in traditional medicinal plants of the family Zingiberaceae. The compound exhibits a range of pharmacological activities including anti-inflammatory, anticancer, antiviral, anti-androgenic, antioxidant, antimicrobial, antifungal, neuroprotective and insecticidal activities. | (E,E)-germacrone |
| ginsenoside rb1 | A ginsenoside found in Panax ginseng and Panax japonicus var. major that is ginsenoside Rd in which the beta-D-glucopyranoside group at position 20 is replaced by a beta-D-glucopyranosyl-beta-D-glucopyranoside group. | ginsenoside Rb1 |
| ginsenoside rb3 | A ginsenoside found in Panax species that is dammarane which is substituted by hydroxy groups at the 3beta, 12beta and 20 pro-S positions, in which the hydroxy groups at positions 3 and 20 have been converted to the corresponding beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranoside and beta-D-xylopyranosyl-(1->6)-beta-D-glucopyranoside respectively, and in which a double bond has been introduced at the 24-25 position. | ginsenoside Rb3 |
| ginsenoside rd | A ginsenoside found in Panax ginseng and Panax japonicus var. major that is (20S)-ginsenoside Rg3 in which the hydroxy group at position 20 has been converted to its beta-D-glucopyranoside. | ginsenoside Rd |
| ginsenoside re | A ginsenoside found in Panax ginseng that is dammarane which is substituted by hydroxy groups at the 3beta, 6alpha, 12beta and 20 pro-S positions, in which the hydroxy groups at positions 6 and 20 have been converted to the corresponding alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranoside and beta-D-glucopyranoside respectively, and in which a double bond has been introduced at the 24-25 position. | ginsenoside Re |
| ginsenoside rg1 | A ginsenoside found in Panax ginseng and Panax japonicus var. major that is dammarane which is substituted by hydroxy groups at the 3beta, 6alpha, 12beta and 20 pro-S positions, in which the hydroxy groups at positions 6 and 20 have been converted to the corresponding beta-D-glucopyranosides, and in which a double bond has been introduced at the 24-25 position. | ginsenoside Rg1 |
| glu-asp-arg | A tripeptide composed of L-glutamic acid, L-aspartic acid, and L-arginine joined in sequence by peptide linkages. | Glu-Asp-Arg |
| glycerylphosphorylcholine | A member of the class of phosphocholines that is the choline ester of sn-glycero-3-phosphate. It is one of the major osmolyte in the renal medullary cells. | choline alfoscerate |
| glycoursodeoxycholic acid | A bile acid glycine conjugate derived from ursoodeoxycholic acid. | glycoursodeoxycholic acid |
| gossypin | A glycosyloxyflavone that is gossypetin attached to a beta-D-glucopyranosyl residue at position 8 via a glycosidic linkage. | gossypin |
| hinokiflavone | A biflavonoid that is apigenin substituted by a 4-(5,7-dihydroxy-4-oxo-4H-chromen-2-yl)phenoxy group at position 6. A diflavonyl ether, it is isolated from Rhus succedanea and has been found to possess significant cytotoxic potential. | hinokiflavone |
| huperzine a | A sesquiterpene alkaloid isolated from a club moss Huperzia serrata that has been shown to exhibit neuroprotective activity. It is also an effective inhibitor of acetylcholinesterase and has attracted interest as a therapeutic candidate for Alzheimer's disease. | huperzine A |
| ilomastat | An N-acyl-amino acid obtained by formal condensation of the carboxy group of (2R)-2-[2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoic acid with the amino group of N-methyl-L-tryptophanamide. A cell permeable broad-spectrum matrix metalloproteinase (MMP) inhibitor | ilomastat |
| jasplakinolide | A cyclodepsipeptide isolated from Jaspis splendens and has been shown to exhibit antineoplastic activity. It is an actin polymerization and stabilization inducer. | jaspamide |
| kynurenic acid | A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4. | kynurenic acid |
| l 779976 | A member of the class of indoles that is (betaS)-beta-methyl-D-tryptophan in which the primary amino group undergoes formal condensation with the carboxy group of 4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidine-1-carboxylic acid and the carboxy group undegoes formal condensation with the amino group of (1R,3S)-cyclohexane-1,3-diyldimethanamine. It is a selective nonpeptidic agonist of the somatostatin subtype-2 (SST2) receptor with Ki of 0.05 nM. | L-779976 |
| lanthionine ketimine | A member of the class of 1,4-thiazines that is 3,6-dihydro-2H-1,4-thiazine substituted by carboxy groups at positions 3 and 5. It is a natural but non-proteogenic amino acid found in human urine and brain. | lanthionine ketimine |
| liraglutide | A lipopeptide that is an analogue of human GLP-1 in which the lysine residue at position 27 is replaced by arginine and a hexadecanoyl group attached to the remaining lysine via a glutamic acid spacer. Used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. | liraglutide |
| loganin | An iridoid monoterpenoid with formula C17H26O10 that is isolated from several plant species and exhibits neuroprotective and anti-inflammatory properties. | loganin |
| ly 379268 | An organic heterobicyclic compound that is (1R,5S)-2-oxabicyclo[3.1.0]hexane carrying amino, carboxy, and carboxy groups at positions 4R, 4R and 6R, respectively. It is a potent agonist of group II metabotropic glutamate receptors mGluR2 and mGluR3 (EC50 = 2.69 nM and 4.48 nM, respectively) that exhibits antipsychotic-like action in animal models of schizophrenia. | LY 379268 |
| maysin | A flavone C-glycoside that is luteolin attached to a disaccharide residue at position 6. It has been isolated from natural product Petrorhagia velutina and Zea mays and exhibits insecticidal and neuroprotective activities. | maysin |
| memantine | A primary aliphatic amine that is the 3,5-dimethyl derivative of 1-aminoadamantane. A low to moderate affinity uncompetitive (open-channel); NMDA receptor antagonist which binds preferentially to the NMDA receptor-operated cation channels. | memantine |
| memantine hydrochloride | A hydrochloride obtained by reaction of memantine with one equivalent of hydrochloric acid. A low to moderate affinity uncompetitive (open-channel); NMDA receptor antagonist which binds preferentially to the NMDA receptor-operated cation channels. | memantine hydrochloride |
| menatetrenone | A menaquinone whose side-chain contains 4 isoprene units in an all-trans-configuration. | menaquinone-4 |
| methyl 3,4-dihydroxybenzoate | A methyl ester resulting from the formal condensation of the carboxy group of 3,4-dihydroxybenzoic acid with methanol. | methyl 3,4-dihydroxybenzoate |
| methylene blue | An organic chloride salt having 3,7-bis(dimethylamino)phenothiazin-5-ium as the counterion. A commonly used dye that also exhibits antioxidant, antimalarial, antidepressant and cardioprotective properties. | methylene blue |
| methylparaben | A 4-hydroxybenzoate ester resulting from the formal condensation of the carboxy group of 4-hydroxybenzoic acid with methanol. It is the most frequently used antimicrobial preservative in cosmetics. It occurs naturally in several fruits, particularly in blueberries. | methylparaben |
| methylprednisolone | The 6alpha-stereoisomer of 6-methylprednisolone. | 6alpha-methylprednisolone |
| morin | A pentahydroxyflavone that is 7-hydroxyflavonol bearing three additional hydroxy substituents at positions 2' 4' and 5. | morin |
| n-(4-(n-(3-methoxypyrazin-2-yl)sulfamoyl)phenyl)-3-(5-nitrothiophene-2-yl)acrylamide | A sulfonamide that is a 3-methoxypyrazin-2-yl derivative of (E)-N-(4-(N-(4,6-dimethylpyrimidin-2-yl)sulfamoyl)phenyl)-3-(5-nitrothiophene-2-yl)acrylamide. Necrosulfonamide specifically blocks necrosis downstream of the activation of RIP3 (the receptor-interacting serine-threonine kinase 3), a key signalling molecule in the programmed necrosis (necroptosis) pathway. | necrosulfonamide |
| n-arachidonoyl l-serine | An N-acyl-amino acid resulting from the formal condensation of the carboxy group of arachidonic acid with the amino group of L-serine. It is an endocannabinoid-like lipid isolated from bovine brains. | N-arachidonoyl-L-serine |
| n-benzylhexadecanamide | A macamide resulting from the formal condensation of the carboxy group of hexadecanoic acid with benzylamine. A moderate inhibitor of fatty acid amide hydrolase. | N-benzylhexadecanamide |
| n,n'-dibenzhydrylethane-1,2-diamine dihydrochloride | A hydrochloride obtained by combining N,N'-bis(diphenylmethyl)ethane-1,2-diamine with two molar equivalent of hydrochloric acid. | AMN082 dihydrochloride |
| neriifolin | A cardenolide glycoside that is digitoxigenin in which the hydroxy goup at position 3 has been converted to its (6-deoxy-3-O-methyl-alpha-L-glucopyranoside derivative. Found in the seeds of Cerbera odollamand in Thevetia ahouia and Thevitia neriifolia. | neriifolin |
| niacinamide | A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group. | nicotinamide |
| nnc 55-0396 | The dihydrochloride salt of NNC 55-0396. It is a stable analogue of mibefradil and a highly selective T-type calcium channel blocker. | NNC 55-0396 dihydrochloride |
| NNC 55-0396 (free base) | | NNC 55-0396 (free base) |
| norvaline | A 2-aminopentanoic acid that has S-configuration. | L-2-aminopentanoic acid zwitterion; L-2-aminopentanoic acid |
| notoginsenoside r1 | A ginsenoside found in Panax notoginseng that is dammarane which is substituted by hydroxy groups at the 3beta, 6alpha, 12beta and 20 pro-S positions, in which the hydroxy groups at positions 6 and 20 have been converted to the corresponding beta-D-xylopyranosyl-(1->2)-beta-D-glucopyranoside and beta-D-glucopyranoside respectively, and in which a double bond has been introduced at the 24-25 position. | notoginsenoside R1 |
| np 031112 | A member of the class of thiadiazolidines that is 1,2,4-thiadiazolidine-3,5-dione which is substituted by a naphthalen-1-yl group at position 2 and by a benzyl group at position 4. It is a non-ATP competitive inhibitor of glycogen synthase kinase 3beta (GSK3beta) and has neuroprotective effects. Currently under clinical investigation for the treatment of Alzheimer's disease and progressive supranuclear palsy. | tideglusib |
| oleuropein aglycone | A secoiridoid that is the methyl ester of 3,4-dihydro-2H-pyran-5-carboxylic acid which is substituted at positions 2, 3, and 4 by hydroxy, ethylidene, and carboxymethyl groups, respectively and in which the carboxylic acid moiety of the carboxymethyl substituent has been converted to the corresponding 3,4-dihydroxyphenethyl ester (the 2R,3E,4S stereoisomer). The most important phenolic compound present in olive cultivars. | oleuropein aglycone |
| p-Glu-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe | A thirteen-membered polypeptide consisting of p-Glu, Arg, Pro, Arg, Leu, Ser, His, Lys, Gly, Pro, Met, Pro and Phe residues joined in sequence. | p-Glu-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe |
| palmidrol | An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid. | palmitoyl ethanolamide |
| phenylisopropyladenosine | A hydrocarbyladenosine in which adenosine is substituted at N-6 by a (2R)-1-phenylpropan-2-yl group. It is a potent adenosine A1 receptor agonist that exhibits neuroprotective and antinociceptive properties. | (-)-N(6)-(2-phenylisopropyl)adenosine; (-)-n6-(2-phenylisopropyl)adenosine |
| pinocembrin | A dihydroxyflavanone in which the two hydroxy groups are located at positions 5 and 7. A natural product found in Piper sarmentosum and Cryptocarya chartacea. | pinocembrin |
| pj-34 | A member of the class of phenanthridines that is 5,6-dihydrophenanthridine substituted at positions 2 and 6 by (N,N-dimethylglycyl)amino and oxo groups, respectively. It is a potent inhibitor of poly(ADP-ribose) polymerases PARP1 and PARP2 (IC50 of 110 nM and 86 nM, respectively) and exhibits anti-cancer, cardioprotective and neuroprotective properties. | PJ34 |
| pn 401 | An acetate ester that is uracil in which the three hydroxy hydrogens are replaced by acetate group. A prodrug for uridine, it is used for the treatment of hereditary orotic aciduria and for management of fluorouracil toxicity. | uridine triacetate |
| protectin d1 | A dihydroxydocosahexaenoic acid that is (4Z,7Z,11E,13E,15Z,19Z)-docosahexaenoic acid in which the two hydroxy substituents are located at positions 10 and 17 (the 10R,17S-stereoisomer). Protectin D1 is one of the specialised proresolving mediators. When produced in neural tissues, it is called neuroprotectin D1 | protectin D1 |
| pterostilbene | A stilbenol that consists of trans-stilbene bearing a hydroxy group at position 4 as well as two methoxy substituents at positions 3' and 5'. | pterostilbene |
| pyrrolidine dithiocarbamate | A member of the class of dithiocarbamic acids that is the N-dithiocarboxy derivative of pyrrolidine. | pyrrolidine dithiocarbamate |
| rasagiline | An indane that consists of 1-aminoindane bearing an N-propargyl substituent. A selective, irreversible monoamine oxidase-B inhibitor. | rasagiline |
| rhapontin | A rhaponticin in which the double bond adopts a trans-configuration. It possesses a range of pharmacological activities including antitumour, antiinflammatory, antilipemic and neuroprotective activities. | trans-rhaponticin |
| rifampin | A member of the class of rifamycins that is a a semisynthetic antibiotic derived from Amycolatopsis rifamycinica (previously known as Amycolatopsis mediterranei and Streptomyces mediterranei). | rifampicin zwitterion; rifampicin |
| rivastigmine | A carbamate ester obtained by formal condensation of the carboxy group of ethyl(methyl)carbamic acid with the phenolic OH group of 3-[(1S)-1-(dimethylamino)ethyl]phenol. A reversible cholinesterase inhibitor. | rivastigmine |
| ro 25-6981 | A member of the class of piperidines that is 4-benzylpiperidine substituted by a 3-hydroxy-3-(4-hydroxyphenyl)-2-methylpropyl group at position 1 (the 1R,2S-stereoisomer). It is a potent antagonist of the GluN2B subunit of the N-methyl-D-aspartate (NMDA) receptor. | Ro 25-6981 |
| rubimaillin | A benzochromene that is 2H-benzo[h]chromene which is substituted by two methyl groups at position 2, a methoxycarbonyl group at position 5, and a hydroxy group at position 6. Found in the Chinese medical plant Rubia cordifola, It has an anti-cancer effect by inhibition of TNF-alpha-induced NF-kappaB activation. It is also a dual inhibitor of acyl-CoA:cholesterol acyltransferase 1 and 2 (ACAT1 and ACAT2), but is more selective for the ACAT2 isozyme. | rubimaillin |
| s-methylthiocitrulline | An L-arginine derivative in which the guanidino NH2 group of L-arginine is replaced by a methylsufanyl group. | S-methyl-L-thiocitrulline |
| salvianolic acid B | A member of the class of 1-benzofurans that is an antioxidant and free radical scavenging compound extracted from S. miltiorrhiza | salvianolic acid B |
| salvigenin | A trimethoxyflavone that is scutellarein in which the hydroxy groups at positions 4', 6, and 7 are replaced by methoxy groups. | salvigenin |
| sb 203580 | A member of the class of imidazoles carrying 4-methylsulfinylphenyl, 4-pyridyl and 4-fluorophenyl substituents at positions 2, 4 and 5 respectively. An inhibitor of mitogen-activated protein kinase. | SB 203580 |
| sb 415286 | A member of the class of maleimides carrying 3-chloro-4-hydroxyphenylamino and 2-nitrophenyl substituents at positions 3 and 4 respectively. | SB 415286 |
| schizandrin b | An organic heterotetracyclic compound that is found in Fructus Schisandrae and Schisandra chinensis. | (+)-schisandrin B; Deoxygomisin A |
| sdz eaa 494 | A member of the class of piperazines that is piperazine substituted by a carboxy group at position 2R and a (1E)-1-phosphonoprop-1-en-3-yl group at position 4. It is an antagonist of N-methyl-D-aspartate receptors (NMDARs) and was in clinical development by Novartis for the treatment of cognition disorders and brain injuries (now discontinued). | midafotel |
| semaglutide | A polypeptide that contains a linear sequence of 31 amino acids joined together by peptide linkages. It is an agonist of glucagon-like peptide-1 receptors (GLP-1 AR) and used for the treatment of type 2 diabetes. | semaglutide |
| sesamin | A lignan that consists of tetrahydro-1H,3H-furo[3,4-c]furan substituted by 1,3-benzodioxole groups at positions 1 and 4 (the 1S,3aR,4S,6aR stereoisomer). Isolated from Cinnamomum camphora, it exhibits cytotoxic activity. | (+)-sesamin |
| SL-327 | A nitrile that is acrylonitrile in which the hydrogen attached to the same carbon as the cyano group has been replaced by an o-(trifluoromethyl)phenyl group, while the remaining hydrogens of the ethenyl group have been replaced by amino and (4-aminophenyl)sulfanyl groups. The configuration of the double bond is not specified. It is an inhibitor of MEK1 and MEK2. | SL-327 |
| su 11248 | | sunitinib |
| ta 0910 | An oligopeptide comprising of (4S)-1-methyl-2,6-dioxohexahydropyrimidine-4-carboxylic acid, L-histidine and L-prolinamide joined in sequence by peptide linkages. It is a thyrotropin-releasing hormone (TRH) analog. Its tetrahydrate form is approved in Japan for the treatment of spinal muscular atrophy. | taltirelin |
| tempol | A member of the class of aminoxyls that is TEMPO carrying a hydroxy substituent at position 4. It is a radical scavenger which exhibits anti-inflammatory and analgesic properties. | 4-hydroxy-TEMPO |
| tenocyclidine | A tertiary amino compound that consists of cyclohexane having piperidin-1-yl and thiophen-2-yl groups attached at position 1. A dissociative anaesthetic drug with halluccinogenic and stimulant effects. Its effects are similar to those of phencyclidine (PCP, an analogue with the thienyl group replaced by phenyl), but it is rather more potent. | tenocyclidine |
| tetrahydroxycurcumin | A beta-diketone that is curcumin in which the two methoxy groups have been replaced by hydroxy groups. It is a metabolite of curcumin. | tetrahydroxycurcumin |
| tetramethylpyrazine | A member of the class of pyrazines that is pyrazine in which all four hydrogens have been replaced by methyl groups. An alkaloid extracted from Chuanxiong (Ligusticum wallichii). | tetramethylpyrazine |
| theanine | A N(5)-alkylglutamine where the alkyl group is ethyl. It has been isolated from green tea. | N(5)-ethyl-L-glutamine zwitterion; N(5)-ethyl-L-glutamine |
| tocotrienol, alpha | A tocotrienol that is chroman-6-ol substituted by methyl groups at positions 2, 5, 7 and 8 and a farnesyl chain at position 2. It has been found in palm oil derived from Elaeis guineensis. | alpha-tocotrienol |
| ursodoxicoltaurine | A bile acid taurine conjugate derived from ursoodeoxycholic acid. | tauroursodeoxycholic acid |
| valproic acid | A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem. | valproic acid |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | Homo sapiens (human) | Potency | 23.2702 | 1 | 25 |
| 15-lipoxygenase, partial | Homo sapiens (human) | Potency | 17.2427 | 1 | 13 |
| 2,3-bisphosphoglycerate-independent phosphoglycerate mutase | Leishmania major strain Friedlin | Potency | 3.7928 | 1 | 2 |
| 67.9K protein | Vaccinia virus | Potency | 12.6741 | 2 | 7 |
| acetylcholinesterase | Homo sapiens (human) | Potency | 24.2214 | 4 | 21 |
| acid sphingomyelinase | Homo sapiens (human) | Potency | 26.7449 | 1 | 4 |
| activating transcription factor 6 | Homo sapiens (human) | Potency | 36.2178 | 2 | 13 |
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | Potency | 10.0000 | 1 | 1 |
| aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 23.8117 | 1 | 30 |
| alpha-galactosidase | Homo sapiens (human) | Potency | 28.0048 | 5 | 9 |
| Alpha-synuclein | Homo sapiens (human) | Potency | 11.5355 | 1 | 11 |
| Amyloid-beta precursor protein | Homo sapiens (human) | Potency | 22.7265 | 1 | 2 |
| apical membrane antigen 1, AMA1 | Plasmodium falciparum 3D7 | Potency | 11.4622 | 1 | 7 |
| AR protein | Homo sapiens (human) | Potency | 17.2591 | 12 | 98 |
| aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 24.9302 | 3 | 26 |
| arylsulfatase A | Homo sapiens (human) | Potency | 13.4847 | 1 | 7 |
| ATAD5 protein, partial | Homo sapiens (human) | Potency | 13.9937 | 4 | 18 |
| Ataxin-2 | Homo sapiens (human) | Potency | 18.5019 | 2 | 15 |
| ATP-dependent phosphofructokinase | Trypanosoma brucei brucei TREU927 | Potency | 8.8146 | 5 | 17 |
| ATPase family AAA domain-containing protein 5 | Homo sapiens (human) | Potency | 20.9901 | 2 | 15 |
| atrial natriuretic peptide receptor 1 precursor | Homo sapiens (human) | Potency | 14.7637 | 1 | 3 |
| atrial natriuretic peptide receptor 2 precursor | Homo sapiens (human) | Potency | 26.1216 | 1 | 2 |
| beta-2 adrenergic receptor | Homo sapiens (human) | Potency | 11.4012 | 2 | 2 |
| Bloom syndrome protein isoform 1 | Homo sapiens (human) | Potency | 12.5921 | 2 | 15 |
| BRCA1 | Homo sapiens (human) | Potency | 17.7828 | 1 | 1 |
| bromodomain adjacent to zinc finger domain 2B | Homo sapiens (human) | Potency | 46.8458 | 1 | 14 |
| C-terminal-binding protein 1 | Homo sapiens (human) | Potency | 16.9469 | 1 | 1 |
| caspase 7, apoptosis-related cysteine protease | Homo sapiens (human) | Potency | 19.1717 | 1 | 2 |
| caspase-1 isoform alpha precursor | Homo sapiens (human) | Potency | 29.0941 | 1 | 3 |
| caspase-3 | Cricetulus griseus (Chinese hamster) | Potency | 72.8099 | 1 | 3 |
| caspase-3 | Homo sapiens (human) | Potency | 19.1717 | 1 | 2 |
| Caspase-7 | Cricetulus griseus (Chinese hamster) | Potency | 72.8099 | 1 | 3 |
| Caspase-7 | Homo sapiens (human) | Potency | 14.2191 | 1 | 2 |
| Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 25.9997 | 3 | 24 |
| cellular tumor antigen p53 isoform a | Homo sapiens (human) | Potency | 17.1765 | 2 | 7 |
| Chain A, 2-oxoglutarate Oxygenase | Homo sapiens (human) | Potency | 25.6977 | 1 | 26 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | Homo sapiens (human) | Potency | 20.2224 | 2 | 7 |
| Chain A, Beta-lactamase | Escherichia coli K-12 | Potency | 22.5455 | 2 | 9 |
| Chain A, Breast cancer type 1 susceptibility protein | Homo sapiens (human) | Potency | 5.0119 | 1 | 3 |
| Chain A, Cruzipain | Trypanosoma cruzi | Potency | 30.0335 | 2 | 6 |
| Chain A, Ferritin light chain | Equus caballus (horse) | Potency | 26.5076 | 2 | 13 |
| Chain A, HADH2 protein | Homo sapiens (human) | Potency | 17.9864 | 2 | 32 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | Homo sapiens (human) | Potency | 57.9438 | 1 | 14 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | Homo sapiens (human) | Potency | 16.4640 | 2 | 24 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | 21.4513 | 3 | 16 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | Homo sapiens (human) | Potency | 16.5252 | 2 | 21 |
| Chain B, HADH2 protein | Homo sapiens (human) | Potency | 17.9864 | 2 | 32 |
| chaperonin GroEL | Methanococcus maripaludis S2 | Potency | 100.0000 | 1 | 1 |
| chaperonin-containing TCP-1 beta subunit homolog | Homo sapiens (human) | Potency | 22.3872 | 1 | 1 |
| chromobox protein homolog 1 | Homo sapiens (human) | Potency | 34.9093 | 2 | 20 |
| CREB-binding protein | Homo sapiens (human) | Potency | 5.4415 | 3 | 3 |
| cytochrome P450 2C19 precursor | Homo sapiens (human) | Potency | 12.8640 | 1 | 9 |
| cytochrome P450 2C9 precursor | Homo sapiens (human) | Potency | 17.5202 | 1 | 11 |
| cytochrome P450 2C9, partial | Homo sapiens (human) | Potency | 12.1309 | 1 | 9 |
| cytochrome P450 2D6 | Homo sapiens (human) | Potency | 11.9654 | 1 | 7 |
| cytochrome P450 2D6 isoform 1 | Homo sapiens (human) | Potency | 17.4859 | 1 | 9 |
| cytochrome P450 3A4 isoform 1 | Homo sapiens (human) | Potency | 15.3207 | 2 | 48 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | Homo sapiens (human) | Potency | 11.4590 | 1 | 8 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 18.5490 | 1 | 14 |
| D(1A) dopamine receptor | Homo sapiens (human) | Potency | 10.4436 | 3 | 11 |
| D(1A) dopamine receptor | Sus scrofa (pig) | Potency | 10.7469 | 1 | 3 |
| Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) | Potency | 25.1189 | 1 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3F isoform a | Homo sapiens (human) | Potency | 26.2564 | 1 | 5 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | Potency | 27.2454 | 2 | 3 |
| DNA polymerase beta | Homo sapiens (human) | Potency | 12.9714 | 1 | 8 |
| DNA polymerase eta isoform 1 | Homo sapiens (human) | Potency | 52.9872 | 1 | 6 |
| DNA polymerase III, partial | Bacillus subtilis | Potency | 11.8160 | 1 | 2 |
| DNA polymerase iota isoform a (long) | Homo sapiens (human) | Potency | 52.6760 | 2 | 17 |
| DNA polymerase kappa isoform 1 | Homo sapiens (human) | Potency | 25.2048 | 1 | 17 |
| dopamine D1 receptor | Homo sapiens (human) | Potency | 13.8373 | 1 | 3 |
| endonuclease IV | Escherichia coli | Potency | 13.7521 | 1 | 3 |
| Endothelin receptor type B | Rattus norvegicus (Norway rat) | Potency | 22.3872 | 1 | 1 |
| Endothelin-1 receptor | Rattus norvegicus (Norway rat) | Potency | 22.3872 | 1 | 1 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 22.6219 | 11 | 94 |
| estrogen receptor 2 (ER beta) | Homo sapiens (human) | Potency | 13.6866 | 2 | 6 |
| estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 14.0075 | 10 | 68 |
| euchromatic histone-lysine N-methyltransferase 2 | Homo sapiens (human) | Potency | 15.4611 | 1 | 45 |
| EWS/FLI fusion protein | Homo sapiens (human) | Potency | 18.7629 | 4 | 28 |
| eyes absent homolog 2 isoform a | Homo sapiens (human) | Potency | 8.4936 | 1 | 1 |
| farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 35.0795 | 4 | 13 |
| flap endonuclease 1 | Homo sapiens (human) | Potency | 39.4580 | 2 | 16 |
| fructose-bisphosphate aldolase A | Oryctolagus cuniculus (rabbit) | Potency | 74.1396 | 1 | 2 |
| Fumarate hydratase | Homo sapiens (human) | Potency | 26.1931 | 1 | 5 |
| G | Vesicular stomatitis virus | Potency | 12.1309 | 1 | 9 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | Potency | 15.4282 | 1 | 25 |
| galactokinase | Homo sapiens (human) | Potency | 10.0000 | 1 | 1 |
| GALC protein | Homo sapiens (human) | Potency | 0.7079 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Potency | 15.4282 | 1 | 25 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Potency | 15.4282 | 1 | 25 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Potency | 15.4282 | 1 | 25 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Potency | 15.4282 | 1 | 25 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Potency | 15.4282 | 1 | 25 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Potency | 15.4282 | 1 | 25 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Potency | 15.4282 | 1 | 25 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Potency | 15.4282 | 1 | 25 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Potency | 15.4282 | 1 | 25 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Potency | 15.4282 | 1 | 25 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Potency | 15.4282 | 1 | 25 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Potency | 15.4282 | 1 | 25 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Potency | 15.4282 | 1 | 25 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Potency | 15.4282 | 1 | 25 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Potency | 15.4282 | 1 | 25 |
| geminin | Homo sapiens (human) | Potency | 14.1043 | 4 | 48 |
| GLI family zinc finger 3 | Homo sapiens (human) | Potency | 15.5458 | 3 | 36 |
| glp-1 receptor, partial | Homo sapiens (human) | Potency | 10.3004 | 1 | 11 |
| GLS protein | Homo sapiens (human) | Potency | 10.9099 | 2 | 22 |
| glucocerebrosidase | Homo sapiens (human) | Potency | 30.3112 | 1 | 14 |
| glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 45.6556 | 4 | 31 |
| glucokinase regulatory protein | Homo sapiens (human) | Potency | 20.4297 | 2 | 4 |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | Potency | 20.4755 | 1 | 8 |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Glycoprotein hormones alpha chain | Homo sapiens (human) | Potency | 0.5012 | 1 | 1 |
| GTP-binding nuclear protein Ran isoform 1 | Homo sapiens (human) | Potency | 22.2175 | 1 | 4 |
| Guanine nucleotide-binding protein G | Homo sapiens (human) | Potency | 12.1897 | 2 | 5 |
| guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1 | Homo sapiens (human) | Potency | 12.5893 | 1 | 1 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | Homo sapiens (human) | Potency | 11.7350 | 2 | 9 |
| heat shock protein beta-1 | Homo sapiens (human) | Potency | 46.2502 | 2 | 10 |
| hemoglobin subunit beta | Homo sapiens (human) | Potency | 39.8107 | 1 | 1 |
| hexokinase-4 isoform 1 | Homo sapiens (human) | Potency | 20.4297 | 2 | 4 |
| Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | Potency | 14.0566 | 2 | 63 |
| histone acetyltransferase KAT2A isoform 1 | Homo sapiens (human) | Potency | 13.1993 | 1 | 8 |
| histone deacetylase 9 isoform 3 | Homo sapiens (human) | Potency | 18.5888 | 2 | 5 |
| Histone H2A.x | Cricetulus griseus (Chinese hamster) | Potency | 31.9662 | 2 | 12 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | Homo sapiens (human) | Potency | 39.1902 | 1 | 6 |
| HLA class I histocompatibility antigen, B alpha chain | Homo sapiens (human) | Potency | 12.1309 | 1 | 9 |
| huntingtin isoform 2 | Homo sapiens (human) | Potency | 22.5284 | 1 | 6 |
| hypothetical protein, conserved | Trypanosoma brucei | Potency | 19.9534 | 4 | 10 |
| hypoxia-inducible factor 1 alpha subunit | Homo sapiens (human) | Potency | 42.0152 | 2 | 10 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | Homo sapiens (human) | Potency | 11.4922 | 2 | 14 |
| IDH1 | Homo sapiens (human) | Potency | 16.1018 | 1 | 12 |
| importin subunit beta-1 isoform 1 | Homo sapiens (human) | Potency | 28.0621 | 2 | 7 |
| Inositol hexakisphosphate kinase 1 | Homo sapiens (human) | Potency | 12.1309 | 1 | 18 |
| Inositol monophosphatase 1 | Rattus norvegicus (Norway rat) | Potency | 7.4763 | 1 | 6 |
| Integrin alpha-IIb | Homo sapiens (human) | Potency | 27.8298 | 1 | 2 |
| Integrin beta-3 | Homo sapiens (human) | Potency | 27.8298 | 1 | 2 |
| Interferon beta | Homo sapiens (human) | Potency | 14.8817 | 3 | 34 |
| interleukin 8 | Homo sapiens (human) | Potency | 75.3096 | 1 | 3 |
| isocitrate dehydrogenase 1, partial | Homo sapiens (human) | Potency | 50.7856 | 1 | 3 |
| lamin isoform A-delta10 | Homo sapiens (human) | Potency | 9.2025 | 2 | 15 |
| lethal factor (plasmid) | Bacillus anthracis str. A2012 | Potency | 10.9167 | 1 | 14 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | Homo sapiens (human) | Potency | 23.7358 | 1 | 2 |
| Luciferase | Photinus pyralis (common eastern firefly) | Potency | 26.9489 | 4 | 19 |
| luciferase | Photuris pensylvanica (Pennsylania firefly) | Potency | 16.7324 | 3 | 6 |
| luteinizing hormone receptor | Homo sapiens (human) | Potency | 84.9214 | 1 | 1 |
| lysosomal alpha-glucosidase preproprotein | Homo sapiens (human) | Potency | 13.2997 | 2 | 7 |
| M-phase phosphoprotein 8 | Homo sapiens (human) | Potency | 30.3448 | 1 | 11 |
| Microtubule-associated protein tau | Homo sapiens (human) | Potency | 12.8271 | 2 | 35 |
| mitogen-activated protein kinase 1 | Homo sapiens (human) | Potency | 19.2701 | 2 | 17 |
| muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | Potency | 6.9975 | 2 | 12 |
| muscleblind-like protein 1 isoform 1 | Homo sapiens (human) | Potency | 30.3093 | 1 | 7 |
| neuropeptide S receptor isoform A | Homo sapiens (human) | Potency | 6.1802 | 3 | 9 |
| NFKB1 protein, partial | Homo sapiens (human) | Potency | 8.2084 | 2 | 14 |
| nonstructural protein 1 | Influenza A virus (A/WSN/1933(H1N1)) | Potency | 7.4542 | 1 | 9 |
| NPC intracellular cholesterol transporter 1 precursor | Homo sapiens (human) | Potency | 27.0829 | 1 | 5 |
| Nrf2 | Homo sapiens (human) | Potency | 20.8964 | 2 | 6 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 66.9046 | 4 | 40 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | Homo sapiens (human) | Potency | 9.2785 | 2 | 8 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | Homo sapiens (human) | Potency | 21.5933 | 1 | 5 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | Homo sapiens (human) | Potency | 37.1337 | 1 | 3 |
| Nuclear receptor ROR-gamma | Homo sapiens (human) | Potency | 28.5731 | 1 | 5 |
| nuclear receptor ROR-gamma isoform 1 | Mus musculus (house mouse) | Potency | 16.0509 | 2 | 51 |
| nuclear receptor subfamily 1, group I, member 2 | Rattus norvegicus (Norway rat) | Potency | 1.5849 | 1 | 1 |
| nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 20.8267 | 3 | 33 |
| Ornithine decarboxylase | Rattus norvegicus (Norway rat) | Potency | 5.0050 | 1 | 2 |
| P53 | Homo sapiens (human) | Potency | 28.1838 | 1 | 1 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | Homo sapiens (human) | Potency | 78.1522 | 1 | 8 |
| Parkin | Homo sapiens (human) | Potency | 27.2873 | 2 | 6 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | Potency | 59.7050 | 2 | 6 |
| peripheral myelin protein 22 | Rattus norvegicus (Norway rat) | Potency | 21.8286 | 2 | 7 |
| peripheral myelin protein 22 isoform 1 | Homo sapiens (human) | Potency | 58.1560 | 1 | 7 |
| peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 62.6405 | 5 | 29 |
| peroxisome proliferator-activated receptor delta | Homo sapiens (human) | Potency | 29.4753 | 5 | 16 |
| phosphoglycerate kinase | Trypanosoma brucei brucei TREU927 | Potency | 20.8584 | 2 | 2 |
| phosphopantetheinyl transferase | Bacillus subtilis | Potency | 40.5054 | 3 | 24 |
| PINK1 | Homo sapiens (human) | Potency | 35.6221 | 1 | 3 |
| plasminogen precursor | Mus musculus (house mouse) | Potency | 6.2058 | 1 | 8 |
| polyprotein | Zika virus | Potency | 26.1931 | 1 | 5 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | Homo sapiens (human) | Potency | 16.3715 | 1 | 8 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) | Potency | 10.2468 | 1 | 15 |
| potassium voltage-gated channel subfamily H member 2 isoform d | Homo sapiens (human) | Potency | 16.1367 | 1 | 10 |
| PPM1D protein | Homo sapiens (human) | Potency | 15.7059 | 1 | 14 |
| pregnane X nuclear receptor | Homo sapiens (human) | Potency | 26.3093 | 3 | 13 |
| pregnane X receptor | Rattus norvegicus (Norway rat) | Potency | 124.4425 | 1 | 7 |
| progesterone receptor | Homo sapiens (human) | Potency | 29.7102 | 3 | 16 |
| putative alpha-glucosidase | Oryza sativa Japonica Group (Japanese rice) | Potency | 39.8107 | 1 | 1 |
| pyruvate kinase | Leishmania mexicana mexicana | Potency | 16.8088 | 5 | 7 |
| pyruvate kinase PKM isoform a | Homo sapiens (human) | Potency | 16.4427 | 4 | 10 |
| pyruvate kinase PKM isoform b | Homo sapiens (human) | Potency | 5.0050 | 2 | 4 |
| Rap guanine nucleotide exchange factor 3 | Homo sapiens (human) | Potency | 67.5438 | 2 | 4 |
| RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 20.1912 | 2 | 18 |
| ras-related protein Rab-9A | Homo sapiens (human) | Potency | 32.3304 | 1 | 6 |
| regulator of G-protein signaling 4 | Homo sapiens (human) | Potency | 9.9653 | 1 | 11 |
| relaxin receptor 1 isoform 1 | Homo sapiens (human) | Potency | 8.3558 | 2 | 2 |
| relaxin receptor 2 isoform 1 | Homo sapiens (human) | Potency | 43.6206 | 1 | 1 |
| retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 25.7628 | 3 | 34 |
| retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 20.2463 | 4 | 31 |
| RGS12 | Homo sapiens (human) | Potency | 12.5893 | 1 | 1 |
| serine-protein kinase ATM isoform a | Homo sapiens (human) | Potency | 14.8981 | 4 | 5 |
| serine/threonine-protein kinase mTOR isoform 1 | Homo sapiens (human) | Potency | 14.1874 | 3 | 13 |
| serine/threonine-protein kinase PLK1 | Homo sapiens (human) | Potency | 22.4850 | 1 | 4 |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | Potency | 5.7988 | 1 | 1 |
| SMAD family member 2 | Homo sapiens (human) | Potency | 33.2578 | 3 | 8 |
| SMAD family member 3 | Homo sapiens (human) | Potency | 33.2578 | 3 | 8 |
| Smad3 | Homo sapiens (human) | Potency | 18.3652 | 1 | 15 |
| snurportin-1 | Homo sapiens (human) | Potency | 28.0621 | 2 | 7 |
| Sodium channel protein type 1 subunit alpha | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Sodium channel protein type 2 subunit alpha | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Sodium channel protein type 3 subunit alpha | Rattus norvegicus (Norway rat) | Potency | 5.7988 | 1 | 1 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | Potency | 34.3555 | 1 | 6 |
| survival motor neuron protein isoform d | Homo sapiens (human) | Potency | 13.1627 | 1 | 15 |
| T cell receptor, partial | Homo sapiens (human) | Potency | 6.2841 | 1 | 1 |
| TAR DNA-binding protein 43 | Homo sapiens (human) | Potency | 19.4563 | 1 | 10 |
| TDP1 protein | Homo sapiens (human) | Potency | 15.3825 | 2 | 94 |
| thioredoxin glutathione reductase | Schistosoma mansoni | Potency | 36.4499 | 1 | 7 |
| thioredoxin reductase | Rattus norvegicus (Norway rat) | Potency | 25.9686 | 4 | 35 |
| Thrombopoietin | Homo sapiens (human) | Potency | 6.2308 | 2 | 12 |
| thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 26.2518 | 3 | 35 |
| thyroid hormone receptor beta isoform a | Homo sapiens (human) | Potency | 33.3458 | 4 | 10 |
| thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 20.8871 | 7 | 39 |
| thyrotropin-releasing hormone receptor | Homo sapiens (human) | Potency | 27.7247 | 1 | 1 |
| transcriptional regulator ERG isoform 3 | Homo sapiens (human) | Potency | 15.8489 | 1 | 1 |
| transient receptor potential cation channel subfamily V member 1 | Homo sapiens (human) | Potency | 25.7877 | 1 | 2 |
| TSHR protein | Homo sapiens (human) | Potency | 15.5035 | 2 | 2 |
| tumor susceptibility gene 101 protein | Homo sapiens (human) | Potency | 19.9526 | 1 | 1 |
| tyrosine-protein kinase Yes | Homo sapiens (human) | Potency | 5.4792 | 1 | 2 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | Homo sapiens (human) | Potency | 21.8058 | 2 | 2 |
| urokinase plasminogen activator surface receptor precursor | Mus musculus (house mouse) | Potency | 6.2058 | 1 | 8 |
| urokinase-type plasminogen activator precursor | Mus musculus (house mouse) | Potency | 6.2058 | 1 | 8 |
| USP1 protein, partial | Homo sapiens (human) | Potency | 43.4111 | 2 | 18 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 19.6715 | 2 | 16 |
| vasopressin V1b receptor | Homo sapiens (human) | Potency | 21.8621 | 1 | 1 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | Homo sapiens (human) | Potency | 40.1969 | 5 | 15 |
| vitamin D3 receptor isoform VDRA | Homo sapiens (human) | Potency | 37.7717 | 1 | 15 |
| Voltage-dependent calcium channel gamma-2 subunit | Mus musculus (house mouse) | Potency | 20.4755 | 1 | 8 |
| Vpr | Human immunodeficiency virus 1 | Potency | 25.3621 | 1 | 3 |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| [tau protein] kinase | Oryctolagus cuniculus (rabbit) | IC50 | 2.0000 | 1 | 1 |
| [Tau protein] kinase | Sus scrofa (pig) | IC50 | 2.9350 | 4 | 4 |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | Homo sapiens (human) | IC50 | 5.9775 | 2 | 4 |
| 10 kDa chaperonin | Escherichia coli | IC50 | 27.5800 | 4 | 8 |
| 10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | IC50 | 30.4000 | 2 | 4 |
| 17-beta-hydroxysteroid dehydrogenase type 2 | Homo sapiens (human) | IC50 | 1.7300 | 1 | 1 |
| 3-oxoacyl-[acyl-carrier-protein] reductase | Plasmodium falciparum 3D7 | IC50 | 0.3200 | 1 | 1 |
| 3-oxoacyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 1.3000 | 1 | 2 |
| 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 | Homo sapiens (human) | IC50 | 7.2833 | 1 | 6 |
| 4-hydroxyphenylpyruvate dioxygenase | Arabidopsis thaliana (thale cress) | IC50 | 73.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | Ki | 0.0032 | 1 | 1 |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | Ki | 0.0048 | 5 | 5 |
| 5-hydroxytryptamine receptor 1B | Homo sapiens (human) | Ki | 0.0035 | 1 | 1 |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | Ki | 0.2015 | 3 | 4 |
| 5-hydroxytryptamine receptor 1D | Homo sapiens (human) | Ki | 0.0054 | 1 | 1 |
| 5-hydroxytryptamine receptor 1D | Rattus norvegicus (Norway rat) | Ki | 0.0020 | 1 | 1 |
| 5-hydroxytryptamine receptor 1F | Rattus norvegicus (Norway rat) | Ki | 0.0020 | 1 | 1 |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | Ki | 0.1524 | 2 | 2 |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | Ki | 0.5571 | 7 | 7 |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | Ki | 0.5571 | 7 | 7 |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | Ki | 0.0450 | 1 | 1 |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | Ki | 0.5500 | 8 | 8 |
| 5-hydroxytryptamine receptor 4 | Homo sapiens (human) | Ki | 0.1362 | 2 | 2 |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | Ki | 0.0465 | 3 | 3 |
| 5-hydroxytryptamine receptor 7 | Cavia porcellus (domestic guinea pig) | IC50 | 27.2000 | 1 | 2 |
| 5-hydroxytryptamine receptor 7 | Homo sapiens (human) | IC50 | 200.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 7 | Homo sapiens (human) | Ki | 0.0035 | 2 | 2 |
| 5-hydroxytryptamine receptor 7 | Rattus norvegicus (Norway rat) | Ki | 0.0009 | 1 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-1 | Homo sapiens (human) | IC50 | 0.1580 | 1 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-2 | Homo sapiens (human) | IC50 | 0.0617 | 1 | 1 |
| 6-phosphogluconate dehydrogenase, decarboxylating | Homo sapiens (human) | IC50 | 0.7200 | 1 | 1 |
| 60 kDa chaperonin | Escherichia coli K-12 | IC50 | 250.0000 | 1 | 3 |
| 60 kDa chaperonin | Escherichia coli | IC50 | 27.5800 | 4 | 8 |
| 60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | IC50 | 30.4000 | 2 | 4 |
| 72 kDa type IV collagenase | Homo sapiens (human) | IC50 | 2.6670 | 15 | 20 |
| 72 kDa type IV collagenase | Homo sapiens (human) | Ki | 0.0004 | 3 | 3 |
| A disintegrin and metalloproteinase with thrombospondin motifs 4 | Homo sapiens (human) | IC50 | 0.4800 | 1 | 1 |
| A disintegrin and metalloproteinase with thrombospondin motifs 5 | Homo sapiens (human) | IC50 | 0.5000 | 1 | 1 |
| Acetylcholine receptor subunit epsilon | Rattus norvegicus (Norway rat) | IC50 | 9.0000 | 1 | 1 |
| Acetylcholinesterase | Electrophorus electricus (electric eel) | IC50 | 43.6823 | 45 | 51 |
| Acetylcholinesterase | Homo sapiens (human) | IC50 | 60.4402 | 69 | 74 |
| Acetylcholinesterase | Mus musculus (house mouse) | IC50 | 4.5904 | 5 | 5 |
| Acetylcholinesterase | Rattus norvegicus (Norway rat) | IC50 | 3.9418 | 27 | 30 |
| Acetylcholinesterase | Tetronarce californica (Pacific electric ray) | IC50 | 187.2000 | 1 | 1 |
| Acetylcholinesterase | Homo sapiens (human) | Ki | 0.0016 | 2 | 4 |
| Acetylcholinesterase | Mus musculus (house mouse) | Ki | 5.6800 | 1 | 1 |
| Acetylcholinesterase | Bos taurus (cattle) | IC50 | 0.3600 | 2 | 2 |
| Acetylcholinesterase | Bos taurus (cattle) | Ki | 0.0013 | 4 | 4 |
| Acyl carrier protein, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| Acyl-CoA desaturase 1 | Rattus norvegicus (Norway rat) | IC50 | 1.7100 | 1 | 1 |
| Adenosine receptor A1 | Homo sapiens (human) | IC50 | 1.8900 | 2 | 2 |
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | IC50 | 0.0294 | 4 | 5 |
| Adenosine receptor A1 | Bos taurus (cattle) | Ki | 0.0082 | 3 | 3 |
| Adenosine receptor A1 | Homo sapiens (human) | Ki | 0.5538 | 4 | 4 |
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | Ki | 0.0248 | 18 | 21 |
| Adenosine receptor A2a | Homo sapiens (human) | IC50 | 6.0680 | 1 | 1 |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | IC50 | 0.2898 | 2 | 4 |
| Adenosine receptor A2a | Homo sapiens (human) | Ki | 1.6852 | 4 | 4 |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | Ki | 2.4882 | 12 | 13 |
| Adenosine receptor A2b | Rattus norvegicus (Norway rat) | IC50 | 0.2899 | 2 | 4 |
| Adenosine receptor A2b | Homo sapiens (human) | Ki | 1.7000 | 1 | 1 |
| Adenosine receptor A2b | Rattus norvegicus (Norway rat) | Ki | 2.6838 | 11 | 12 |
| Adenosine receptor A3 | Rattus norvegicus (Norway rat) | IC50 | 0.0497 | 1 | 2 |
| Adenosine receptor A3 | Homo sapiens (human) | Ki | 8.5083 | 4 | 4 |
| Adenosine receptor A3 | Rattus norvegicus (Norway rat) | Ki | 0.0166 | 5 | 5 |
| Adenylate cyclase type 5 | Rattus norvegicus (Norway rat) | Ki | 0.0087 | 1 | 2 |
| ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 | Homo sapiens (human) | IC50 | 21.8000 | 1 | 1 |
| Aldo-keto reductase family 1 member A1 | Bos taurus (cattle) | IC50 | 57.4000 | 1 | 1 |
| Aldo-keto reductase family 1 member A1 | Homo sapiens (human) | IC50 | 50.0500 | 2 | 2 |
| Aldo-keto reductase family 1 member A1 | Rattus norvegicus (Norway rat) | IC50 | 53.1000 | 2 | 2 |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | IC50 | 2.0650 | 2 | 2 |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | IC50 | 47.3812 | 6 | 6 |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | Ki | 0.9500 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | Ki | 3.7560 | 1 | 1 |
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | IC50 | 0.1833 | 3 | 3 |
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | Ki | 0.0460 | 1 | 1 |
| Aldo-keto reductase family 1 member B7 | Rattus norvegicus (Norway rat) | IC50 | 56.1000 | 1 | 1 |
| Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | IC50 | 21.1200 | 2 | 2 |
| Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | IC50 | 15.8800 | 2 | 2 |
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | IC50 | 2.7050 | 2 | 2 |
| Aldo-keto reductase family 1 member C4 | Homo sapiens (human) | IC50 | 5.2750 | 2 | 2 |
| ALK tyrosine kinase receptor | Homo sapiens (human) | IC50 | 1.1773 | 2 | 2 |
| alkaline phosphatase, germ cell type preproprotein | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| alkaline phosphatase, intestinal | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Alpha-(1,3)-fucosyltransferase 7 | Homo sapiens (human) | IC50 | 7.2833 | 1 | 6 |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 2.9500 | 1 | 2 |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | Ki | 0.1800 | 1 | 1 |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 0.0210 | 1 | 1 |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 2.9500 | 1 | 2 |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | Ki | 0.1800 | 1 | 1 |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 2.9500 | 1 | 2 |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | Ki | 0.1800 | 1 | 1 |
| Alpha-amylase 1A | Homo sapiens (human) | IC50 | 1,400.0000 | 1 | 1 |
| Alpha-synuclein | Homo sapiens (human) | IC50 | 46.0640 | 4 | 5 |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | IC50 | 59.4436 | 45 | 46 |
| Amine oxidase [flavin-containing] A | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | Ki | 4.5300 | 5 | 7 |
| Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | IC50 | 80.6986 | 4 | 5 |
| Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | Ki | 0.0142 | 1 | 1 |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | IC50 | 3.8622 | 57 | 59 |
| Amine oxidase [flavin-containing] B | Mus musculus (house mouse) | IC50 | 0.3000 | 2 | 2 |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | IC50 | 1.9798 | 6 | 8 |
| Amine oxidase [flavin-containing] B | Bos taurus (cattle) | Ki | 0.5000 | 1 | 1 |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | Ki | 4.4222 | 8 | 10 |
| Amine oxidase [flavin-containing] B | Mus musculus (house mouse) | Ki | 0.5000 | 1 | 1 |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | Ki | 0.1739 | 3 | 3 |
| Aminopeptidase N | Homo sapiens (human) | IC50 | 15.5000 | 1 | 1 |
| Aminopeptidase N | Sus scrofa (pig) | IC50 | 15.5000 | 1 | 1 |
| Amyloid-beta precursor protein | Homo sapiens (human) | IC50 | 12.2806 | 39 | 40 |
| Androgen receptor | Rattus norvegicus (Norway rat) | IC50 | 226.6300 | 2 | 2 |
| Androgen receptor | Rattus norvegicus (Norway rat) | Ki | 17.7860 | 1 | 1 |
| Angiopoietin-1 receptor | Homo sapiens (human) | IC50 | 10.0090 | 2 | 2 |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | IC50 | 1.1100 | 1 | 2 |
| Anthrax toxin receptor 2 | Homo sapiens (human) | IC50 | 300.0000 | 1 | 1 |
| AP2-associated protein kinase 1 | Homo sapiens (human) | IC50 | 0.0462 | 2 | 2 |
| Apelin receptor | Homo sapiens (human) | IC50 | 0.0012 | 1 | 1 |
| Apelin receptor | Homo sapiens (human) | Ki | 0.0007 | 6 | 6 |
| Apelin receptor | Rattus norvegicus (Norway rat) | Ki | 0.0003 | 1 | 1 |
| Apoptosis regulator Bcl-2 | Homo sapiens (human) | IC50 | 0.4500 | 1 | 1 |
| Apoptosis regulator Bcl-2 | Homo sapiens (human) | Ki | 0.3622 | 2 | 2 |
| Apoptotic peptidase activating factor 1 | Homo sapiens (human) | IC50 | 57.7500 | 2 | 2 |
| Arginase | Leishmania amazonensis | Ki | 0.7000 | 1 | 1 |
| Arginase-1 | Bos taurus (cattle) | IC50 | 285.0000 | 1 | 1 |
| Aromatase | Homo sapiens (human) | IC50 | 2.1795 | 2 | 4 |
| Arrestin, beta 1 | Homo sapiens (human) | IC50 | 1.5240 | 1 | 1 |
| Arylacetamide deacetylase | Homo sapiens (human) | Ki | 300.0000 | 1 | 1 |
| ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | IC50 | 111.6667 | 1 | 3 |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | IC50 | 14.0822 | 3 | 3 |
| Aurora kinase A | Homo sapiens (human) | IC50 | 1.8370 | 1 | 1 |
| Aurora kinase B | Homo sapiens (human) | IC50 | 7.3675 | 2 | 4 |
| Bcl-2-like protein 1 | Homo sapiens (human) | IC50 | 0.5900 | 1 | 1 |
| Bcl-2-like protein 10 | Homo sapiens (human) | IC50 | 0.3600 | 1 | 1 |
| Bcl-2-like protein 2 | Homo sapiens (human) | IC50 | 2.3300 | 1 | 1 |
| Bcl-2-related protein A1 | Homo sapiens (human) | IC50 | 1.7900 | 1 | 1 |
| Bcl2-associated agonist of cell death | Homo sapiens (human) | Ki | 0.4900 | 1 | 1 |
| Beta lactamase (plasmid) | Pseudomonas aeruginosa | IC50 | 7.7510 | 1 | 1 |
| Beta-adrenergic receptor kinase 1 | Bos taurus (cattle) | IC50 | 130.0000 | 1 | 1 |
| Beta-casein | Bos taurus (cattle) | IC50 | 100.0000 | 1 | 3 |
| Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein) | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 2.8100 | 2 | 3 |
| Beta-secretase 1 | Homo sapiens (human) | IC50 | 68.5497 | 10 | 11 |
| BH3-interacting domain death agonist | Homo sapiens (human) | IC50 | 1.0733 | 6 | 6 |
| Bifunctional epoxide hydrolase 2 | Homo sapiens (human) | IC50 | 2.2590 | 6 | 6 |
| Bifunctional epoxide hydrolase 2 | Mus musculus (house mouse) | IC50 | 0.4220 | 1 | 1 |
| Bifunctional epoxide hydrolase 2 | Rattus norvegicus (Norway rat) | IC50 | 0.3700 | 1 | 1 |
| Bile acid receptor | Homo sapiens (human) | IC50 | 49.8550 | 2 | 2 |
| Bile salt export pump | Homo sapiens (human) | IC50 | 432.4689 | 6 | 18 |
| Bile salt export pump | Rattus norvegicus (Norway rat) | IC50 | 678.2333 | 1 | 3 |
| Bile salt export pump | Rattus norvegicus (Norway rat) | Ki | 11.9000 | 1 | 1 |
| Breakpoint cluster region protein | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | IC50 | 26.1260 | 5 | 5 |
| C-C chemokine receptor type 2 | Homo sapiens (human) | IC50 | 35.0000 | 2 | 2 |
| C-C motif chemokine 2 | Homo sapiens (human) | IC50 | 6.9183 | 1 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | Homo sapiens (human) | IC50 | 1,000.0000 | 1 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | Homo sapiens (human) | Ki | 60.0000 | 1 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | Homo sapiens (human) | IC50 | 1,000.0000 | 1 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | Homo sapiens (human) | Ki | 60.0000 | 1 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | Homo sapiens (human) | IC50 | 1,000.0000 | 1 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | Homo sapiens (human) | Ki | 60.0000 | 1 | 1 |
| cAMP-dependent protein kinase catalytic subunit alpha | Bos taurus (cattle) | IC50 | 21.4434 | 2 | 15 |
| cAMP-dependent protein kinase catalytic subunit alpha | Homo sapiens (human) | IC50 | 27.2900 | 2 | 2 |
| cAMP-dependent protein kinase catalytic subunit alpha | Homo sapiens (human) | Ki | 0.4600 | 1 | 1 |
| cAMP-dependent protein kinase catalytic subunit alpha | Mus musculus (house mouse) | Ki | 0.4950 | 1 | 2 |
| cAMP-dependent protein kinase catalytic subunit beta | Homo sapiens (human) | IC50 | 27.2900 | 2 | 2 |
| cAMP-dependent protein kinase catalytic subunit beta | Homo sapiens (human) | Ki | 0.4600 | 1 | 1 |
| cAMP-dependent protein kinase catalytic subunit gamma | Homo sapiens (human) | IC50 | 27.2900 | 2 | 2 |
| cAMP-dependent protein kinase catalytic subunit gamma | Homo sapiens (human) | Ki | 0.4600 | 1 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | IC50 | 0.3900 | 1 | 1 |
| Canalicular multispecific organic anion transporter 1 | Homo sapiens (human) | IC50 | 106.3333 | 1 | 3 |
| Canalicular multispecific organic anion transporter 1 | Rattus norvegicus (Norway rat) | Ki | 7.9500 | 1 | 1 |
| Cannabinoid receptor 1 | Homo sapiens (human) | IC50 | 0.4579 | 9 | 9 |
| Cannabinoid receptor 1 | Homo sapiens (human) | Ki | 1.3418 | 73 | 82 |
| Cannabinoid receptor 1 | Mus musculus (house mouse) | Ki | 0.0186 | 4 | 4 |
| Cannabinoid receptor 1 | Rattus norvegicus (Norway rat) | Ki | 152,001.9136 | 6 | 6 |
| Cannabinoid receptor 2 | Mus musculus (house mouse) | Ki | 0.0060 | 1 | 1 |
| Cannabinoid receptor 2 | Homo sapiens (human) | IC50 | 0.5820 | 6 | 6 |
| Cannabinoid receptor 2 | Homo sapiens (human) | Ki | 0.9041 | 72 | 81 |
| Carbonic anhydrase 1 | Homo sapiens (human) | Ki | 9.5850 | 2 | 6 |
| Carbonic anhydrase 12 | Homo sapiens (human) | Ki | 0.8900 | 1 | 2 |
| Carbonic anhydrase 14 | Homo sapiens (human) | Ki | 2.4950 | 1 | 2 |
| Carbonic anhydrase 2 | Homo sapiens (human) | Ki | 9.6967 | 2 | 6 |
| Carbonic anhydrase 3 | Bos taurus (cattle) | Ki | 13.5500 | 1 | 4 |
| Carbonic anhydrase 4 | Homo sapiens (human) | Ki | 13.5500 | 1 | 4 |
| Carbonic anhydrase 7 | Homo sapiens (human) | Ki | 0.7950 | 1 | 2 |
| Carbonic anhydrase 9 | Homo sapiens (human) | Ki | 3.1450 | 1 | 2 |
| Carboxylic ester hydrolase | Equus caballus (horse) | IC50 | 0.3333 | 3 | 3 |
| Carboxylic ester hydrolase | Rattus norvegicus (Norway rat) | IC50 | 14.7998 | 12 | 12 |
| Carboxylic ester hydrolase | Equus caballus (horse) | Ki | 0.0020 | 3 | 3 |
| Casein kinase I isoform alpha | Homo sapiens (human) | IC50 | 0.0010 | 1 | 1 |
| Casein kinase I isoform delta | Homo sapiens (human) | IC50 | 0.4147 | 3 | 3 |
| Casein kinase I isoform epsilon | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
| Casein kinase II subunit alpha | Homo sapiens (human) | IC50 | 24.1660 | 5 | 5 |
| Casein kinase II subunit alpha 3 | Homo sapiens (human) | IC50 | 5.2550 | 2 | 2 |
| Casein kinase II subunit alpha' | Homo sapiens (human) | IC50 | 24.1660 | 5 | 5 |
| Casein kinase II subunit beta | Homo sapiens (human) | IC50 | 24.1660 | 5 | 5 |
| Caspase-1 | Homo sapiens (human) | IC50 | 6.1795 | 2 | 2 |
| caspase-3 isoform a preproprotein | Homo sapiens (human) | IC50 | 17.0000 | 1 | 1 |
| caspase-9 isoform alpha precursor | Homo sapiens (human) | IC50 | 17.0000 | 1 | 1 |
| Cationic trypsin | Bos taurus (cattle) | IC50 | 110.8000 | 1 | 1 |
| CDGSH iron-sulfur domain-containing protein 1 | Homo sapiens (human) | IC50 | 2.3600 | 1 | 1 |
| CDGSH iron-sulfur domain-containing protein 1 | Homo sapiens (human) | Ki | 0.1010 | 1 | 1 |
| Cell division control protein 42 homolog | Homo sapiens (human) | IC50 | 6.5000 | 2 | 2 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | IC50 | 0.3285 | 4 | 4 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | Ki | 12.0000 | 1 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | IC50 | 0.4367 | 3 | 3 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | Ki | 12.0000 | 1 | 1 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | IC50 | 11.4760 | 1 | 1 |
| Chain A, Acetylcholinesterase | Tetronarce californica (Pacific electric ray) | Ki | 0.2500 | 1 | 1 |
| Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit | Bos taurus (cattle) | IC50 | 2.2800 | 1 | 5 |
| Chain A, Erk2 | Homo sapiens (human) | Ki | 0.0004 | 1 | 1 |
| Chain A, Exotoxin A | Pseudomonas aeruginosa | Ki | 0.1400 | 1 | 1 |
| Chain A, NAD-dependent deacetylase | Thermotoga maritima | IC50 | 1,000.0000 | 1 | 1 |
| Chain A, POLYMERASE PA | Influenza A virus | IC50 | 1.9000 | 1 | 1 |
| Chain A, Polymerase Pa | Influenza A virus (A/California/04/2009(H1N1)) | IC50 | 1.9000 | 1 | 4 |
| Chain A, Rho-associated protein kinase 1 | Homo sapiens (human) | Ki | 0.5300 | 1 | 3 |
| Chain B, Rho-associated protein kinase 1 | Homo sapiens (human) | Ki | 0.5300 | 1 | 1 |
| Chain E, cAMP-dependent protein kinase, alpha-catalytic subunit | Mus musculus (house mouse) | Ki | 0.5300 | 1 | 1 |
| Chain E, Fibrin beta chain | Homo sapiens (human) | IC50 | 46.2655 | 2 | 2 |
| Chain I, cAMP-dependent protein kinase inhibitor alpha | synthetic construct | IC50 | 2.2800 | 1 | 2 |
| Chain I, cAMP-dependent protein kinase inhibitor, alpha form | synthetic construct | Ki | 0.5300 | 1 | 1 |
| Cholecystokinin receptor type A | Homo sapiens (human) | Ki | 0.3020 | 1 | 1 |
| Cholesteryl ester transfer protein | Homo sapiens (human) | IC50 | 0.0400 | 1 | 1 |
| Cholinesterase | Canis lupus familiaris (dog) | IC50 | 5,003.1350 | 1 | 2 |
| Cholinesterase | Equus caballus (horse) | IC50 | 14.3796 | 30 | 31 |
| Cholinesterase | Homo sapiens (human) | IC50 | 193.2368 | 49 | 53 |
| Cholinesterase | Mus musculus (house mouse) | IC50 | 0.5557 | 3 | 3 |
| Cholinesterase | Equus caballus (horse) | Ki | 0.0020 | 1 | 1 |
| Cholinesterase | Homo sapiens (human) | Ki | 0.0002 | 1 | 1 |
| Citron Rho-interacting kinase | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
| Class A sortase SrtA | Staphylococcus aureus | IC50 | 20.0560 | 5 | 5 |
| CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 | Homo sapiens (human) | IC50 | 7.2833 | 1 | 6 |
| Coagulation factor VII | Homo sapiens (human) | Ki | 8,000.0000 | 1 | 1 |
| Cocaine esterase | Homo sapiens (human) | Ki | 7,900.0000 | 1 | 1 |
| Collagenase 3 | Homo sapiens (human) | IC50 | 0.0036 | 3 | 3 |
| Complex I intermediate-associated protein 30, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| Corticotropin-releasing factor receptor 2 | Homo sapiens (human) | Ki | 5.0000 | 1 | 1 |
| COUP transcription factor 2 isoform a | Homo sapiens (human) | IC50 | 1.3150 | 1 | 1 |
| CPG DNA methylase | Spiroplasma monobiae | Ki | 0.0280 | 1 | 1 |
| CREB-binding protein | Homo sapiens (human) | IC50 | 33.3333 | 6 | 6 |
| Cruzipain | Trypanosoma cruzi | IC50 | 89.5000 | 2 | 4 |
| Cyclin-A1 | Homo sapiens (human) | IC50 | 15.1900 | 2 | 2 |
| Cyclin-A2 | Homo sapiens (human) | IC50 | 13.4600 | 3 | 3 |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | IC50 | 60.7514 | 4 | 7 |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | IC50 | 42.5950 | 4 | 4 |
| Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | IC50 | 13.4700 | 3 | 3 |
| Cyclin-dependent kinase 7 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Cyclin-dependent kinase 9 | Homo sapiens (human) | IC50 | 14.0000 | 2 | 2 |
| Cyclin-dependent-like kinase 5 | Homo sapiens (human) | IC50 | 13.4700 | 3 | 3 |
| Cyclin-G-associated kinase | Homo sapiens (human) | IC50 | 0.4133 | 3 | 3 |
| Cyclin-H | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Cyclin-T1 | Homo sapiens (human) | IC50 | 14.0000 | 2 | 2 |
| Cysteine protease | Trypanosoma brucei rhodesiense | IC50 | 7.7500 | 1 | 1 |
| Cytochrome c oxidase subunit NDUFA4 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| Cytochrome P450 1A1 | Homo sapiens (human) | IC50 | 7.9060 | 1 | 1 |
| Cytochrome P450 1A1 | Homo sapiens (human) | Ki | 0.5700 | 1 | 2 |
| Cytochrome P450 1A2 | Homo sapiens (human) | IC50 | 1.7455 | 2 | 2 |
| Cytochrome P450 1B1 | Homo sapiens (human) | IC50 | 1.6790 | 1 | 1 |
| Cytochrome P450 1B1 | Homo sapiens (human) | Ki | 0.9100 | 1 | 1 |
| Cytochrome P450 2A6 | Homo sapiens (human) | Ki | 9,150.0000 | 1 | 1 |
| Cytochrome P450 2C19 | Homo sapiens (human) | IC50 | 0.4027 | 2 | 2 |
| Cytochrome P450 2C19 | Homo sapiens (human) | Ki | 0.0020 | 1 | 1 |
| Cytochrome P450 2C8 | Homo sapiens (human) | IC50 | 0.1400 | 1 | 1 |
| Cytochrome P450 2C9 | Homo sapiens (human) | IC50 | 4.1254 | 2 | 3 |
| Cytochrome P450 2D6 | Homo sapiens (human) | IC50 | 2.0000 | 1 | 1 |
| Cytochrome P450 3A4 | Homo sapiens (human) | IC50 | 0.0527 | 4 | 5 |
| Cytochrome P450 3A5 | Homo sapiens (human) | IC50 | 40.0000 | 1 | 1 |
| D-amino-acid oxidase | Sus scrofa (pig) | IC50 | 1.0700 | 2 | 2 |
| Death-associated protein kinase 1 | Homo sapiens (human) | IC50 | 54.2000 | 2 | 3 |
| Dehydrogenase/reductase SDR family member 9 | Homo sapiens (human) | IC50 | 1,000.0000 | 1 | 1 |
| Delta-type opioid receptor | Mus musculus (house mouse) | IC50 | 18.0087 | 3 | 3 |
| Delta-type opioid receptor | Homo sapiens (human) | Ki | 26.0000 | 1 | 1 |
| Diacylglycerol lipase-alpha | Homo sapiens (human) | IC50 | 63.6500 | 1 | 2 |
| Dihydrolipoyl dehydrogenase | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 1,000.0000 | 1 | 1 |
| Dihydrolipoyl dehydrogenase, mitochondrial | Sus scrofa (pig) | IC50 | 1,000.0000 | 1 | 1 |
| Dipeptidyl peptidase 3 | Homo sapiens (human) | IC50 | 85.0000 | 1 | 1 |
| Dipeptidyl peptidase 4 | Homo sapiens (human) | IC50 | 117.6050 | 2 | 2 |
| Disintegrin and metalloproteinase domain-containing protein 10 | Homo sapiens (human) | IC50 | 0.1356 | 2 | 2 |
| Disintegrin and metalloproteinase domain-containing protein 12 | Homo sapiens (human) | IC50 | 0.0059 | 1 | 1 |
| Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) | IC50 | 5.3344 | 4 | 4 |
| Disintegrin and metalloproteinase domain-containing protein 9 | Homo sapiens (human) | IC50 | 0.0286 | 2 | 2 |
| DNA (cytosine-5)-methyltransferase 1 | Homo sapiens (human) | IC50 | 0.5000 | 1 | 1 |
| DNA gyrase subunit A | Mycobacterium tuberculosis H37Rv | IC50 | 50.0000 | 1 | 1 |
| DNA gyrase subunit B | Mycobacterium tuberculosis H37Rv | IC50 | 50.0000 | 1 | 1 |
| DNA repair protein RAD52 homolog | Homo sapiens (human) | IC50 | 2.5108 | 5 | 5 |
| DNA topoisomerase 1 | Homo sapiens (human) | IC50 | 250.0000 | 1 | 4 |
| DNA topoisomerase 2-alpha | Homo sapiens (human) | IC50 | 250.0000 | 1 | 4 |
| DNA-3-methyladenine glycosylase | Homo sapiens (human) | IC50 | 2.6000 | 1 | 1 |
| DNA-dependent protein kinase catalytic subunit | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| DNA-directed RNA polymerase subunit beta | Escherichia coli O127:H6 str. E2348/69 | IC50 | 511.3333 | 3 | 3 |
| DNA-directed RNA polymerase subunit beta | Mycobacterium tuberculosis H37Rv | IC50 | 0.0100 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens (human) | IC50 | 61.0000 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 2 | Homo sapiens (human) | IC50 | 61.0000 | 1 | 1 |
| Dual specificity protein kinase CLK1 | Homo sapiens (human) | IC50 | 0.0710 | 1 | 1 |
| Dual specificity protein kinase CLK1 | Mus musculus (house mouse) | IC50 | 0.0360 | 4 | 4 |
| Dual specificity protein kinase CLK2 | Mus musculus (house mouse) | IC50 | 0.3900 | 3 | 3 |
| Dual specificity protein kinase CLK3 | Mus musculus (house mouse) | IC50 | 6.0500 | 4 | 4 |
| Dual specificity protein kinase CLK4 | Mus musculus (house mouse) | IC50 | 0.0393 | 3 | 3 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | IC50 | 1.3531 | 11 | 11 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Rattus norvegicus (Norway rat) | IC50 | 0.1050 | 4 | 4 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1B | Homo sapiens (human) | IC50 | 0.0550 | 4 | 4 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Homo sapiens (human) | IC50 | 0.0855 | 4 | 4 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 3 | Homo sapiens (human) | IC50 | 0.4167 | 3 | 3 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 4 | Homo sapiens (human) | IC50 | 0.5200 | 1 | 1 |
| Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | Homo sapiens (human) | IC50 | 10.3000 | 1 | 1 |
| Endothelial PAS domain-containing protein 1 | Homo sapiens (human) | IC50 | 0.0360 | 1 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | IC50 | 0.0300 | 1 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | Escherichia coli K-12 | IC50 | 10.0000 | 2 | 2 |
| Enoyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 1.8167 | 2 | 3 |
| Enoyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | Ki | 0.0910 | 3 | 3 |
| Ephrin type-B receptor 2 | Homo sapiens (human) | IC50 | 7.8000 | 1 | 1 |
| Ephrin type-B receptor 4 | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| Epidermal growth factor receptor | Homo sapiens (human) | IC50 | 61.2223 | 18 | 20 |
| Estrogen receptor | Homo sapiens (human) | IC50 | 7.9120 | 1 | 1 |
| Estrogen receptor | Homo sapiens (human) | Ki | 2.2600 | 1 | 1 |
| estrogen receptor beta isoform 1 | Homo sapiens (human) | IC50 | 2.9272 | 1 | 2 |
| Eukaryotic initiation factor 4A-I | Homo sapiens (human) | IC50 | 0.1390 | 4 | 4 |
| eukaryotic translation initiation factor 4 gamma 1 isoform 4 | Homo sapiens (human) | IC50 | 1.1500 | 1 | 1 |
| eukaryotic translation initiation factor 4E isoform 1 | Mus musculus (house mouse) | IC50 | 1.1500 | 1 | 1 |
| Fatty acid synthase | Gallus gallus (chicken) | IC50 | 68.0000 | 3 | 3 |
| Fatty acid synthase | Homo sapiens (human) | IC50 | 51.9700 | 1 | 1 |
| Fatty-acid amide hydrolase 1 | Homo sapiens (human) | IC50 | 250.4500 | 2 | 2 |
| Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | IC50 | 4.1559 | 2 | 2 |
| Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | Ki | 0.0269 | 1 | 1 |
| Fibroblast growth factor receptor 1 | Homo sapiens (human) | IC50 | 4.5190 | 4 | 6 |
| Focal adhesion kinase 1 | Homo sapiens (human) | IC50 | 1.6000 | 1 | 1 |
| G protein-coupled receptor kinase 5 | Homo sapiens (human) | IC50 | 0.8300 | 1 | 1 |
| G-protein coupled receptor 35 | Homo sapiens (human) | IC50 | 20.3000 | 2 | 2 |
| G-protein coupled receptor 35 | Homo sapiens (human) | Ki | 137.0000 | 1 | 1 |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | IC50 | 60.7514 | 4 | 7 |
| G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | IC50 | 36.9667 | 2 | 3 |
| G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | IC50 | 36.9667 | 2 | 3 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | Ki | 33.3355 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Homo sapiens (human) | IC50 | 1,453.0000 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Homo sapiens (human) | Ki | 77.6247 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Ki | 33.3355 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Homo sapiens (human) | IC50 | 1,453.0000 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Homo sapiens (human) | Ki | 77.6247 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Ki | 35.2184 | 3 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Homo sapiens (human) | IC50 | 1,453.0000 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Homo sapiens (human) | Ki | 77.6247 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Ki | 33.3355 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Homo sapiens (human) | IC50 | 1,453.0000 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Homo sapiens (human) | Ki | 77.6247 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Ki | 33.3355 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Homo sapiens (human) | IC50 | 1,453.0000 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Homo sapiens (human) | Ki | 77.6247 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Ki | 33.3355 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Homo sapiens (human) | IC50 | 1,453.0000 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Homo sapiens (human) | Ki | 77.6247 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Ki | 33.3355 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Homo sapiens (human) | IC50 | 1,453.0000 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Homo sapiens (human) | Ki | 77.6247 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Ki | 33.3355 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Homo sapiens (human) | IC50 | 1,453.0000 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Homo sapiens (human) | Ki | 77.6247 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Ki | 33.3355 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Homo sapiens (human) | IC50 | 1,453.0000 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Homo sapiens (human) | Ki | 77.6247 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Ki | 33.3355 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit delta | Homo sapiens (human) | IC50 | 6.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | Homo sapiens (human) | Ki | 77.6247 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Ki | 33.3355 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit epsilon | Homo sapiens (human) | IC50 | 6.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | Homo sapiens (human) | Ki | 77.6247 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Ki | 33.3355 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Homo sapiens (human) | IC50 | 6.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Homo sapiens (human) | Ki | 77.6247 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Ki | 33.3355 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Homo sapiens (human) | IC50 | 6.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Homo sapiens (human) | Ki | 77.6247 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Ki | 33.3355 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Homo sapiens (human) | IC50 | 6.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Homo sapiens (human) | Ki | 77.6247 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Ki | 33.3355 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit pi | Homo sapiens (human) | IC50 | 6.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | Homo sapiens (human) | Ki | 77.6247 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Ki | 33.3355 | 2 | 3 |
| Gamma-aminobutyric acid receptor subunit theta | Homo sapiens (human) | IC50 | 6.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit theta | Homo sapiens (human) | Ki | 77.6247 | 1 | 1 |
| Gamma-butyrobetaine dioxygenase | Homo sapiens (human) | IC50 | 10.9517 | 6 | 6 |
| Gamma-butyrobetaine dioxygenase | Homo sapiens (human) | Ki | 16.0000 | 1 | 1 |
| Gastrin/cholecystokinin type B receptor | Homo sapiens (human) | Ki | 0.3020 | 1 | 1 |
| Genome polyprotein | Zika virus | IC50 | 87.0000 | 1 | 1 |
| Glucagon-like peptide 1 receptor | Homo sapiens (human) | IC50 | 0.0024 | 2 | 2 |
| Glucagon-like peptide 1 receptor | Homo sapiens (human) | Ki | 0.0054 | 2 | 2 |
| Glucocorticoid receptor | Homo sapiens (human) | IC50 | 0.0110 | 1 | 1 |
| Glucocorticoid receptor | Homo sapiens (human) | Ki | 0.0050 | 1 | 1 |
| Glucose transporter | Leishmania mexicana | IC50 | 0.2420 | 1 | 1 |
| Glucose-6-phosphate 1-dehydrogenase | Saccharomyces cerevisiae S288C | IC50 | 0.2500 | 1 | 1 |
| glucose-6-phosphate 1-dehydrogenase isoform b | Homo sapiens (human) | IC50 | 13.2000 | 1 | 1 |
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | Plasmodium berghei | IC50 | 15.0867 | 3 | 3 |
| Glutamate receptor 1 | Rattus norvegicus (Norway rat) | IC50 | 118.0000 | 2 | 3 |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | IC50 | 118.0000 | 2 | 3 |
| Glutamate receptor 3 | Rattus norvegicus (Norway rat) | IC50 | 118.0000 | 2 | 3 |
| Glutamate receptor 4 | Rattus norvegicus (Norway rat) | IC50 | 118.0000 | 2 | 3 |
| Glutamate receptor ionotropic, kainate 1 | Rattus norvegicus (Norway rat) | IC50 | 820.0000 | 2 | 5 |
| Glutamate receptor ionotropic, kainate 2 | Rattus norvegicus (Norway rat) | IC50 | 820.0000 | 2 | 5 |
| Glutamate receptor ionotropic, kainate 3 | Rattus norvegicus (Norway rat) | IC50 | 820.0000 | 2 | 5 |
| Glutamate receptor ionotropic, kainate 4 | Rattus norvegicus (Norway rat) | IC50 | 820.0000 | 2 | 5 |
| Glutamate receptor ionotropic, kainate 5 | Rattus norvegicus (Norway rat) | IC50 | 820.0000 | 2 | 5 |
| Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | IC50 | 3.5675 | 17 | 17 |
| Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | Ki | 0.2637 | 6 | 8 |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | IC50 | 29.4422 | 31 | 37 |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | Ki | 0.5349 | 8 | 12 |
| Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | IC50 | 7.6094 | 12 | 12 |
| Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | Ki | 0.1833 | 4 | 6 |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | IC50 | 33.7748 | 26 | 31 |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | Ki | 0.0926 | 7 | 11 |
| Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | IC50 | 3.0328 | 12 | 12 |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | IC50 | 28.4272 | 29 | 35 |
| Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | Ki | 0.2536 | 7 | 9 |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | Ki | 0.0926 | 7 | 11 |
| Glutamate receptor ionotropic, NMDA 2C | Homo sapiens (human) | IC50 | 5.0040 | 3 | 3 |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | IC50 | 35.4515 | 23 | 28 |
| Glutamate receptor ionotropic, NMDA 2C | Homo sapiens (human) | Ki | 0.1833 | 4 | 6 |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | Ki | 0.1432 | 7 | 12 |
| Glutamate receptor ionotropic, NMDA 2D | Homo sapiens (human) | IC50 | 5.0040 | 3 | 3 |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | IC50 | 35.4515 | 23 | 28 |
| Glutamate receptor ionotropic, NMDA 2D | Homo sapiens (human) | Ki | 0.1833 | 4 | 6 |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | Ki | 0.0926 | 7 | 11 |
| Glutamate receptor ionotropic, NMDA 3A | Homo sapiens (human) | IC50 | 5.0040 | 3 | 3 |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | IC50 | 35.4515 | 23 | 28 |
| Glutamate receptor ionotropic, NMDA 3A | Homo sapiens (human) | Ki | 0.1833 | 4 | 6 |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | Ki | 0.0926 | 7 | 11 |
| Glutamate receptor ionotropic, NMDA 3B | Homo sapiens (human) | IC50 | 5.0040 | 3 | 3 |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | IC50 | 35.4515 | 23 | 28 |
| Glutamate receptor ionotropic, NMDA 3B | Homo sapiens (human) | Ki | 0.1833 | 4 | 6 |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | Ki | 0.0926 | 7 | 11 |
| Glutathione reductase | Plasmodium falciparum 3D7 | IC50 | 6.4000 | 1 | 1 |
| Glutathione reductase, mitochondrial | Homo sapiens (human) | IC50 | 16.2000 | 2 | 2 |
| Glutathione S-transferase omega-1 | Homo sapiens (human) | IC50 | 75.0000 | 1 | 1 |
| Glutathione S-transferase P | Homo sapiens (human) | IC50 | 69.0000 | 1 | 1 |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | IC50 | 0.0110 | 1 | 1 |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Ki | 0.0050 | 1 | 1 |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | IC50 | 0.0110 | 1 | 1 |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Ki | 0.0050 | 1 | 1 |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | IC50 | 0.0110 | 1 | 1 |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Ki | 0.0050 | 1 | 1 |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | IC50 | 0.0110 | 1 | 1 |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | Ki | 0.0050 | 1 | 1 |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | IC50 | 1.5870 | 5 | 6 |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | Ki | 0.0308 | 1 | 1 |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | IC50 | 4.4879 | 31 | 36 |
| Glycogen synthase kinase-3 beta | Rattus norvegicus (Norway rat) | IC50 | 0.0660 | 1 | 1 |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | Ki | 0.0240 | 1 | 1 |
| Glycogen synthase kinase-3 beta | Sus scrofa (pig) | IC50 | 2.9350 | 4 | 4 |
| Heat shock protein HSP 90-beta | Homo sapiens (human) | IC50 | 155.0000 | 1 | 1 |
| Heme oxygenase 1 | Rattus norvegicus (Norway rat) | IC50 | 14.0000 | 2 | 2 |
| Heme oxygenase 2 | Rattus norvegicus (Norway rat) | IC50 | 14.0000 | 2 | 2 |
| Hepatocyte growth factor receptor | Homo sapiens (human) | IC50 | 7.4287 | 7 | 7 |
| Hepatocyte growth factor receptor | Homo sapiens (human) | Ki | 3.3000 | 1 | 1 |
| hexokinase | Trypanosoma brucei brucei TREU927 | IC50 | 0.9009 | 1 | 1 |
| Hexose transporter 1 | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 0.3100 | 1 | 1 |
| high affinity choline transporter 1 isoform a | Homo sapiens (human) | IC50 | 1.8613 | 2 | 2 |
| Histone acetyltransferase KAT2B | Homo sapiens (human) | IC50 | 32.9667 | 6 | 6 |
| Histone acetyltransferase KAT5 | Homo sapiens (human) | IC50 | 68.0000 | 3 | 3 |
| Histone acetyltransferase KAT8 | Homo sapiens (human) | IC50 | 43.0000 | 1 | 1 |
| Histone acetyltransferase KAT8 | Homo sapiens (human) | Ki | 64.0000 | 1 | 1 |
| Histone acetyltransferase p300 | Homo sapiens (human) | IC50 | 18.4292 | 11 | 12 |
| Histone deacetylase 1 | Homo sapiens (human) | IC50 | 1,020.8011 | 8 | 9 |
| Histone deacetylase 1 | Homo sapiens (human) | Ki | 207.0433 | 2 | 3 |
| Histone deacetylase 11 | Homo sapiens (human) | IC50 | 2,807.3333 | 3 | 3 |
| Histone deacetylase 11 | Homo sapiens (human) | Ki | 285.1700 | 1 | 2 |
| Histone deacetylase 2 | Homo sapiens (human) | IC50 | 1,547.7900 | 6 | 6 |
| Histone deacetylase 2 | Homo sapiens (human) | Ki | 222.6700 | 2 | 3 |
| Histone deacetylase 3 | Homo sapiens (human) | IC50 | 1,569.6117 | 6 | 6 |
| Histone deacetylase 3 | Homo sapiens (human) | Ki | 285.1700 | 1 | 2 |
| Histone deacetylase 4 | Homo sapiens (human) | IC50 | 2,284.4000 | 5 | 5 |
| Histone deacetylase 4 | Homo sapiens (human) | Ki | 285.1700 | 1 | 2 |
| Histone deacetylase 5 | Homo sapiens (human) | IC50 | 1,904.2333 | 6 | 6 |
| Histone deacetylase 5 | Homo sapiens (human) | Ki | 285.1700 | 1 | 2 |
| Histone deacetylase 6 | Homo sapiens (human) | IC50 | 1,295.1789 | 9 | 9 |
| Histone deacetylase 6 | Homo sapiens (human) | Ki | 285.1700 | 1 | 2 |
| Histone deacetylase 7 | Homo sapiens (human) | IC50 | 2,605.5000 | 4 | 4 |
| Histone deacetylase 7 | Homo sapiens (human) | Ki | 285.1700 | 1 | 2 |
| Histone deacetylase 8 | Homo sapiens (human) | IC50 | 1,741.8600 | 5 | 5 |
| Histone deacetylase 8 | Homo sapiens (human) | Ki | 211.7733 | 2 | 3 |
| Histone deacetylase 9 | Homo sapiens (human) | IC50 | 2,085.1400 | 5 | 5 |
| Histone deacetylase 9 | Homo sapiens (human) | Ki | 285.1700 | 1 | 2 |
| Histone-lysine N-methyltransferase EHMT1 | Homo sapiens (human) | IC50 | 0.7300 | 1 | 1 |
| Histone-lysine N-methyltransferase EHMT2 | Homo sapiens (human) | IC50 | 0.4000 | 1 | 1 |
| Histone-lysine N-methyltransferase SETD7 | Homo sapiens (human) | IC50 | 6.0200 | 1 | 1 |
| hypothetical protein SA1422 | Staphylococcus aureus subsp. aureus N315 | IC50 | 42.9000 | 2 | 2 |
| Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | IC50 | 0.0360 | 1 | 1 |
| Ileal sodium/bile acid cotransporter | Homo sapiens (human) | Ki | 28.0000 | 1 | 1 |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | Ki | 0.0940 | 3 | 3 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 | Homo sapiens (human) | IC50 | 0.9200 | 1 | 1 |
| Inhibin alpha chain | Homo sapiens (human) | IC50 | 5.2000 | 1 | 1 |
| Insulin receptor | Homo sapiens (human) | IC50 | 3.2000 | 1 | 1 |
| Insulin-degrading enzyme | Homo sapiens (human) | IC50 | 33.3520 | 3 | 3 |
| Integrase | Human immunodeficiency virus 1 | IC50 | 29.1179 | 10 | 10 |
| integrase, partial | Human immunodeficiency virus 1 | IC50 | 17.9040 | 2 | 4 |
| Interstitial collagenase | Homo sapiens (human) | IC50 | 0.4064 | 12 | 12 |
| Interstitial collagenase | Homo sapiens (human) | Ki | 0.0004 | 1 | 1 |
| intestinal alkaline phosphatase precursor | Mus musculus (house mouse) | IC50 | 18.7000 | 1 | 1 |
| Islet amyloid polypeptide | Homo sapiens (human) | IC50 | 7.8000 | 1 | 1 |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | IC50 | 168.3452 | 3 | 6 |
| L-lactate dehydrogenase A chain | Homo sapiens (human) | Ki | 6.5000 | 1 | 1 |
| Lactoylglutathione lyase | Homo sapiens (human) | Ki | 15.1022 | 2 | 2 |
| Lanosterol 14-alpha demethylase | Homo sapiens (human) | IC50 | 30.0000 | 1 | 1 |
| large T antigen | Betapolyomavirus macacae | IC50 | 34.6700 | 1 | 2 |
| lens epithelium-derived growth factor p75 | Homo sapiens (human) | IC50 | 17.9040 | 2 | 4 |
| Lethal factor | Bacillus anthracis | IC50 | 0.0970 | 1 | 1 |
| Leucine-rich repeat serine/threonine-protein kinase 2 | Homo sapiens (human) | IC50 | 0.0215 | 2 | 2 |
| Liver carboxylesterase 1 | Homo sapiens (human) | Ki | 363.0000 | 1 | 1 |
| Low molecular weight phosphotyrosine protein phosphatase | Bos taurus (cattle) | IC50 | 10.0000 | 1 | 1 |
| Lysine-specific histone demethylase 1A | Homo sapiens (human) | IC50 | 3.2317 | 6 | 6 |
| Lysosomal Pro-X carboxypeptidase | Homo sapiens (human) | IC50 | 0.0126 | 1 | 2 |
| Macrophage colony-stimulating factor 1 receptor | Homo sapiens (human) | IC50 | 0.0888 | 4 | 4 |
| Macrophage metalloelastase | Homo sapiens (human) | IC50 | 0.0057 | 7 | 7 |
| Macrophage migration inhibitory factor | Homo sapiens (human) | IC50 | 2.4000 | 1 | 1 |
| Macrophage migration inhibitory factor | Homo sapiens (human) | Ki | 0.5700 | 2 | 2 |
| MAP kinase-activated protein kinase 5 | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | GI50 | 0.1986 | 53 | 53 |
| Mast/stem cell growth factor receptor Kit | Mus musculus (house mouse) | GI50 | 0.0030 | 1 | 1 |
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | IC50 | 0.2639 | 18 | 18 |
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | Ki | 0.0040 | 1 | 1 |
| Matrilysin | Homo sapiens (human) | IC50 | 7.2487 | 4 | 9 |
| Matrix metalloproteinase-14 | Homo sapiens (human) | IC50 | 0.6275 | 11 | 11 |
| Matrix metalloproteinase-15 | Homo sapiens (human) | IC50 | 0.0060 | 2 | 2 |
| Matrix metalloproteinase-16 | Homo sapiens (human) | IC50 | 0.0080 | 2 | 2 |
| Matrix metalloproteinase-17 | Homo sapiens (human) | IC50 | 0.0034 | 1 | 1 |
| Matrix metalloproteinase-26 | Homo sapiens (human) | IC50 | 0.0170 | 2 | 2 |
| Matrix metalloproteinase-9 | Homo sapiens (human) | IC50 | 0.0034 | 12 | 12 |
| Matrix metalloproteinase-9 | Homo sapiens (human) | Ki | 0.0004 | 2 | 2 |
| Mcl-1 | Homo sapiens (human) | IC50 | 2.9883 | 1 | 1 |
| Melatonin receptor type 1A | Homo sapiens (human) | Ki | 1.9000 | 1 | 1 |
| Metabotropic glutamate receptor 1 | Homo sapiens (human) | Ki | 100.0000 | 1 | 1 |
| Metabotropic glutamate receptor 2 | Homo sapiens (human) | Ki | 0.4135 | 3 | 5 |
| Metabotropic glutamate receptor 3 | Homo sapiens (human) | Ki | 0.2141 | 3 | 5 |
| Metabotropic glutamate receptor 4 | Homo sapiens (human) | Ki | 21.0000 | 1 | 1 |
| Metabotropic glutamate receptor 5 | Homo sapiens (human) | Ki | 100.0000 | 1 | 1 |
| Metabotropic glutamate receptor 6 | Homo sapiens (human) | Ki | 0.4000 | 1 | 1 |
| Metabotropic glutamate receptor 7 | Homo sapiens (human) | Ki | 100.0000 | 1 | 1 |
| Metabotropic glutamate receptor 8 | Homo sapiens (human) | Ki | 1.7000 | 1 | 1 |
| Methionine aminopeptidase 2 | Homo sapiens (human) | IC50 | 2.4300 | 1 | 1 |
| microphthalmia-associated transcription factor isoform 9 | Homo sapiens (human) | IC50 | 6.3810 | 3 | 3 |
| Microtubule-associated protein tau | Homo sapiens (human) | IC50 | 28.7778 | 7 | 9 |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | IC50 | 0.6860 | 1 | 1 |
| Mitogen-activated protein kinase 1 | Rattus norvegicus (Norway rat) | IC50 | 343.3493 | 2 | 3 |
| Mitogen-activated protein kinase 10 | Homo sapiens (human) | IC50 | 8.0560 | 4 | 5 |
| Mitogen-activated protein kinase 10 | Homo sapiens (human) | Ki | 0.0900 | 1 | 1 |
| Mitogen-activated protein kinase 11 | Homo sapiens (human) | IC50 | 0.2646 | 26 | 27 |
| Mitogen-activated protein kinase 11 | Homo sapiens (human) | Ki | 1,300.0000 | 1 | 1 |
| Mitogen-activated protein kinase 12 | Homo sapiens (human) | IC50 | 0.2329 | 21 | 22 |
| Mitogen-activated protein kinase 12 | Homo sapiens (human) | Ki | 1,300.0000 | 1 | 1 |
| Mitogen-activated protein kinase 13 | Homo sapiens (human) | IC50 | 0.2329 | 21 | 22 |
| Mitogen-activated protein kinase 13 | Homo sapiens (human) | Ki | 1,300.0000 | 1 | 1 |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | IC50 | 15.2565 | 75 | 79 |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | Ki | 433.3583 | 3 | 3 |
| Mitogen-activated protein kinase 14 | Mus musculus (house mouse) | IC50 | 0.0560 | 1 | 3 |
| Mitogen-activated protein kinase 2 | Pneumocystis carinii | IC50 | 0.1050 | 1 | 1 |
| Mitogen-activated protein kinase 9 | Homo sapiens (human) | IC50 | 2.3871 | 7 | 7 |
| MO15-related protein kinase Pfmrk | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 500.0000 | 1 | 1 |
| MPI protein | Homo sapiens (human) | IC50 | 0.2905 | 2 | 2 |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | IC50 | 0.0180 | 1 | 1 |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | Ki | 100.0000 | 1 | 1 |
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | IC50 | 33.1567 | 1 | 3 |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | IC50 | 10.6660 | 1 | 1 |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | Ki | 2.5690 | 1 | 1 |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | Ki | 100.0000 | 1 | 1 |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | Ki | 100.0000 | 1 | 1 |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | Ki | 100.0000 | 1 | 1 |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | Ki | 100.0000 | 1 | 1 |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | IC50 | 0.0020 | 1 | 1 |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | Ki | 100.0000 | 1 | 1 |
| Myeloperoxidase | Homo sapiens (human) | Ki | 0.0460 | 2 | 2 |
| Myosin light chain kinase, smooth muscle | Homo sapiens (human) | IC50 | 12.6000 | 2 | 2 |
| Myosin light chain kinase, smooth muscle | Homo sapiens (human) | Ki | 36.0000 | 1 | 1 |
| Myotonin-protein kinase | Homo sapiens (human) | IC50 | 4.5000 | 2 | 2 |
| N-acylethanolamine-hydrolyzing acid amidase | Homo sapiens (human) | IC50 | 75.0000 | 1 | 2 |
| N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | Homo sapiens (human) | Ki | 0.0500 | 1 | 1 |
| NACHT, LRR and PYD domains-containing protein 3 | Homo sapiens (human) | IC50 | 24.2000 | 1 | 1 |
| NACHT, LRR and PYD domains-containing protein 3 | Mus musculus (house mouse) | IC50 | 10.0000 | 1 | 1 |
| NAD kinase | Homo sapiens (human) | IC50 | 0.9600 | 1 | 1 |
| NAD kinase | Homo sapiens (human) | Ki | 3.2800 | 1 | 1 |
| NAD-dependent histone deacetylase SIR2 | Saccharomyces cerevisiae S288C | IC50 | 50.0000 | 1 | 1 |
| NAD-dependent protein deacetylase | Schistosoma mansoni | IC50 | 221.5500 | 2 | 2 |
| NAD-dependent protein deacetylase HST2 | Saccharomyces cerevisiae S288C | IC50 | 91.0000 | 1 | 1 |
| NAD-dependent protein deacetylase sirtuin-1 | Homo sapiens (human) | IC50 | 130.9500 | 12 | 12 |
| NAD-dependent protein deacetylase sirtuin-2 | Homo sapiens (human) | IC50 | 34.5200 | 15 | 15 |
| NAD-dependent protein deacetylase sirtuin-3, mitochondrial | Homo sapiens (human) | IC50 | 78.4571 | 7 | 7 |
| NAD-dependent protein deacetylase sirtuin-6 | Homo sapiens (human) | IC50 | 173.3500 | 4 | 4 |
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | Homo sapiens (human) | IC50 | 68.6500 | 4 | 4 |
| NAD(+) hydrolase SARM1 | Homo sapiens (human) | IC50 | 43.8000 | 1 | 1 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] 1 subunit C2 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH-ubiquinone oxidoreductase chain 1 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH-ubiquinone oxidoreductase chain 2 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH-ubiquinone oxidoreductase chain 3 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH-ubiquinone oxidoreductase chain 4 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH-ubiquinone oxidoreductase chain 4L | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH-ubiquinone oxidoreductase chain 5 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| NADH-ubiquinone oxidoreductase chain 6 | Homo sapiens (human) | IC50 | 14.5000 | 2 | 2 |
| Neuraminidase | Influenza A virus (A/Wilson-Smith/1933(H1N1)) | IC50 | 63.8000 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | IC50 | 6.0000 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | IC50 | 0.8200 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Ki | 0.0900 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | IC50 | 6.0000 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | Homo sapiens (human) | IC50 | 7.0000 | 1 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | Rattus norvegicus (Norway rat) | IC50 | 0.8200 | 1 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Ki | 0.0900 | 1 | 1 |
| Neuronal acetylcholine receptor subunit beta-4 | Rattus norvegicus (Norway rat) | IC50 | 6.0000 | 1 | 1 |
| Neuronal proto-oncogene tyrosine-protein kinase Src | Mus musculus (house mouse) | IC50 | 2.2000 | 1 | 1 |
| Neutrophil collagenase | Homo sapiens (human) | IC50 | 0.0054 | 2 | 2 |
| Neutrophil collagenase | Homo sapiens (human) | Ki | 0.0002 | 2 | 2 |
| neutrophil cytosol factor 1 | Homo sapiens (human) | IC50 | 0.3900 | 1 | 2 |
| Neutrophil cytosol factor 1 | Homo sapiens (human) | Ki | 125.0000 | 3 | 3 |
| Neutrophil elastase | Homo sapiens (human) | IC50 | 6.4125 | 2 | 2 |
| NH(3)-dependent NAD(+) synthetase | Bacillus subtilis subsp. subtilis str. 168 | IC50 | 1.0000 | 1 | 1 |
| Nitric oxide synthase, brain | Homo sapiens (human) | IC50 | 0.0600 | 1 | 1 |
| Nitric oxide synthase, brain | Homo sapiens (human) | Ki | 0.0500 | 1 | 1 |
| Nitric oxide synthase, brain | Rattus norvegicus (Norway rat) | IC50 | 0.0600 | 1 | 1 |
| Nitric oxide synthase, brain | Rattus norvegicus (Norway rat) | Ki | 0.0500 | 1 | 1 |
| Nitric oxide synthase, endothelial | Homo sapiens (human) | IC50 | 0.4000 | 1 | 1 |
| Nitric oxide synthase, endothelial | Rattus norvegicus (Norway rat) | IC50 | 2.9000 | 1 | 1 |
| Nitric oxide synthase, inducible | Homo sapiens (human) | IC50 | 0.3000 | 1 | 1 |
| NUAK family SNF1-like kinase 1 | Homo sapiens (human) | IC50 | 0.0480 | 1 | 1 |
| Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) | IC50 | 35.8500 | 2 | 2 |
| Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) | IC50 | 35.8500 | 2 | 2 |
| P2X purinoceptor 7 | Homo sapiens (human) | IC50 | 5.0000 | 1 | 1 |
| P2X purinoceptor 7 | Rattus norvegicus (Norway rat) | IC50 | 30.0000 | 1 | 1 |
| P2Y purinoceptor 12 | Homo sapiens (human) | Ki | 36.4000 | 1 | 1 |
| Pancreatic triacylglycerol lipase | Sus scrofa (pig) | IC50 | 100.0000 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP14 | Homo sapiens (human) | Ki | 76.2000 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | Homo sapiens (human) | IC50 | 3.6000 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | Homo sapiens (human) | Ki | 3.4000 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP3 | Homo sapiens (human) | Ki | 124.0000 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP4 | Homo sapiens (human) | Ki | 24.2000 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | IC50 | 20.0000 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | Ki | 200.0000 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 | Homo sapiens (human) | Ki | 187.0000 | 1 | 1 |
| perilipin-1 | Homo sapiens (human) | IC50 | 6.2885 | 1 | 2 |
| perilipin-5 | Homo sapiens (human) | IC50 | 5.6665 | 1 | 2 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Homo sapiens (human) | IC50 | 11.0000 | 1 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | Homo sapiens (human) | IC50 | 12.0000 | 1 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Homo sapiens (human) | IC50 | 13.0000 | 1 | 1 |
| phosphoethanolamine/phosphocholine phosphatase isoform 1 | Homo sapiens (human) | IC50 | 0.1110 | 1 | 1 |
| Phosphoglycerate mutase 1 | Homo sapiens (human) | IC50 | 0.4900 | 2 | 2 |
| Phospholipase A2 | Homo sapiens (human) | IC50 | 11.1000 | 1 | 1 |
| phosphomannomutase 2 | Homo sapiens (human) | IC50 | 0.6720 | 1 | 1 |
| Plasminogen activator inhibitor 1 | Homo sapiens (human) | IC50 | 0.0910 | 1 | 1 |
| Platelet-activating factor receptor | Cavia porcellus (domestic guinea pig) | IC50 | 4.5000 | 1 | 1 |
| Platelet-derived growth factor receptor alpha | Homo sapiens (human) | GI50 | 0.3305 | 2 | 2 |
| Platelet-derived growth factor receptor alpha | Homo sapiens (human) | IC50 | 0.0610 | 4 | 4 |
| Platelet-derived growth factor receptor alpha | Mus musculus (house mouse) | IC50 | 0.0186 | 7 | 7 |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | GI50 | 0.1140 | 1 | 1 |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | IC50 | 12.8953 | 22 | 24 |
| Platelet-derived growth factor receptor beta | Mus musculus (house mouse) | IC50 | 0.0186 | 7 | 7 |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | Ki | 0.0080 | 1 | 1 |
| Poly [ADP-ribose] polymerase 1 | Homo sapiens (human) | IC50 | 54.6213 | 17 | 24 |
| Poly [ADP-ribose] polymerase 2 | Homo sapiens (human) | IC50 | 0.1687 | 3 | 5 |
| Poly [ADP-ribose] polymerase 2 | Mus musculus (house mouse) | IC50 | 64.7825 | 1 | 4 |
| Poly [ADP-ribose] polymerase tankyrase-1 | Homo sapiens (human) | IC50 | 1.1077 | 4 | 6 |
| Poly [ADP-ribose] polymerase tankyrase-2 | Homo sapiens (human) | IC50 | 1.2683 | 3 | 5 |
| Polyamine deacetylase HDAC10 | Homo sapiens (human) | IC50 | 2,807.3333 | 3 | 3 |
| Polyamine deacetylase HDAC10 | Homo sapiens (human) | Ki | 285.1700 | 1 | 2 |
| Polymerase acidic protein | Influenza A virus (A/Puerto Rico/8/1934(H1N1)) | IC50 | 5.8600 | 1 | 1 |
| Polyphenol oxidase 2 | Agaricus bisporus | IC50 | 200.0000 | 1 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | IC50 | 8.9460 | 5 | 5 |
| Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | Ki | 24.2000 | 1 | 2 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Homo sapiens (human) | IC50 | 12.0150 | 2 | 2 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | IC50 | 2.9490 | 1 | 1 |
| Potassium voltage-gated channel subfamily D member 3 | Homo sapiens (human) | IC50 | 50.1187 | 1 | 1 |
| Potassium voltage-gated channel subfamily E member 1 | Homo sapiens (human) | IC50 | 63.0957 | 1 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | IC50 | 3.8389 | 5 | 5 |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | Ki | 25.1189 | 1 | 1 |
| Potassium voltage-gated channel subfamily KQT member 1 | Homo sapiens (human) | IC50 | 63.0957 | 1 | 1 |
| Probable linoleate 9S-lipoxygenase 5 | Solanum tuberosum (potato) | IC50 | 43.0000 | 1 | 1 |
| Procathepsin L | Homo sapiens (human) | IC50 | 1.1100 | 1 | 2 |
| Programmed cell death 1 ligand 1 | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Programmed cell death protein 1 | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Prolyl endopeptidase | Homo sapiens (human) | IC50 | 12.1500 | 2 | 2 |
| Prolyl endopeptidase | Sus scrofa (pig) | IC50 | 0.0060 | 1 | 1 |
| Prostaglandin E synthase | Homo sapiens (human) | IC50 | 1.8000 | 3 | 4 |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | IC50 | 20,021.7403 | 7 | 9 |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | IC50 | 63.8350 | 1 | 2 |
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | IC50 | 1.0503 | 2 | 2 |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | IC50 | 15,027.9675 | 6 | 8 |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | IC50 | 11.3000 | 1 | 1 |
| Prostaglandin G/H synthase 2 | Bos taurus (cattle) | IC50 | 0.0006 | 1 | 1 |
| Proteasome subunit beta type-5 | Homo sapiens (human) | IC50 | 7.8172 | 5 | 5 |
| Protein delta homolog 1 | Homo sapiens (human) | Ki | 0.0063 | 1 | 1 |
| Protein E6 | Human papillomavirus 16 | IC50 | 4.0000 | 1 | 1 |
| Protein kinase C alpha type | Homo sapiens (human) | IC50 | 42.1500 | 2 | 2 |
| Protein kinase C alpha type | Rattus norvegicus (Norway rat) | IC50 | 36.5170 | 4 | 4 |
| Protein kinase C alpha type | Rattus norvegicus (Norway rat) | Ki | 25.0000 | 2 | 2 |
| Protein kinase C beta type | Homo sapiens (human) | IC50 | 75.0000 | 1 | 1 |
| Protein kinase C beta type | Rattus norvegicus (Norway rat) | IC50 | 49.2136 | 5 | 5 |
| Protein kinase C beta type | Rattus norvegicus (Norway rat) | Ki | 25.0000 | 2 | 2 |
| Protein kinase C delta type | Homo sapiens (human) | IC50 | 75.0000 | 1 | 1 |
| Protein kinase C delta type | Rattus norvegicus (Norway rat) | IC50 | 36.5170 | 4 | 4 |
| Protein kinase C delta type | Rattus norvegicus (Norway rat) | Ki | 25.0000 | 2 | 2 |
| Protein kinase C epsilon type | Homo sapiens (human) | IC50 | 27.0000 | 3 | 3 |
| Protein kinase C epsilon type | Rattus norvegicus (Norway rat) | IC50 | 36.5170 | 4 | 4 |
| Protein kinase C epsilon type | Rattus norvegicus (Norway rat) | Ki | 25.0000 | 2 | 2 |
| Protein kinase C eta type | Homo sapiens (human) | IC50 | 75.0000 | 1 | 1 |
| Protein kinase C eta type | Rattus norvegicus (Norway rat) | IC50 | 36.5170 | 4 | 4 |
| Protein kinase C eta type | Rattus norvegicus (Norway rat) | Ki | 25.0000 | 2 | 2 |
| Protein kinase C gamma type | Homo sapiens (human) | IC50 | 75.0000 | 1 | 1 |
| Protein kinase C gamma type | Rattus norvegicus (Norway rat) | IC50 | 36.5170 | 4 | 4 |
| Protein kinase C gamma type | Rattus norvegicus (Norway rat) | Ki | 25.0000 | 2 | 2 |
| Protein kinase C iota type | Homo sapiens (human) | IC50 | 75.0000 | 1 | 1 |
| Protein kinase C theta type | Homo sapiens (human) | IC50 | 75.0000 | 1 | 1 |
| Protein kinase C theta type | Rattus norvegicus (Norway rat) | IC50 | 36.5170 | 4 | 4 |
| Protein kinase C theta type | Rattus norvegicus (Norway rat) | Ki | 25.0000 | 2 | 2 |
| Protein kinase C zeta type | Homo sapiens (human) | IC50 | 75.0000 | 1 | 1 |
| Protein kinase C zeta type | Rattus norvegicus (Norway rat) | IC50 | 36.5170 | 4 | 4 |
| Protein kinase C zeta type | Rattus norvegicus (Norway rat) | Ki | 25.0000 | 2 | 2 |
| Protein mono-ADP-ribosyltransferase PARP10 | Homo sapiens (human) | IC50 | 6.3123 | 2 | 4 |
| Protein mono-ADP-ribosyltransferase PARP12 | Homo sapiens (human) | IC50 | 0.2269 | 1 | 2 |
| Protein mono-ADP-ribosyltransferase PARP14 | Homo sapiens (human) | IC50 | 4.1843 | 1 | 2 |
| Protein mono-ADP-ribosyltransferase PARP15 | Homo sapiens (human) | IC50 | 10.9708 | 2 | 3 |
| Protein mono-ADP-ribosyltransferase PARP3 | Homo sapiens (human) | IC50 | 1.4377 | 1 | 2 |
| Protein mono-ADP-ribosyltransferase PARP4 | Homo sapiens (human) | IC50 | 0.7586 | 1 | 1 |
| Prothrombin | Homo sapiens (human) | IC50 | 0.2500 | 1 | 1 |
| Proto-oncogene tyrosine-protein kinase receptor Ret | Homo sapiens (human) | IC50 | 0.3500 | 5 | 5 |
| Proto-oncogene tyrosine-protein kinase Src | Gallus gallus (chicken) | IC50 | 0.5550 | 1 | 1 |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | IC50 | 1.8509 | 3 | 3 |
| Proton-coupled amino acid transporter 1 | Homo sapiens (human) | Ki | 24,600.0000 | 1 | 2 |
| RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| RAF proto-oncogene serine/threonine-protein kinase | Homo sapiens (human) | IC50 | 2.6060 | 5 | 5 |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | IC50 | 10.1125 | 1 | 2 |
| Receptor-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | IC50 | 1.0359 | 7 | 8 |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | IC50 | 0.1042 | 27 | 27 |
| Receptor-type tyrosine-protein phosphatase S | Homo sapiens (human) | IC50 | 4.3000 | 1 | 1 |
| Renin | Homo sapiens (human) | Ki | 0.0006 | 1 | 1 |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | IC50 | 1.1100 | 1 | 2 |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | IC50 | 7.4600 | 2 | 7 |
| Replicase polyprotein 1ab | Human coronavirus 229E | IC50 | 1.1100 | 1 | 2 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | IC50 | 3.8727 | 20 | 38 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | IC50 | 8.5578 | 2 | 9 |
| Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | IC50 | 31.3650 | 2 | 2 |
| Rho-associated protein kinase 1 | Homo sapiens (human) | IC50 | 1.0502 | 10 | 10 |
| Rho-associated protein kinase 1 | Homo sapiens (human) | Ki | 0.4300 | 6 | 7 |
| Rho-associated protein kinase 2 | Bos taurus (cattle) | IC50 | 1.8042 | 1 | 12 |
| Rho-associated protein kinase 2 | Homo sapiens (human) | IC50 | 1.3060 | 14 | 14 |
| Rho-associated protein kinase 2 | Rattus norvegicus (Norway rat) | IC50 | 1.9000 | 1 | 1 |
| Rho-associated protein kinase 2 | Homo sapiens (human) | Ki | 0.3300 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-1 | Homo sapiens (human) | IC50 | 0.1313 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-3 | Homo sapiens (human) | IC50 | 0.1839 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-5 | Homo sapiens (human) | IC50 | 5.0000 | 1 | 1 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | IC50 | 5.1000 | 1 | 1 |
| RNA polymerase beta subunit (EC 2.7.7.6), partial | Escherichia coli | IC50 | 11.6872 | 1 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Oryctolagus cuniculus (rabbit) | IC50 | 7.5000 | 2 | 2 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Oryctolagus cuniculus (rabbit) | Ki | 5.8000 | 1 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | Homo sapiens (human) | IC50 | 7.0000 | 1 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | Homo sapiens (human) | Ki | 53.0000 | 1 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | Rattus norvegicus (Norway rat) | Ki | 5.8000 | 1 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 | Homo sapiens (human) | IC50 | 7.0000 | 1 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 | Homo sapiens (human) | Ki | 8.6000 | 1 | 1 |
| Seed linoleate 13S-lipoxygenase-1 | Glycine max (soybean) | IC50 | 51.9000 | 1 | 1 |
| Serine/threonine-protein kinase 36 | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
| Serine/threonine-protein kinase B-raf | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
| Serine/threonine-protein kinase Chk1 | Homo sapiens (human) | IC50 | 0.0773 | 1 | 1 |
| Serine/threonine-protein kinase Chk2 | Homo sapiens (human) | IC50 | 0.0168 | 1 | 1 |
| Serine/threonine-protein kinase D1 | Homo sapiens (human) | IC50 | 75.0000 | 1 | 1 |
| Serine/threonine-protein kinase D3 | Homo sapiens (human) | IC50 | 75.0000 | 1 | 1 |
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| Serine/threonine-protein kinase N1 | Homo sapiens (human) | IC50 | 1.7000 | 1 | 1 |
| Serine/threonine-protein kinase N2 | Homo sapiens (human) | IC50 | 1.8533 | 3 | 3 |
| Serine/threonine-protein kinase Nek2 | Homo sapiens (human) | IC50 | 12.0000 | 1 | 1 |
| Serine/threonine-protein kinase NLK | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
| Serine/threonine-protein kinase PAK 1 | Homo sapiens (human) | IC50 | 16.0000 | 1 | 1 |
| Serine/threonine-protein kinase PAK 4 | Homo sapiens (human) | IC50 | 0.5692 | 2 | 2 |
| Serine/threonine-protein kinase PAK 4 | Homo sapiens (human) | Ki | 0.5000 | 1 | 1 |
| Serine/threonine-protein kinase PAK 5 | Homo sapiens (human) | Ki | 0.5000 | 1 | 1 |
| Serine/threonine-protein kinase PAK 6 | Homo sapiens (human) | Ki | 0.5000 | 1 | 1 |
| Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | IC50 | 37.1467 | 5 | 6 |
| Serine/threonine-protein kinase PLK1 | Homo sapiens (human) | IC50 | 8.7367 | 3 | 3 |
| Serine/threonine-protein kinase PLK1 | Homo sapiens (human) | Ki | 12.4000 | 1 | 4 |
| Serine/threonine-protein kinase PLK2 | Homo sapiens (human) | Ki | 12.4000 | 1 | 4 |
| Serine/threonine-protein kinase PLK3 | Homo sapiens (human) | Ki | 12.4000 | 1 | 4 |
| Serine/threonine-protein kinase PLK4 | Homo sapiens (human) | Ki | 12.4000 | 1 | 4 |
| Serine/threonine-protein kinase TBK1 | Homo sapiens (human) | IC50 | 0.2200 | 1 | 1 |
| Serine/threonine-protein kinase/endoribonuclease IRE1 | Homo sapiens (human) | IC50 | 1.3000 | 1 | 1 |
| Sigma non-opioid intracellular receptor 1 | Cavia porcellus (domestic guinea pig) | IC50 | 10.0000 | 1 | 1 |
| Sigma non-opioid intracellular receptor 1 | Rattus norvegicus (Norway rat) | IC50 | 0.9700 | 1 | 2 |
| Sigma non-opioid intracellular receptor 1 | Cavia porcellus (domestic guinea pig) | Ki | 10.0000 | 1 | 1 |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | Ki | 59.1670 | 1 | 2 |
| Sigma non-opioid intracellular receptor 1 | Rattus norvegicus (Norway rat) | Ki | 59.1670 | 1 | 1 |
| Signal transducer and activator of transcription 3 | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | IC50 | 27.8298 | 2 | 2 |
| Sodium- and chloride-dependent creatine transporter 1 | Homo sapiens (human) | IC50 | 5.0000 | 1 | 1 |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | IC50 | 1,000.0000 | 1 | 1 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | IC50 | 3.7870 | 1 | 1 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | Ki | 3.7560 | 1 | 1 |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | IC50 | 0.5050 | 2 | 2 |
| Sodium/hydrogen exchanger | Amphiuma tridactylum (three-toed salamander) | IC50 | 8.7000 | 1 | 1 |
| Sodium/hydrogen exchanger 1 | Homo sapiens (human) | IC50 | 0.8000 | 1 | 1 |
| Sodium/hydrogen exchanger 1 | Oryctolagus cuniculus (rabbit) | IC50 | 0.0200 | 1 | 1 |
| Sodium/hydrogen exchanger 1 | Rattus norvegicus (Norway rat) | IC50 | 0.0100 | 1 | 1 |
| Sodium/hydrogen exchanger 1 | Oryctolagus cuniculus (rabbit) | Ki | 0.0200 | 2 | 2 |
| Sodium/hydrogen exchanger 1 | Rattus norvegicus (Norway rat) | Ki | 0.0100 | 2 | 2 |
| Sodium/hydrogen exchanger 2 | Oryctolagus cuniculus (rabbit) | IC50 | 0.5000 | 1 | 1 |
| Sodium/hydrogen exchanger 2 | Oryctolagus cuniculus (rabbit) | Ki | 0.5000 | 2 | 2 |
| Sodium/hydrogen exchanger 2 | Rattus norvegicus (Norway rat) | Ki | 0.0800 | 2 | 2 |
| Sodium/hydrogen exchanger 3 | Rattus norvegicus (Norway rat) | IC50 | 2.4000 | 1 | 1 |
| Sodium/hydrogen exchanger 3 | Rattus norvegicus (Norway rat) | Ki | 2.4000 | 2 | 2 |
| Sodium/hydrogen exchanger 5 | Homo sapiens (human) | IC50 | 0.4200 | 1 | 1 |
| Sodium/hydrogen exchanger 5 | Homo sapiens (human) | Ki | 0.4200 | 2 | 2 |
| Solute carrier family 15 member 1 | Rattus norvegicus (Norway rat) | Ki | 8,000.0000 | 1 | 1 |
| Solute carrier family 15 member 2 | Homo sapiens (human) | IC50 | 28.0000 | 1 | 1 |
| Solute carrier family 15 member 2 | Rattus norvegicus (Norway rat) | Ki | 66.0000 | 1 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 1 | Homo sapiens (human) | IC50 | 0.2280 | 1 | 1 |
| Solute carrier family 22 member 1 | Homo sapiens (human) | IC50 | 16.6500 | 2 | 2 |
| Solute carrier family 22 member 12 | Homo sapiens (human) | IC50 | 2.0000 | 1 | 1 |
| Solute carrier family 22 member 12 | Rattus norvegicus (Norway rat) | IC50 | 18.0000 | 1 | 1 |
| Solute carrier family 22 member 12 | Homo sapiens (human) | Ki | 5.7400 | 1 | 1 |
| Solute carrier organic anion transporter family member 1A1 | Rattus norvegicus (Norway rat) | Ki | 18.2000 | 1 | 1 |
| Solute carrier organic anion transporter family member 1A2 | Homo sapiens (human) | Ki | 51.0000 | 1 | 1 |
| Solute carrier organic anion transporter family member 1A4 | Rattus norvegicus (Norway rat) | Ki | 1.4300 | 2 | 2 |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | IC50 | 1.5000 | 4 | 4 |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | Ki | 9.0500 | 2 | 2 |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | IC50 | 1.5000 | 1 | 1 |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | Ki | 3.2000 | 2 | 2 |
| Solute carrier organic anion transporter family member 2B1 | Homo sapiens (human) | IC50 | 65.0000 | 1 | 1 |
| Solute carrier organic anion transporter family member 2B1 | Homo sapiens (human) | Ki | 63.0000 | 1 | 1 |
| Sortase A | Streptococcus mutans | IC50 | 18.7000 | 1 | 2 |
| Spike glycoprotein | Betacoronavirus England 1 | IC50 | 1.1100 | 1 | 2 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | IC50 | 1.1100 | 1 | 2 |
| Squalene monooxygenase | Rattus norvegicus (Norway rat) | IC50 | 0.6900 | 2 | 2 |
| Stromelysin-1 | Homo sapiens (human) | IC50 | 0.0104 | 9 | 9 |
| Stromelysin-1 | Homo sapiens (human) | Ki | 0.0265 | 2 | 2 |
| Structural capsid protein | Human immunodeficiency virus 1 | IC50 | 0.0467 | 1 | 1 |
| Sulfhydryl oxidase 1 | Homo sapiens (human) | IC50 | 5.4000 | 1 | 1 |
| SUMO-activating enzyme subunit 1 | Homo sapiens (human) | IC50 | 2.2000 | 1 | 1 |
| Telomerase reverse transcriptase | Homo sapiens (human) | IC50 | 1.0867 | 3 | 3 |
| TGF-beta receptor type-1 | Homo sapiens (human) | IC50 | 18.0000 | 2 | 2 |
| Thioredoxin reductase 1, cytoplasmic | Homo sapiens (human) | IC50 | 107.3429 | 4 | 7 |
| Thioredoxin reductase 2, mitochondrial | Homo sapiens (human) | IC50 | 120.2333 | 3 | 6 |
| Thioredoxin reductase 3 | Homo sapiens (human) | IC50 | 120.2333 | 3 | 6 |
| Thiosulfate sulfurtransferase | Homo sapiens (human) | IC50 | 55.0750 | 2 | 4 |
| Thromboxane-A synthase | Homo sapiens (human) | IC50 | 0.4940 | 1 | 1 |
| Tissue factor | Homo sapiens (human) | IC50 | 1,166.6711 | 3 | 3 |
| Tissue factor | Homo sapiens (human) | Ki | 8,000.0000 | 1 | 1 |
| Tissue-type plasminogen activator | Homo sapiens (human) | IC50 | 0.0910 | 1 | 1 |
| toll-like receptor 9 | Homo sapiens (human) | IC50 | 8.3620 | 1 | 1 |
| Toxin B | Clostridioides difficile | IC50 | 0.0172 | 1 | 1 |
| TPA: protein transporter TIM10 | Saccharomyces cerevisiae S288C | IC50 | 10.0933 | 2 | 3 |
| TPA: protein transporter TIM23 | Saccharomyces cerevisiae S288C | IC50 | 0.8800 | 1 | 1 |
| TRAF2 and NCK-interacting protein kinase | Homo sapiens (human) | IC50 | 1.0000 | 1 | 1 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | Human alphaherpesvirus 1 (Herpes simplex virus type 1) | IC50 | 85.4210 | 1 | 1 |
| Transcription factor p65 | Homo sapiens (human) | IC50 | 35.8500 | 2 | 2 |
| Transient receptor potential cation channel subfamily A member 1 | Homo sapiens (human) | IC50 | 13.0000 | 1 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | Rattus norvegicus (Norway rat) | IC50 | 10.2500 | 2 | 2 |
| Transient receptor potential cation channel subfamily M member 8 | Homo sapiens (human) | IC50 | 8.0533 | 3 | 3 |
| Transient receptor potential cation channel subfamily M member 8 | Rattus norvegicus (Norway rat) | IC50 | 0.1600 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 1 | Homo sapiens (human) | IC50 | 5.0667 | 3 | 3 |
| Transient receptor potential cation channel subfamily V member 2 | Homo sapiens (human) | IC50 | 1.5000 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 2 | Rattus norvegicus (Norway rat) | IC50 | 7.1667 | 3 | 3 |
| Transient receptor potential cation channel subfamily V member 3 | Homo sapiens (human) | IC50 | 66.0000 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 4 | Homo sapiens (human) | IC50 | 1.3000 | 1 | 1 |
| Translocator protein | Rattus norvegicus (Norway rat) | IC50 | 0.0390 | 1 | 2 |
| Transmembrane protease serine 2 | Homo sapiens (human) | IC50 | 1.1100 | 1 | 2 |
| Trypsin-1 | Homo sapiens (human) | IC50 | 1,000.0000 | 1 | 1 |
| Trypsin-2 | Homo sapiens (human) | IC50 | 1,000.0000 | 1 | 1 |
| Trypsin-3 | Homo sapiens (human) | IC50 | 1,000.0000 | 1 | 1 |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | Ki | 1.7000 | 1 | 1 |
| Tyrosinase | Homo sapiens (human) | IC50 | 5.0000 | 1 | 1 |
| Tyrosinase | Mus musculus (house mouse) | IC50 | 0.0340 | 1 | 1 |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | IC50 | 12.5054 | 5 | 5 |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | IC50 | 4.2140 | 1 | 1 |
| Tyrosine-protein kinase HCK | Homo sapiens (human) | IC50 | 0.1900 | 1 | 1 |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | IC50 | 2.1153 | 3 | 3 |
| Tyrosine-protein kinase receptor UFO | Homo sapiens (human) | IC50 | 0.0090 | 2 | 2 |
| Tyrosine-protein kinase SYK | Homo sapiens (human) | IC50 | 14.0800 | 2 | 2 |
| Tyrosine-protein kinase Yes | Homo sapiens (human) | Ki | 7.9000 | 1 | 1 |
| UDP-glucose 4-epimerase | Homo sapiens (human) | IC50 | 0.0140 | 1 | 1 |
| UDP-glucuronosyltransferase 2B7 | Homo sapiens (human) | Ki | 1,600.0000 | 1 | 1 |
| Urease subunit alpha | Helicobacter pylori 26695 | IC50 | 30.4725 | 4 | 4 |
| Urease subunit alpha | Helicobacter pylori 26695 | Ki | 0.2260 | 1 | 1 |
| Urease subunit beta | Helicobacter pylori 26695 | IC50 | 30.4725 | 4 | 4 |
| Urease subunit beta | Helicobacter pylori 26695 | Ki | 0.2260 | 1 | 1 |
| Urokinase-type plasminogen activator | Homo sapiens (human) | IC50 | 0.0910 | 1 | 1 |
| Urokinase-type plasminogen activator | Mus musculus (house mouse) | IC50 | 0.0910 | 1 | 1 |
| Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | IC50 | 0.0458 | 2 | 2 |
| Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | Ki | 0.0020 | 1 | 1 |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | GI50 | 0.0330 | 1 | 1 |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | IC50 | 3.7676 | 57 | 59 |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | Ki | 0.0075 | 4 | 4 |
| Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | IC50 | 0.0089 | 1 | 1 |
| Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | Ki | 0.0170 | 1 | 1 |
| Vesicular glutamate transporter 3 | Rattus norvegicus (Norway rat) | Ki | 945.0000 | 2 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | IC50 | 100.8897 | 4 | 4 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Rattus norvegicus (Norway rat) | IC50 | 100.0000 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | Rattus norvegicus (Norway rat) | IC50 | 100.0000 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | Homo sapiens (human) | IC50 | 62.3000 | 2 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | Homo sapiens (human) | IC50 | 62.3000 | 2 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | Homo sapiens (human) | IC50 | 62.3000 | 2 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | Rattus norvegicus (Norway rat) | IC50 | 100.0000 | 1 | 1 |
| Voltage-dependent N-type calcium channel subunit alpha-1B | Homo sapiens (human) | IC50 | 7.0000 | 2 | 2 |
| Voltage-dependent T-type calcium channel subunit alpha-1H | Homo sapiens (human) | IC50 | 2.0000 | 2 | 2 |
| Xanthine dehydrogenase/oxidase | Homo sapiens (human) | IC50 | 272.4350 | 3 | 4 |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 26S proteasome regulatory subunit 6B | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| 3-phosphoinositide-dependent protein kinase 1 | Homo sapiens (human) | Kd | 6.1000 | 3 | 5 |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | EC50 | 0.0005 | 1 | 1 |
| 5-hydroxytryptamine receptor 4 | Homo sapiens (human) | EC50 | 10.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 5A | Homo sapiens (human) | EC50 | 85.8470 | 1 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-1 | Homo sapiens (human) | Kd | 8.1240 | 6 | 10 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-2 | Homo sapiens (human) | EC50 | 0.0168 | 1 | 2 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-2 | Homo sapiens (human) | Kd | 4.0534 | 3 | 5 |
| 5'-AMP-activated protein kinase subunit beta-1 | Homo sapiens (human) | EC50 | 0.0168 | 1 | 2 |
| 5'-AMP-activated protein kinase subunit gamma-1 | Homo sapiens (human) | EC50 | 0.0168 | 1 | 2 |
| 5'-AMP-activated protein kinase subunit gamma-1 | Homo sapiens (human) | Kd | 20.3800 | 1 | 3 |
| 5'-AMP-activated protein kinase subunit gamma-2 | Homo sapiens (human) | Kd | 20.5780 | 1 | 3 |
| AarF domain-containing protein kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Acetylcholinesterase | Homo sapiens (human) | Kd | 0.0170 | 1 | 1 |
| Actin-related protein 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Actin-related protein 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Activated CDC42 kinase 1 | Homo sapiens (human) | Kd | 16.2500 | 4 | 8 |
| Activin receptor type-1 | Homo sapiens (human) | Kd | 18.8889 | 4 | 9 |
| Activin receptor type-1B | Homo sapiens (human) | Kd | 15.7500 | 4 | 8 |
| Activin receptor type-2A | Homo sapiens (human) | Kd | 10.0000 | 3 | 5 |
| Activin receptor type-2B | Homo sapiens (human) | Kd | 17.5000 | 4 | 8 |
| Acyl-CoA dehydrogenase family member 10 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Acyl-CoA dehydrogenase family member 11 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Adenine phosphoribosyltransferase | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Adenosine kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Adenosine receptor A1 | Homo sapiens (human) | EC50 | 1.2000 | 1 | 1 |
| Adenosine receptor A2a | Homo sapiens (human) | EC50 | 0.9500 | 1 | 1 |
| Adenosine receptor A2b | Homo sapiens (human) | EC50 | 1.3150 | 2 | 2 |
| Adenosine receptor A3 | Homo sapiens (human) | EC50 | 0.0270 | 1 | 1 |
| Adenylate kinase 2, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| ADP/ATP translocase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| ADP/ATP translocase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Albumin | Homo sapiens (human) | Kd | 12.0000 | 1 | 1 |
| ALK tyrosine kinase receptor | Homo sapiens (human) | Kd | 4.1020 | 3 | 5 |
| Alpha-synuclein | Homo sapiens (human) | Kd | 3.5000 | 4 | 4 |
| Amyloid-beta precursor protein | Homo sapiens (human) | EC50 | 8.4100 | 1 | 1 |
| Angiopoietin-1 receptor | Homo sapiens (human) | Kd | 10.0000 | 3 | 5 |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | EC50 | 1.6330 | 1 | 3 |
| Ankyrin repeat and protein kinase domain-containing protein 1 | Homo sapiens (human) | Kd | 4.1860 | 3 | 5 |
| AP2-associated protein kinase 1 | Homo sapiens (human) | Kd | 6.7152 | 8 | 12 |
| Apelin receptor | Homo sapiens (human) | EC50 | 0.0129 | 28 | 29 |
| Apelin receptor | Rattus norvegicus (Norway rat) | EC50 | 0.0045 | 4 | 4 |
| Apelin receptor | Homo sapiens (human) | Kd | 0.0005 | 1 | 1 |
| Apelin receptor | Mus musculus (house mouse) | Kd | 0.0045 | 1 | 1 |
| Arachidonate 5-lipoxygenase-activating protein | Homo sapiens (human) | EC50 | 0.0059 | 1 | 1 |
| Aryl hydrocarbon receptor | Homo sapiens (human) | EC50 | 0.3000 | 1 | 1 |
| ATP-dependent 6-phosphofructokinase, platelet type | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| ATP-dependent RNA helicase DDX1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| ATP-dependent RNA helicase DDX3X | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| ATP-dependent RNA helicase DDX42 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| ATP-dependent RNA helicase DHX30 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Atypical kinase COQ8A, mitochondrial | Homo sapiens (human) | Kd | 17.5000 | 4 | 8 |
| Atypical kinase COQ8B, mitochondrial | Homo sapiens (human) | Kd | 7.2400 | 3 | 5 |
| Aurora kinase A | Homo sapiens (human) | Kd | 13.5222 | 5 | 9 |
| Aurora kinase B | Homo sapiens (human) | Kd | 10.3696 | 4 | 8 |
| Aurora kinase C | Homo sapiens (human) | Kd | 3.0400 | 5 | 7 |
| BDNF/NT-3 growth factors receptor | Homo sapiens (human) | Kd | 4.3540 | 3 | 5 |
| Beta-adrenergic receptor kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| BMP-2-inducible protein kinase | Homo sapiens (human) | Kd | 8.3967 | 6 | 10 |
| Bone morphogenetic protein receptor type-1A | Homo sapiens (human) | Kd | 17.5000 | 4 | 8 |
| Bone morphogenetic protein receptor type-1B | Homo sapiens (human) | Kd | 17.6167 | 3 | 6 |
| Bone morphogenetic protein receptor type-2 | Homo sapiens (human) | Kd | 10.5398 | 4 | 8 |
| Breakpoint cluster region protein | Homo sapiens (human) | EC50 | 1.0000 | 1 | 1 |
| Breakpoint cluster region protein | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Bromodomain-containing protein 7 | Homo sapiens (human) | Kd | 11.0000 | 1 | 1 |
| Bromodomain-containing protein 9 | Homo sapiens (human) | Kd | 17.0000 | 1 | 1 |
| Calcium-dependent protein kinase 1 | Plasmodium falciparum 3D7 | Kd | 1.0750 | 1 | 2 |
| Calcium/calmodulin-dependent protein kinase kinase 1 | Homo sapiens (human) | Kd | 3.6933 | 4 | 6 |
| Calcium/calmodulin-dependent protein kinase kinase 2 | Homo sapiens (human) | Kd | 13.3667 | 5 | 9 |
| Calcium/calmodulin-dependent protein kinase type 1 | Homo sapiens (human) | Kd | 4.1517 | 4 | 6 |
| Calcium/calmodulin-dependent protein kinase type 1D | Homo sapiens (human) | Kd | 3.7717 | 4 | 6 |
| Calcium/calmodulin-dependent protein kinase type 1G | Homo sapiens (human) | Kd | 4.3740 | 3 | 5 |
| Calcium/calmodulin-dependent protein kinase type II subunit alpha | Homo sapiens (human) | Kd | 2.9971 | 5 | 7 |
| Calcium/calmodulin-dependent protein kinase type II subunit beta | Homo sapiens (human) | Kd | 4.5667 | 4 | 6 |
| Calcium/calmodulin-dependent protein kinase type II subunit delta | Homo sapiens (human) | Kd | 12.4844 | 5 | 9 |
| Calcium/calmodulin-dependent protein kinase type II subunit gamma | Homo sapiens (human) | Kd | 7.7207 | 7 | 11 |
| Calcium/calmodulin-dependent protein kinase type IV | Homo sapiens (human) | Kd | 12.8489 | 4 | 9 |
| cAMP-dependent protein kinase catalytic subunit alpha | Homo sapiens (human) | Kd | 18.5714 | 3 | 7 |
| cAMP-dependent protein kinase catalytic subunit beta | Homo sapiens (human) | Kd | 17.5000 | 4 | 8 |
| cAMP-dependent protein kinase catalytic subunit gamma | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| cAMP-dependent protein kinase catalytic subunit PRKX | Homo sapiens (human) | Kd | 13.3333 | 4 | 6 |
| cAMP-dependent protein kinase type II-alpha regulatory subunit | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Cannabinoid receptor 1 | Homo sapiens (human) | EC50 | 0.1868 | 14 | 14 |
| Cannabinoid receptor 1 | Mus musculus (house mouse) | EC50 | 0.2601 | 2 | 2 |
| Cannabinoid receptor 1 | Rattus norvegicus (Norway rat) | EC50 | 0.1631 | 2 | 2 |
| Cannabinoid receptor 2 | Rattus norvegicus (Norway rat) | EC50 | 0.0015 | 1 | 1 |
| Cannabinoid receptor 2 | Homo sapiens (human) | EC50 | 0.0288 | 17 | 17 |
| Casein kinase I isoform alpha | Homo sapiens (human) | Kd | 11.3438 | 3 | 6 |
| Casein kinase I isoform alpha-like | Homo sapiens (human) | Kd | 1.1250 | 2 | 4 |
| Casein kinase I isoform delta | Homo sapiens (human) | Kd | 7.6235 | 4 | 8 |
| Casein kinase I isoform epsilon | Homo sapiens (human) | Kd | 9.1307 | 5 | 10 |
| Casein kinase I isoform gamma-1 | Homo sapiens (human) | Kd | 10.7705 | 4 | 8 |
| Casein kinase I isoform gamma-2 | Homo sapiens (human) | Kd | 13.7912 | 4 | 8 |
| Casein kinase I isoform gamma-3 | Homo sapiens (human) | Kd | 10.4582 | 4 | 8 |
| Casein kinase II subunit alpha | Homo sapiens (human) | Kd | 4.2124 | 3 | 5 |
| Casein kinase II subunit alpha' | Homo sapiens (human) | Kd | 10.5126 | 4 | 8 |
| Cell division control protein 2 homolog | Plasmodium falciparum 3D7 | Kd | 10.0000 | 1 | 2 |
| Cell division cycle 7-related protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| cGMP-dependent protein kinase 1 | Homo sapiens (human) | Kd | 18.8889 | 4 | 9 |
| cGMP-dependent protein kinase 2 | Homo sapiens (human) | Kd | 10.0000 | 3 | 5 |
| Chain A, Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | Kd | 21.6000 | 1 | 1 |
| Chain A, Troponin C, slow skeletal and cardiac muscles | Homo sapiens (human) | Kd | 1,100.0000 | 1 | 1 |
| Choline-phosphate cytidylyltransferase A | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Cholinesterase | Equus caballus (horse) | Kd | 1.1500 | 1 | 1 |
| Chromodomain-helicase-DNA-binding protein 4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Citron Rho-interacting kinase | Homo sapiens (human) | Kd | 15.1770 | 4 | 8 |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Cyclin-dependent kinase 10 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Cyclin-dependent kinase 11A | Homo sapiens (human) | Kd | 10.0000 | 3 | 5 |
| Cyclin-dependent kinase 11B | Homo sapiens (human) | Kd | 10.0000 | 3 | 5 |
| Cyclin-dependent kinase 12 | Homo sapiens (human) | Kd | 21.1600 | 1 | 3 |
| Cyclin-dependent kinase 13 | Homo sapiens (human) | Kd | 16.9036 | 2 | 5 |
| Cyclin-dependent kinase 14 | Homo sapiens (human) | Kd | 4.1620 | 3 | 5 |
| Cyclin-dependent kinase 15 | Homo sapiens (human) | Kd | 10.0000 | 2 | 3 |
| Cyclin-dependent kinase 16 | Homo sapiens (human) | Kd | 10.2785 | 6 | 11 |
| Cyclin-dependent kinase 17 | Homo sapiens (human) | Kd | 10.8100 | 4 | 8 |
| Cyclin-dependent kinase 18 | Homo sapiens (human) | Kd | 9.1833 | 4 | 6 |
| Cyclin-dependent kinase 19 | Homo sapiens (human) | Kd | 10.0000 | 3 | 5 |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | Kd | 16.6667 | 5 | 9 |
| Cyclin-dependent kinase 3 | Homo sapiens (human) | Kd | 13.8780 | 4 | 8 |
| Cyclin-dependent kinase 4 | Homo sapiens (human) | Kd | 16.8857 | 3 | 7 |
| Cyclin-dependent kinase 6 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Cyclin-dependent kinase 7 | Homo sapiens (human) | Kd | 10.2740 | 4 | 8 |
| Cyclin-dependent kinase 8 | Homo sapiens (human) | Kd | 10.0000 | 3 | 5 |
| Cyclin-dependent kinase 9 | Homo sapiens (human) | Kd | 16.0279 | 4 | 9 |
| Cyclin-dependent kinase-like 1 | Homo sapiens (human) | Kd | 10.0000 | 1 | 2 |
| Cyclin-dependent kinase-like 2 | Homo sapiens (human) | Kd | 4.0667 | 2 | 3 |
| Cyclin-dependent kinase-like 3 | Homo sapiens (human) | Kd | 10.0000 | 2 | 3 |
| Cyclin-dependent kinase-like 5 | Homo sapiens (human) | Kd | 20.0000 | 3 | 6 |
| Cyclin-dependent-like kinase 5 | Homo sapiens (human) | Kd | 17.1125 | 4 | 8 |
| Cyclin-G-associated kinase | Homo sapiens (human) | Kd | 5.1403 | 7 | 12 |
| Cysteine--tRNA ligase, cytoplasmic | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Cytochrome c1, heme protein, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Cytochrome P450 1A2 | Homo sapiens (human) | EC50 | 0.0123 | 1 | 1 |
| Cytochrome P450 2B6 | Homo sapiens (human) | EC50 | 1.3000 | 1 | 1 |
| Cytochrome P450 2C19 | Homo sapiens (human) | EC50 | 0.0123 | 1 | 1 |
| Cytochrome P450 2E1 | Homo sapiens (human) | EC50 | 0.0005 | 1 | 1 |
| Cytochrome P450 3A4 | Homo sapiens (human) | EC50 | 0.0123 | 1 | 1 |
| Cytoplasmic tyrosine-protein kinase BMX | Homo sapiens (human) | Kd | 10.0000 | 3 | 5 |
| dCTP pyrophosphatase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Death-associated protein kinase 1 | Homo sapiens (human) | Kd | 4.0720 | 3 | 5 |
| Death-associated protein kinase 2 | Homo sapiens (human) | Kd | 3.0557 | 5 | 7 |
| Death-associated protein kinase 3 | Homo sapiens (human) | Kd | 3.4184 | 6 | 9 |
| delta-type opioid receptor | Homo sapiens (human) | EC50 | 36.8205 | 2 | 2 |
| Delta(24)-sterol reductase | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Deoxycytidine kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Discoidin domain-containing receptor 2 | Homo sapiens (human) | Kd | 15.3625 | 4 | 8 |
| DNA replication licensing factor MCM4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| DNA topoisomerase 2-alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| DNA topoisomerase 2-beta | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| DnaJ homolog subfamily A member 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Dual serine/threonine and tyrosine protein kinase | Homo sapiens (human) | Kd | 5.6500 | 1 | 2 |
| Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens (human) | Kd | 10.3712 | 4 | 8 |
| Dual specificity mitogen-activated protein kinase kinase 2 | Homo sapiens (human) | Kd | 10.1509 | 4 | 8 |
| Dual specificity mitogen-activated protein kinase kinase 3 | Homo sapiens (human) | Kd | 16.4625 | 4 | 8 |
| Dual specificity mitogen-activated protein kinase kinase 4 | Homo sapiens (human) | Kd | 8.1400 | 3 | 5 |
| Dual specificity mitogen-activated protein kinase kinase 5 | Homo sapiens (human) | Kd | 12.9942 | 2 | 5 |
| Dual specificity mitogen-activated protein kinase kinase 6 | Homo sapiens (human) | Kd | 18.3556 | 4 | 9 |
| Dual specificity mitogen-activated protein kinase kinase 7 | Homo sapiens (human) | Kd | 10.0000 | 1 | 2 |
| Dual specificity protein kinase CLK1 | Homo sapiens (human) | Kd | 4.2462 | 8 | 12 |
| Dual specificity protein kinase CLK2 | Homo sapiens (human) | Kd | 6.8118 | 8 | 12 |
| Dual specificity protein kinase CLK3 | Homo sapiens (human) | Kd | 13.8875 | 5 | 8 |
| Dual specificity protein kinase CLK4 | Homo sapiens (human) | Kd | 9.1955 | 8 | 12 |
| Dual specificity protein kinase TTK | Homo sapiens (human) | Kd | 12.9708 | 6 | 12 |
| Dual specificity testis-specific protein kinase 1 | Homo sapiens (human) | Kd | 17.5000 | 4 | 8 |
| Dual specificity testis-specific protein kinase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | Kd | 10.5833 | 4 | 7 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1B | Homo sapiens (human) | Kd | 4.5067 | 4 | 6 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Homo sapiens (human) | Kd | 2.9525 | 3 | 4 |
| Dynamin-like 120 kDa protein, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| eIF-2-alpha kinase GCN2 | Homo sapiens (human) | Kd | 4.1080 | 3 | 5 |
| EKC/KEOPS complex subunit TP53RK | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Electron transfer flavoprotein subunit beta | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Elongation factor Tu, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Ephrin type-A receptor 1 | Homo sapiens (human) | Kd | 17.5000 | 4 | 8 |
| Ephrin type-A receptor 2 | Homo sapiens (human) | Kd | 17.5000 | 4 | 8 |
| Ephrin type-A receptor 3 | Homo sapiens (human) | Kd | 5.2600 | 3 | 5 |
| Ephrin type-A receptor 4 | Homo sapiens (human) | Kd | 17.5000 | 4 | 8 |
| Ephrin type-A receptor 5 | Homo sapiens (human) | Kd | 15.2333 | 5 | 9 |
| Ephrin type-A receptor 6 | Homo sapiens (human) | Kd | 1.2133 | 4 | 6 |
| Ephrin type-A receptor 7 | Homo sapiens (human) | Kd | 11.8620 | 6 | 10 |
| Ephrin type-A receptor 8 | Homo sapiens (human) | Kd | 10.0000 | 3 | 5 |
| Ephrin type-B receptor 1 | Homo sapiens (human) | Kd | 3.3371 | 5 | 7 |
| Ephrin type-B receptor 2 | Homo sapiens (human) | Kd | 16.3111 | 5 | 9 |
| Ephrin type-B receptor 3 | Homo sapiens (human) | Kd | 18.8889 | 4 | 9 |
| Ephrin type-B receptor 4 | Homo sapiens (human) | Kd | 16.5300 | 5 | 10 |
| Ephrin type-B receptor 6 | Homo sapiens (human) | Kd | 15.8250 | 3 | 6 |
| Epidermal growth factor receptor | Homo sapiens (human) | Kd | 6.6490 | 30 | 54 |
| Epithelial discoidin domain-containing receptor 1 | Homo sapiens (human) | Kd | 11.1111 | 5 | 9 |
| Estrogen receptor | Rattus norvegicus (Norway rat) | EC50 | 12.0430 | 1 | 2 |
| Estrogen receptor beta | Rattus norvegicus (Norway rat) | EC50 | 12.0430 | 1 | 2 |
| Eukaryotic peptide chain release factor GTP-binding subunit ERF3B | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Eukaryotic translation initiation factor 2-alpha kinase 1 | Homo sapiens (human) | Kd | 22.0000 | 2 | 5 |
| Eukaryotic translation initiation factor 5B | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Exosome RNA helicase MTR4 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Ferrochelatase, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Fibroblast growth factor receptor 1 | Homo sapiens (human) | Kd | 9.6617 | 5 | 9 |
| Fibroblast growth factor receptor 2 | Homo sapiens (human) | Kd | 3.2529 | 5 | 7 |
| Fibroblast growth factor receptor 3 | Homo sapiens (human) | Kd | 4.1245 | 7 | 11 |
| Fibroblast growth factor receptor 4 | Homo sapiens (human) | Kd | 8.4200 | 3 | 5 |
| Focal adhesion kinase 1 | Homo sapiens (human) | Kd | 11.2540 | 6 | 10 |
| G protein-coupled receptor GPR35 | Rattus norvegicus (Norway rat) | EC50 | 66.0000 | 1 | 1 |
| G protein-coupled receptor kinase 4 | Homo sapiens (human) | Kd | 3.4267 | 2 | 3 |
| G protein-coupled receptor kinase 6 | Homo sapiens (human) | Kd | 20.5383 | 1 | 3 |
| G-protein coupled bile acid receptor 1 | Homo sapiens (human) | EC50 | 54.8875 | 3 | 4 |
| G-protein coupled receptor 35 | Homo sapiens (human) | EC50 | 164.6118 | 11 | 11 |
| Gamma-butyrobetaine dioxygenase | Homo sapiens (human) | Kd | 4.1000 | 2 | 2 |
| General transcription and DNA repair factor IIH helicase subunit XPD | Homo sapiens (human) | Kd | 20.4083 | 1 | 3 |
| Glucagon-like peptide 1 receptor | Homo sapiens (human) | EC50 | 0.0082 | 9 | 9 |
| Glucagon-like peptide 1 receptor | Homo sapiens (human) | Kd | 6.2700 | 1 | 1 |
| Glutamate receptor 1 | Rattus norvegicus (Norway rat) | EC50 | 0.1704 | 2 | 2 |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | EC50 | 0.1704 | 2 | 2 |
| Glutamate receptor 3 | Rattus norvegicus (Norway rat) | EC50 | 0.1704 | 2 | 2 |
| Glutamate receptor 4 | Rattus norvegicus (Norway rat) | EC50 | 0.1704 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | Kd | 5.0186 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | Kd | 5.0186 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | Kd | 5.0186 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | Kd | 5.0186 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | Kd | 5.0186 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | Kd | 5.0186 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | Kd | 5.0186 | 2 | 2 |
| Glycine--tRNA ligase | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Glycogen phosphorylase, brain form | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Glycogen phosphorylase, liver form | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | Kd | 15.6167 | 5 | 9 |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | EC50 | 38.1100 | 2 | 2 |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | Kd | 15.4250 | 4 | 8 |
| glycogen synthase kinase-3 beta isoform 1 | Homo sapiens (human) | EC50 | 150.1197 | 1 | 2 |
| GTP-binding nuclear protein Ran | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Guanine nucleotide-binding protein G(i) subunit alpha-2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Heme oxygenase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Hepatocyte growth factor receptor | Homo sapiens (human) | Kd | 10.5308 | 8 | 13 |
| hexokinase HKDC1 | Homo sapiens (human) | EC50 | 38.8000 | 1 | 1 |
| hexokinase-1 isoform HKI | Homo sapiens (human) | EC50 | 41.9000 | 1 | 1 |
| High affinity nerve growth factor receptor | Homo sapiens (human) | Kd | 7.5255 | 7 | 11 |
| Histamine H3 receptor | Rattus norvegicus (Norway rat) | EC50 | 500.0000 | 1 | 1 |
| Homeodomain-interacting protein kinase 1 | Homo sapiens (human) | Kd | 5.0938 | 3 | 4 |
| Homeodomain-interacting protein kinase 2 | Homo sapiens (human) | Kd | 3.3540 | 2 | 3 |
| Homeodomain-interacting protein kinase 3 | Homo sapiens (human) | Kd | 2.5780 | 3 | 4 |
| Homeodomain-interacting protein kinase 4 | Homo sapiens (human) | Kd | 3.4400 | 2 | 3 |
| Hormonally up-regulated neu tumor-associated kinase | Homo sapiens (human) | Kd | 3.6667 | 2 | 3 |
| Inhibitor of nuclear factor kappa-B kinase subunit alpha | Homo sapiens (human) | Kd | 3.6800 | 2 | 3 |
| Inhibitor of nuclear factor kappa-B kinase subunit beta | Homo sapiens (human) | Kd | 10.0000 | 2 | 3 |
| Inhibitor of nuclear factor kappa-B kinase subunit epsilon | Homo sapiens (human) | Kd | 10.4489 | 4 | 8 |
| Inosine-5'-monophosphate dehydrogenase 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Insulin receptor | Homo sapiens (human) | Kd | 11.1860 | 6 | 10 |
| Insulin receptor-related protein | Homo sapiens (human) | Kd | 4.2580 | 3 | 5 |
| Insulin-like growth factor 1 receptor | Homo sapiens (human) | Kd | 14.7250 | 4 | 8 |
| Integrin-linked protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Interferon-induced, double-stranded RNA-activated protein kinase | Homo sapiens (human) | Kd | 4.4020 | 3 | 5 |
| Interleukin-1 receptor-associated kinase 1 | Homo sapiens (human) | Kd | 14.4226 | 4 | 7 |
| Interleukin-1 receptor-associated kinase 3 | Homo sapiens (human) | Kd | 14.1025 | 4 | 8 |
| Interleukin-1 receptor-associated kinase 4 | Homo sapiens (human) | Kd | 14.5382 | 2 | 5 |
| Isoleucine--tRNA ligase, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Leucine-rich repeat serine/threonine-protein kinase 2 | Homo sapiens (human) | Kd | 5.0465 | 2 | 4 |
| Leukocyte tyrosine kinase receptor | Homo sapiens (human) | Kd | 5.0800 | 3 | 5 |
| Leukotriene C4 synthase | Cavia porcellus (domestic guinea pig) | Kd | 5.4650 | 1 | 2 |
| LIM domain kinase 1 | Homo sapiens (human) | Kd | 18.8889 | 4 | 9 |
| LIM domain kinase 2 | Homo sapiens (human) | Kd | 18.8889 | 4 | 9 |
| Long-chain-fatty-acid--CoA ligase 5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Lymphocyte antigen 96 | Homo sapiens (human) | Kd | 379.0000 | 1 | 1 |
| Macrophage colony-stimulating factor 1 receptor | Homo sapiens (human) | Kd | 4.0013 | 3 | 5 |
| Macrophage-stimulating protein receptor | Homo sapiens (human) | Kd | 21.4286 | 3 | 7 |
| MAP kinase-activated protein kinase 2 | Homo sapiens (human) | Kd | 17.5000 | 4 | 8 |
| MAP kinase-activated protein kinase 5 | Homo sapiens (human) | Kd | 17.5000 | 4 | 8 |
| MAP kinase-interacting serine/threonine-protein kinase 1 | Homo sapiens (human) | Kd | 8.7800 | 3 | 5 |
| MAP kinase-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | Kd | 9.1400 | 3 | 5 |
| MAP/microtubule affinity-regulating kinase 3 | Homo sapiens (human) | Kd | 9.3819 | 5 | 9 |
| MAP/microtubule affinity-regulating kinase 4 | Homo sapiens (human) | Kd | 15.1000 | 4 | 8 |
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | Kd | 3.3677 | 24 | 50 |
| Maternal embryonic leucine zipper kinase | Homo sapiens (human) | Kd | 6.7906 | 4 | 8 |
| Megakaryocyte-associated tyrosine-protein kinase | Homo sapiens (human) | Kd | 9.2333 | 2 | 3 |
| Membrane-associated progesterone receptor component 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase | Homo sapiens (human) | Kd | 17.5000 | 4 | 8 |
| Metabotropic glutamate receptor 1 | Homo sapiens (human) | EC50 | 100.0000 | 1 | 1 |
| Metabotropic glutamate receptor 2 | Homo sapiens (human) | EC50 | 0.0027 | 3 | 3 |
| Metabotropic glutamate receptor 3 | Homo sapiens (human) | EC50 | 0.0046 | 3 | 3 |
| Metabotropic glutamate receptor 4 | Homo sapiens (human) | EC50 | 21.1000 | 1 | 1 |
| Metabotropic glutamate receptor 6 | Homo sapiens (human) | EC50 | 50.2005 | 2 | 2 |
| Metabotropic glutamate receptor 7 | Homo sapiens (human) | EC50 | 50.0792 | 2 | 2 |
| Metabotropic glutamate receptor 8 | Homo sapiens (human) | EC50 | 1.6900 | 2 | 2 |
| Microtubule-associated protein tau | Homo sapiens (human) | EC50 | 0.3600 | 2 | 2 |
| Microtubule-associated serine/threonine-protein kinase 1 | Homo sapiens (human) | Kd | 3.4667 | 2 | 3 |
| Midasin | Homo sapiens (human) | Kd | 30.0000 | 1 | 5 |
| Misshapen-like kinase 1 | Homo sapiens (human) | Kd | 10.0145 | 3 | 4 |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | Kd | 18.8889 | 4 | 9 |
| Mitogen-activated protein kinase 10 | Homo sapiens (human) | Kd | 12.7128 | 5 | 9 |
| Mitogen-activated protein kinase 11 | Homo sapiens (human) | EC50 | 0.0600 | 1 | 1 |
| Mitogen-activated protein kinase 11 | Homo sapiens (human) | Kd | 12.0400 | 6 | 10 |
| Mitogen-activated protein kinase 12 | Homo sapiens (human) | EC50 | 0.0600 | 1 | 1 |
| Mitogen-activated protein kinase 12 | Homo sapiens (human) | Kd | 4.9586 | 5 | 7 |
| Mitogen-activated protein kinase 13 | Homo sapiens (human) | EC50 | 0.0600 | 1 | 1 |
| Mitogen-activated protein kinase 13 | Homo sapiens (human) | Kd | 7.5025 | 3 | 4 |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | EC50 | 0.0600 | 2 | 2 |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | Kd | 10.0064 | 8 | 12 |
| Mitogen-activated protein kinase 14 | Mus musculus (house mouse) | Kd | 0.0200 | 2 | 2 |
| Mitogen-activated protein kinase 15 | Homo sapiens (human) | Kd | 17.5000 | 4 | 8 |
| Mitogen-activated protein kinase 3 | Homo sapiens (human) | Kd | 17.5000 | 4 | 8 |
| Mitogen-activated protein kinase 4 | Homo sapiens (human) | Kd | 10.0000 | 3 | 5 |
| Mitogen-activated protein kinase 6 | Homo sapiens (human) | Kd | 10.0000 | 3 | 5 |
| Mitogen-activated protein kinase 7 | Homo sapiens (human) | Kd | 17.4875 | 4 | 8 |
| Mitogen-activated protein kinase 8 | Homo sapiens (human) | Kd | 13.7111 | 5 | 9 |
| Mitogen-activated protein kinase 9 | Homo sapiens (human) | Kd | 12.5283 | 5 | 9 |
| Mitogen-activated protein kinase kinase kinase 1 | Homo sapiens (human) | Kd | 20.0000 | 3 | 6 |
| Mitogen-activated protein kinase kinase kinase 10 | Homo sapiens (human) | Kd | 10.0000 | 3 | 5 |
| Mitogen-activated protein kinase kinase kinase 11 | Homo sapiens (human) | Kd | 10.8746 | 4 | 8 |
| Mitogen-activated protein kinase kinase kinase 12 | Homo sapiens (human) | Kd | 5.0500 | 1 | 2 |
| Mitogen-activated protein kinase kinase kinase 13 | Homo sapiens (human) | Kd | 3.3967 | 2 | 3 |
| Mitogen-activated protein kinase kinase kinase 15 | Homo sapiens (human) | Kd | 4.2000 | 2 | 3 |
| Mitogen-activated protein kinase kinase kinase 19 | Homo sapiens (human) | Kd | 3.3447 | 2 | 3 |
| Mitogen-activated protein kinase kinase kinase 2 | Homo sapiens (human) | Kd | 12.0835 | 3 | 6 |
| Mitogen-activated protein kinase kinase kinase 20 | Homo sapiens (human) | Kd | 16.1000 | 4 | 8 |
| Mitogen-activated protein kinase kinase kinase 3 | Homo sapiens (human) | Kd | 12.2840 | 3 | 6 |
| Mitogen-activated protein kinase kinase kinase 4 | Homo sapiens (human) | Kd | 15.3444 | 5 | 9 |
| Mitogen-activated protein kinase kinase kinase 5 | Homo sapiens (human) | Kd | 18.8889 | 4 | 9 |
| Mitogen-activated protein kinase kinase kinase 6 | Homo sapiens (human) | Kd | 20.0000 | 3 | 6 |
| Mitogen-activated protein kinase kinase kinase 7 | Homo sapiens (human) | Kd | 3.3953 | 2 | 3 |
| Mitogen-activated protein kinase kinase kinase 9 | Homo sapiens (human) | Kd | 6.0400 | 3 | 5 |
| Mitogen-activated protein kinase kinase kinase kinase 1 | Homo sapiens (human) | Kd | 10.0371 | 4 | 8 |
| Mitogen-activated protein kinase kinase kinase kinase 2 | Homo sapiens (human) | Kd | 18.3388 | 3 | 6 |
| Mitogen-activated protein kinase kinase kinase kinase 3 | Homo sapiens (human) | Kd | 10.1335 | 4 | 8 |
| Mitogen-activated protein kinase kinase kinase kinase 4 | Homo sapiens (human) | Kd | 8.5110 | 4 | 8 |
| Mitogen-activated protein kinase kinase kinase kinase 5 | Homo sapiens (human) | Kd | 8.1471 | 6 | 10 |
| Mitotic checkpoint serine/threonine-protein kinase BUB1 | Homo sapiens (human) | Kd | 23.3768 | 1 | 4 |
| mu-type opioid receptor isoform MOR-1 | Homo sapiens (human) | EC50 | 51.0195 | 2 | 2 |
| Multifunctional protein ADE2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Muscle, skeletal receptor tyrosine-protein kinase | Homo sapiens (human) | Kd | 4.2940 | 3 | 5 |
| Myosin light chain kinase 2, skeletal/cardiac muscle | Homo sapiens (human) | Kd | 2.8944 | 5 | 7 |
| Myosin light chain kinase 3 | Homo sapiens (human) | Kd | 20.0046 | 2 | 5 |
| Myosin light chain kinase family member 4 | Homo sapiens (human) | Kd | 4.0090 | 3 | 5 |
| Myosin light chain kinase, smooth muscle | Gallus gallus (chicken) | Kd | 5.0115 | 1 | 2 |
| Myosin light chain kinase, smooth muscle | Homo sapiens (human) | Kd | 14.0863 | 5 | 10 |
| Myosin-10 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Myosin-14 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Myosin-IIIa | Homo sapiens (human) | Kd | 8.6200 | 3 | 5 |
| Myosin-IIIb | Homo sapiens (human) | Kd | 6.7000 | 3 | 5 |
| Myotonin-protein kinase | Homo sapiens (human) | Kd | 10.0000 | 3 | 5 |
| NAD kinase | Homo sapiens (human) | Kd | 1.7800 | 1 | 1 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Non-receptor tyrosine-protein kinase TNK1 | Homo sapiens (human) | Kd | 14.0050 | 4 | 8 |
| Non-receptor tyrosine-protein kinase TYK2 | Homo sapiens (human) | Kd | 10.6836 | 6 | 11 |
| NPC1-like intracellular cholesterol transporter 1 | Homo sapiens (human) | EC50 | 8.7000 | 1 | 1 |
| NT-3 growth factor receptor | Homo sapiens (human) | Kd | 7.0600 | 3 | 5 |
| NUAK family SNF1-like kinase 1 | Homo sapiens (human) | Kd | 4.0288 | 3 | 5 |
| NUAK family SNF1-like kinase 2 | Homo sapiens (human) | Kd | 13.8062 | 4 | 8 |
| Nuclear factor erythroid 2-related factor 2 | Homo sapiens (human) | EC50 | 21.0000 | 1 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | Homo sapiens (human) | EC50 | 3.6991 | 10 | 11 |
| Nuclear receptor subfamily 1 group I member 2 | Rattus norvegicus (Norway rat) | EC50 | 4.0000 | 1 | 1 |
| Nucleolar GTP-binding protein 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Obg-like ATPase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Oxysterols receptor LXR-alpha | Homo sapiens (human) | EC50 | 1.3333 | 3 | 3 |
| Oxysterols receptor LXR-alpha | Homo sapiens (human) | Kd | 2.2000 | 1 | 1 |
| Oxysterols receptor LXR-beta | Homo sapiens (human) | EC50 | 125.2000 | 1 | 1 |
| Oxysterols receptor LXR-beta | Homo sapiens (human) | Kd | 73.2000 | 1 | 1 |
| PAS domain-containing serine/threonine-protein kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Peripheral plasma membrane protein CASK | Homo sapiens (human) | Kd | 10.0000 | 1 | 2 |
| Peroxisomal acyl-coenzyme A oxidase 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Peroxisomal acyl-coenzyme A oxidase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | EC50 | 3.5000 | 1 | 1 |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | EC50 | 16.3500 | 2 | 2 |
| Phenylalanine--tRNA ligase beta subunit | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Phosphatidylethanolamine-binding protein 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Phosphatidylinositol 4-kinase beta | Homo sapiens (human) | Kd | 10.0000 | 2 | 3 |
| Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta | Homo sapiens (human) | Kd | 10.0000 | 2 | 3 |
| Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma | Homo sapiens (human) | Kd | 10.0000 | 2 | 3 |
| Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha | Homo sapiens (human) | Kd | 7.2400 | 3 | 5 |
| Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma | Homo sapiens (human) | Kd | 6.3000 | 1 | 2 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Homo sapiens (human) | Kd | 10.0000 | 21 | 33 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Homo sapiens (human) | Kd | 10.0000 | 2 | 3 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | Homo sapiens (human) | Kd | 10.0000 | 2 | 3 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Homo sapiens (human) | Kd | 10.0000 | 2 | 3 |
| Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Phosphatidylinositol 5-phosphate 4-kinase type-2 beta | Homo sapiens (human) | Kd | 4.0234 | 3 | 5 |
| Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma | Homo sapiens (human) | Kd | 22.0000 | 2 | 5 |
| Phospholipase A2 | Homo sapiens (human) | Kd | 10.0000 | 1 | 1 |
| Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | Homo sapiens (human) | Kd | 8.0757 | 6 | 10 |
| Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | Homo sapiens (human) | Kd | 2.8795 | 5 | 7 |
| Platelet-derived growth factor receptor alpha | Homo sapiens (human) | Kd | 4.0005 | 3 | 5 |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | Kd | 8.0005 | 6 | 10 |
| Poly [ADP-ribose] polymerase 1 | Homo sapiens (human) | EC50 | 0.0200 | 1 | 1 |
| Poly [ADP-ribose] polymerase 1 | Homo sapiens (human) | Kd | 0.1100 | 1 | 1 |
| Poly [ADP-ribose] polymerase tankyrase-2 | Homo sapiens (human) | Kd | 8.9000 | 1 | 1 |
| Polycomb protein EED | Homo sapiens (human) | Kd | 15.1000 | 1 | 1 |
| POsterior Segregation | Caenorhabditis elegans | EC50 | 96.2865 | 1 | 2 |
| Probable ATP-dependent RNA helicase DDX6 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Procathepsin L | Homo sapiens (human) | EC50 | 1.6330 | 1 | 3 |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | Kd | 5.0175 | 1 | 2 |
| Protein delta homolog 1 | Homo sapiens (human) | Kd | 0.1000 | 1 | 1 |
| Protein kinase C alpha type | Homo sapiens (human) | Kd | 21.2000 | 3 | 5 |
| Protein kinase C beta type | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Protein kinase C delta type | Homo sapiens (human) | Kd | 14.3486 | 4 | 8 |
| Protein kinase C epsilon type | Homo sapiens (human) | Kd | 10.0000 | 3 | 5 |
| Protein kinase C eta type | Homo sapiens (human) | Kd | 10.0000 | 3 | 5 |
| Protein kinase C iota type | Homo sapiens (human) | Kd | 23.3333 | 2 | 6 |
| Protein kinase C theta type | Homo sapiens (human) | Kd | 15.3625 | 4 | 8 |
| Protein kinase C zeta type | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Protein mono-ADP-ribosyltransferase PARP3 | Homo sapiens (human) | Kd | 0.7000 | 1 | 1 |
| Protein-tyrosine kinase 2-beta | Homo sapiens (human) | Kd | 17.0246 | 4 | 10 |
| Protein-tyrosine kinase 6 | Homo sapiens (human) | Kd | 14.6000 | 5 | 9 |
| Prothrombin | Homo sapiens (human) | Kd | 0.0078 | 1 | 1 |
| Proto-oncogene tyrosine-protein kinase receptor Ret | Homo sapiens (human) | Kd | 6.3240 | 11 | 19 |
| Proto-oncogene tyrosine-protein kinase ROS | Homo sapiens (human) | Kd | 10.0000 | 3 | 5 |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | Kd | 12.2222 | 5 | 9 |
| Putative heat shock protein HSP 90-beta 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Pyridoxal kinase | Homo sapiens (human) | Kd | 25.2042 | 1 | 5 |
| Rab-like protein 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | Kd | 17.5000 | 4 | 8 |
| RAC-beta serine/threonine-protein kinase | Homo sapiens (human) | Kd | 14.7625 | 4 | 8 |
| RAC-gamma serine/threonine-protein kinase | Homo sapiens (human) | Kd | 17.5000 | 4 | 8 |
| RAF proto-oncogene serine/threonine-protein kinase | Homo sapiens (human) | Kd | 6.3920 | 3 | 5 |
| Ras-related C3 botulinum toxin substrate 1 | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Ras-related protein Rab-10 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Ras-related protein Rab-27A | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Ras-related protein Rab-6A | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | Kd | 10.0000 | 3 | 5 |
| Receptor tyrosine-protein kinase erbB-3 | Homo sapiens (human) | Kd | 10.0000 | 2 | 3 |
| Receptor tyrosine-protein kinase erbB-4 | Homo sapiens (human) | Kd | 8.2667 | 2 | 3 |
| Receptor-interacting serine/threonine-protein kinase 1 | Homo sapiens (human) | Kd | 3.5800 | 4 | 6 |
| Receptor-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | Kd | 13.5720 | 5 | 9 |
| Receptor-interacting serine/threonine-protein kinase 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Receptor-interacting serine/threonine-protein kinase 4 | Homo sapiens (human) | Kd | 4.7333 | 2 | 3 |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | Kd | 4.6167 | 25 | 39 |
| recombinase A | Mycobacterium tuberculosis H37Rv | EC50 | 78.6500 | 2 | 2 |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | EC50 | 1.6330 | 1 | 3 |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | EC50 | 1.6330 | 1 | 3 |
| Replicase polyprotein 1ab | Human coronavirus 229E | EC50 | 1.6330 | 1 | 3 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | EC50 | 4.8313 | 4 | 7 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | EC50 | 3.9138 | 2 | 5 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | Kd | 11.9500 | 2 | 2 |
| Rho-associated protein kinase 1 | Homo sapiens (human) | Kd | 11.9710 | 3 | 6 |
| Rho-associated protein kinase 2 | Homo sapiens (human) | Kd | 10.1859 | 4 | 7 |
| Rhodopsin kinase GRK1 | Homo sapiens (human) | Kd | 3.5267 | 2 | 3 |
| Rhodopsin kinase GRK7 | Homo sapiens (human) | Kd | 3.4533 | 2 | 3 |
| Ribosomal protein S6 kinase alpha-1 | Homo sapiens (human) | Kd | 7.2516 | 7 | 13 |
| Ribosomal protein S6 kinase alpha-2 | Homo sapiens (human) | Kd | 4.8898 | 8 | 12 |
| Ribosomal protein S6 kinase alpha-3 | Homo sapiens (human) | Kd | 8.4966 | 6 | 10 |
| Ribosomal protein S6 kinase alpha-4 | Homo sapiens (human) | Kd | 8.4542 | 7 | 13 |
| Ribosomal protein S6 kinase alpha-5 | Homo sapiens (human) | Kd | 7.5663 | 9 | 15 |
| Ribosomal protein S6 kinase alpha-6 | Homo sapiens (human) | Kd | 11.3615 | 7 | 13 |
| Ribosomal protein S6 kinase beta-1 | Homo sapiens (human) | Kd | 16.7080 | 3 | 6 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | Kd | 12.1577 | 1 | 3 |
| RNA cytidine acetyltransferase | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| RPL19A | Saccharomyces cerevisiae (brewer's yeast) | EC50 | 0.7570 | 2 | 2 |
| S-adenosylmethionine synthase isoform type-2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Septin-9 | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Serine/threonine-protein kinase 10 | Homo sapiens (human) | Kd | 9.4069 | 5 | 9 |
| Serine/threonine-protein kinase 16 | Homo sapiens (human) | Kd | 11.1470 | 6 | 10 |
| Serine/threonine-protein kinase 17A | Homo sapiens (human) | Kd | 2.8636 | 5 | 7 |
| Serine/threonine-protein kinase 17B | Homo sapiens (human) | Kd | 2.9671 | 5 | 7 |
| Serine/threonine-protein kinase 24 | Homo sapiens (human) | Kd | 7.7533 | 4 | 7 |
| Serine/threonine-protein kinase 25 | Homo sapiens (human) | Kd | 4.1740 | 3 | 5 |
| Serine/threonine-protein kinase 26 | Homo sapiens (human) | Kd | 10.4068 | 4 | 8 |
| Serine/threonine-protein kinase 3 | Homo sapiens (human) | Kd | 10.3214 | 4 | 8 |
| Serine/threonine-protein kinase 3 | Mus musculus (house mouse) | Kd | 0.1600 | 1 | 1 |
| Serine/threonine-protein kinase 32A | Homo sapiens (human) | Kd | 5.6500 | 1 | 2 |
| Serine/threonine-protein kinase 32B | Homo sapiens (human) | Kd | 6.8400 | 3 | 5 |
| Serine/threonine-protein kinase 32C | Homo sapiens (human) | Kd | 10.0000 | 3 | 5 |
| Serine/threonine-protein kinase 33 | Homo sapiens (human) | Kd | 4.0102 | 3 | 5 |
| serine/threonine-protein kinase 33 isoform a | Homo sapiens (human) | EC50 | 9.5830 | 1 | 1 |
| Serine/threonine-protein kinase 35 | Homo sapiens (human) | Kd | 4.2000 | 2 | 3 |
| Serine/threonine-protein kinase 36 | Homo sapiens (human) | Kd | 5.5767 | 4 | 6 |
| Serine/threonine-protein kinase 38 | Homo sapiens (human) | Kd | 3.6067 | 2 | 3 |
| Serine/threonine-protein kinase 38-like | Homo sapiens (human) | Kd | 10.5512 | 5 | 8 |
| Serine/threonine-protein kinase 4 | Homo sapiens (human) | Kd | 11.7988 | 6 | 12 |
| Serine/threonine-protein kinase A-Raf | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Serine/threonine-protein kinase ATR | Homo sapiens (human) | Kd | 30.0000 | 1 | 1 |
| Serine/threonine-protein kinase B-raf | Homo sapiens (human) | Kd | 13.0343 | 7 | 14 |
| Serine/threonine-protein kinase BRSK1 | Homo sapiens (human) | Kd | 6.1000 | 3 | 5 |
| Serine/threonine-protein kinase BRSK2 | Homo sapiens (human) | Kd | 4.6600 | 3 | 5 |
| Serine/threonine-protein kinase Chk1 | Homo sapiens (human) | Kd | 10.5242 | 4 | 8 |
| Serine/threonine-protein kinase Chk2 | Homo sapiens (human) | Kd | 3.3390 | 2 | 3 |
| Serine/threonine-protein kinase D1 | Homo sapiens (human) | Kd | 4.1860 | 3 | 5 |
| Serine/threonine-protein kinase D2 | Homo sapiens (human) | Kd | 7.3351 | 4 | 8 |
| Serine/threonine-protein kinase D3 | Homo sapiens (human) | Kd | 9.4782 | 4 | 8 |
| Serine/threonine-protein kinase DCLK1 | Homo sapiens (human) | Kd | 4.2220 | 3 | 5 |
| Serine/threonine-protein kinase DCLK2 | Homo sapiens (human) | Kd | 5.6200 | 3 | 5 |
| Serine/threonine-protein kinase DCLK3 | Homo sapiens (human) | Kd | 4.0660 | 3 | 5 |
| Serine/threonine-protein kinase ICK | Homo sapiens (human) | Kd | 14.1880 | 3 | 5 |
| Serine/threonine-protein kinase LATS1 | Homo sapiens (human) | Kd | 7.1004 | 4 | 8 |
| Serine/threonine-protein kinase LATS2 | Homo sapiens (human) | Kd | 4.2760 | 3 | 5 |
| Serine/threonine-protein kinase MAK | Homo sapiens (human) | Kd | 10.0000 | 2 | 3 |
| Serine/threonine-protein kinase MARK1 | Homo sapiens (human) | Kd | 4.7200 | 3 | 5 |
| Serine/threonine-protein kinase MARK2 | Homo sapiens (human) | Kd | 9.3626 | 5 | 9 |
| Serine/threonine-protein kinase MRCK alpha | Homo sapiens (human) | Kd | 16.5500 | 4 | 8 |
| Serine/threonine-protein kinase MRCK beta | Homo sapiens (human) | Kd | 15.6750 | 4 | 8 |
| Serine/threonine-protein kinase MRCK gamma | Homo sapiens (human) | Kd | 15.1000 | 4 | 8 |
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | Kd | 10.0000 | 1 | 2 |
| Serine/threonine-protein kinase N1 | Homo sapiens (human) | Kd | 12.5523 | 4 | 9 |
| Serine/threonine-protein kinase N2 | Homo sapiens (human) | Kd | 10.8124 | 4 | 8 |
| Serine/threonine-protein kinase N3 | Homo sapiens (human) | Kd | 22.5248 | 1 | 4 |
| Serine/threonine-protein kinase Nek1 | Homo sapiens (human) | Kd | 18.8889 | 4 | 9 |
| Serine/threonine-protein kinase Nek11 | Homo sapiens (human) | Kd | 10.0000 | 1 | 2 |
| Serine/threonine-protein kinase Nek2 | Homo sapiens (human) | Kd | 11.5200 | 6 | 10 |
| Serine/threonine-protein kinase Nek3 | Homo sapiens (human) | Kd | 22.0000 | 2 | 5 |
| Serine/threonine-protein kinase Nek4 | Homo sapiens (human) | Kd | 10.0000 | 1 | 2 |
| Serine/threonine-protein kinase Nek5 | Homo sapiens (human) | Kd | 10.0000 | 3 | 5 |
| Serine/threonine-protein kinase Nek6 | Homo sapiens (human) | Kd | 10.0000 | 3 | 5 |
| Serine/threonine-protein kinase Nek7 | Homo sapiens (human) | Kd | 13.1857 | 4 | 7 |
| Serine/threonine-protein kinase Nek9 | Homo sapiens (human) | Kd | 17.5000 | 4 | 8 |
| Serine/threonine-protein kinase NIM1 | Homo sapiens (human) | Kd | 3.9000 | 2 | 3 |
| Serine/threonine-protein kinase NLK | Homo sapiens (human) | Kd | 15.0062 | 4 | 8 |
| Serine/threonine-protein kinase OSR1 | Homo sapiens (human) | Kd | 3.6867 | 2 | 3 |
| Serine/threonine-protein kinase PAK 1 | Homo sapiens (human) | Kd | 10.0000 | 3 | 5 |
| Serine/threonine-protein kinase PAK 2 | Homo sapiens (human) | Kd | 17.5000 | 4 | 8 |
| Serine/threonine-protein kinase PAK 3 | Homo sapiens (human) | Kd | 4.0096 | 3 | 5 |
| Serine/threonine-protein kinase PAK 4 | Homo sapiens (human) | Kd | 14.6125 | 4 | 8 |
| Serine/threonine-protein kinase PAK 5 | Homo sapiens (human) | Kd | 4.3840 | 3 | 5 |
| Serine/threonine-protein kinase PAK 6 | Homo sapiens (human) | Kd | 9.5333 | 4 | 6 |
| Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | Kd | 17.5000 | 4 | 8 |
| Serine/threonine-protein kinase pim-2 | Homo sapiens (human) | Kd | 9.1667 | 4 | 6 |
| Serine/threonine-protein kinase pim-3 | Homo sapiens (human) | Kd | 5.4400 | 3 | 5 |
| Serine/threonine-protein kinase PknB | Mycobacterium tuberculosis H37Rv | Kd | 5.0435 | 1 | 2 |
| Serine/threonine-protein kinase PLK1 | Homo sapiens (human) | Kd | 17.5000 | 4 | 8 |
| Serine/threonine-protein kinase PLK2 | Homo sapiens (human) | Kd | 6.4667 | 2 | 3 |
| Serine/threonine-protein kinase PLK3 | Homo sapiens (human) | Kd | 10.0000 | 3 | 5 |
| Serine/threonine-protein kinase PLK4 | Homo sapiens (human) | Kd | 11.1330 | 6 | 10 |
| Serine/threonine-protein kinase PRP4 homolog | Homo sapiens (human) | Kd | 3.5933 | 2 | 3 |
| Serine/threonine-protein kinase receptor R3 | Homo sapiens (human) | Kd | 10.0000 | 3 | 5 |
| Serine/threonine-protein kinase RIO1 | Homo sapiens (human) | Kd | 4.0210 | 3 | 5 |
| Serine/threonine-protein kinase RIO2 | Homo sapiens (human) | Kd | 2.5745 | 3 | 4 |
| Serine/threonine-protein kinase RIO3 | Homo sapiens (human) | Kd | 6.2800 | 3 | 5 |
| Serine/threonine-protein kinase SBK1 | Homo sapiens (human) | Kd | 5.1000 | 1 | 2 |
| Serine/threonine-protein kinase Sgk3 | Homo sapiens (human) | Kd | 5.1100 | 1 | 2 |
| Serine/threonine-protein kinase SIK1 | Homo sapiens (human) | Kd | 5.9200 | 3 | 5 |
| Serine/threonine-protein kinase SIK2 | Homo sapiens (human) | Kd | 13.9675 | 4 | 8 |
| Serine/threonine-protein kinase SIK3 | Homo sapiens (human) | Kd | 18.9833 | 3 | 6 |
| Serine/threonine-protein kinase STK11 | Homo sapiens (human) | Kd | 13.7642 | 4 | 8 |
| Serine/threonine-protein kinase TAO1 | Homo sapiens (human) | Kd | 14.1850 | 5 | 8 |
| Serine/threonine-protein kinase TAO2 | Homo sapiens (human) | Kd | 22.0000 | 2 | 5 |
| Serine/threonine-protein kinase TAO3 | Homo sapiens (human) | Kd | 16.7367 | 3 | 6 |
| Serine/threonine-protein kinase TBK1 | Homo sapiens (human) | Kd | 11.9570 | 3 | 6 |
| Serine/threonine-protein kinase TNNI3K | Homo sapiens (human) | Kd | 7.4000 | 3 | 5 |
| Serine/threonine-protein kinase tousled-like 1 | Homo sapiens (human) | Kd | 4.4440 | 3 | 5 |
| Serine/threonine-protein kinase tousled-like 2 | Homo sapiens (human) | Kd | 4.1980 | 3 | 5 |
| Serine/threonine-protein kinase ULK1 | Homo sapiens (human) | Kd | 12.0360 | 3 | 6 |
| Serine/threonine-protein kinase ULK2 | Homo sapiens (human) | Kd | 3.3420 | 2 | 3 |
| Serine/threonine-protein kinase ULK3 | Homo sapiens (human) | Kd | 11.8682 | 3 | 6 |
| Serine/threonine-protein kinase ULK3 | Mus musculus (house mouse) | Kd | 0.1100 | 1 | 1 |
| Serine/threonine-protein kinase VRK2 | Homo sapiens (human) | Kd | 10.0000 | 1 | 2 |
| Serine/threonine-protein kinase/endoribonuclease IRE1 | Homo sapiens (human) | Kd | 16.8667 | 3 | 6 |
| Serine/threonine-protein kinase/endoribonuclease IRE2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Signal recognition particle receptor subunit alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Signal transducer and activator of transcription 1-alpha/beta | Homo sapiens (human) | Kd | 0.7000 | 1 | 1 |
| SNF-related serine/threonine-protein kinase | Homo sapiens (human) | Kd | 5.3200 | 1 | 2 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | EC50 | 57.3065 | 1 | 2 |
| Sodium/bile acid cotransporter | Homo sapiens (human) | Kd | 64.3000 | 1 | 1 |
| Spike glycoprotein | Betacoronavirus England 1 | EC50 | 1.6330 | 1 | 3 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | EC50 | 1.6330 | 1 | 3 |
| SRSF protein kinase 1 | Homo sapiens (human) | Kd | 4.1500 | 3 | 5 |
| SRSF protein kinase 2 | Homo sapiens (human) | Kd | 4.1140 | 3 | 5 |
| SRSF protein kinase 3 | Homo sapiens (human) | Kd | 3.3727 | 2 | 3 |
| STE20-like serine/threonine-protein kinase | Homo sapiens (human) | Kd | 6.8649 | 6 | 11 |
| STE20-related kinase adapter protein alpha | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| STE20/SPS1-related proline-alanine-rich protein kinase | Homo sapiens (human) | Kd | 3.4267 | 2 | 3 |
| streptokinase A precursor | Streptococcus pyogenes M1 GAS | EC50 | 4.8703 | 2 | 3 |
| Structural maintenance of chromosomes protein 1A | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Structural maintenance of chromosomes protein 2 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 4 |
| Testis-specific serine/threonine-protein kinase 1 | Homo sapiens (human) | Kd | 7.7800 | 3 | 5 |
| TGF-beta receptor type-1 | Homo sapiens (human) | Kd | 16.7750 | 4 | 8 |
| TGF-beta receptor type-2 | Homo sapiens (human) | Kd | 15.4500 | 4 | 8 |
| Thyroid hormone receptor-associated protein 3 | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| TRAF2 and NCK-interacting protein kinase | Homo sapiens (human) | Kd | 5.7865 | 6 | 11 |
| Transient receptor potential cation channel subfamily A member 1 | Homo sapiens (human) | EC50 | 0.6400 | 2 | 2 |
| Transient receptor potential cation channel subfamily A member 1 | Rattus norvegicus (Norway rat) | EC50 | 2.5667 | 3 | 3 |
| Transient receptor potential cation channel subfamily M member 6 | Homo sapiens (human) | Kd | 10.0000 | 1 | 2 |
| Transient receptor potential cation channel subfamily V member 1 | Homo sapiens (human) | EC50 | 5.6500 | 4 | 4 |
| Transient receptor potential cation channel subfamily V member 2 | Homo sapiens (human) | EC50 | 1.7000 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 2 | Rattus norvegicus (Norway rat) | EC50 | 1.7000 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 3 | Homo sapiens (human) | EC50 | 1.0000 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 4 | Homo sapiens (human) | EC50 | 5.1000 | 1 | 1 |
| Transmembrane protease serine 2 | Homo sapiens (human) | EC50 | 1.6330 | 1 | 3 |
| Transporter | Rattus norvegicus (Norway rat) | EC50 | 0.0005 | 1 | 1 |
| Transthyretin | Homo sapiens (human) | EC50 | 8.6000 | 1 | 1 |
| Transthyretin | Homo sapiens (human) | Kd | 0.4000 | 2 | 2 |
| Tubulin alpha-1A chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin alpha-1A chain | Rattus norvegicus (Norway rat) | Kd | 10.0000 | 1 | 2 |
| Tubulin alpha-1B chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin alpha-1C chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin alpha-3C chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin alpha-3E chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin alpha-4A chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin beta chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin beta-1 chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin beta-2A chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin beta-2B chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin beta-3 chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin beta-4A chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin beta-4B chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin beta-6 chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Tubulin beta-8 chain | Homo sapiens (human) | Kd | 149.7630 | 1 | 2 |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | EC50 | 0.2040 | 1 | 1 |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | EC50 | 0.2040 | 1 | 1 |
| Tyrosine--tRNA ligase, cytoplasmic | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | EC50 | 1.0000 | 1 | 1 |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | Kd | 4.8334 | 40 | 75 |
| Tyrosine-protein kinase ABL2 | Homo sapiens (human) | Kd | 14.4200 | 5 | 10 |
| Tyrosine-protein kinase Blk | Homo sapiens (human) | Kd | 4.0390 | 3 | 5 |
| Tyrosine-protein kinase BTK | Homo sapiens (human) | Kd | 16.5125 | 4 | 8 |
| Tyrosine-protein kinase CSK | Homo sapiens (human) | Kd | 17.5000 | 4 | 8 |
| Tyrosine-protein kinase Fer | Homo sapiens (human) | Kd | 9.6332 | 5 | 9 |
| Tyrosine-protein kinase Fes/Fps | Homo sapiens (human) | Kd | 14.1100 | 4 | 8 |
| Tyrosine-protein kinase Fgr | Homo sapiens (human) | Kd | 5.8787 | 6 | 9 |
| Tyrosine-protein kinase FRK | Homo sapiens (human) | Kd | 11.0656 | 5 | 9 |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | Kd | 14.5460 | 5 | 10 |
| Tyrosine-protein kinase HCK | Homo sapiens (human) | Kd | 9.7648 | 5 | 9 |
| Tyrosine-protein kinase ITK/TSK | Homo sapiens (human) | Kd | 4.0078 | 3 | 5 |
| Tyrosine-protein kinase JAK1 | Homo sapiens (human) | Kd | 7.8954 | 8 | 13 |
| Tyrosine-protein kinase JAK2 | Homo sapiens (human) | Kd | 7.4529 | 5 | 7 |
| Tyrosine-protein kinase JAK3 | Homo sapiens (human) | Kd | 4.7200 | 3 | 5 |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | Kd | 7.6616 | 5 | 9 |
| Tyrosine-protein kinase Lyn | Homo sapiens (human) | Kd | 10.3005 | 6 | 11 |
| Tyrosine-protein kinase Mer | Homo sapiens (human) | Kd | 8.3463 | 4 | 6 |
| Tyrosine-protein kinase receptor Tie-1 | Homo sapiens (human) | Kd | 8.7800 | 3 | 5 |
| Tyrosine-protein kinase receptor TYRO3 | Homo sapiens (human) | Kd | 4.0294 | 3 | 5 |
| Tyrosine-protein kinase receptor UFO | Homo sapiens (human) | Kd | 4.0054 | 3 | 5 |
| Tyrosine-protein kinase Srms | Homo sapiens (human) | Kd | 10.0000 | 3 | 5 |
| Tyrosine-protein kinase SYK | Homo sapiens (human) | EC50 | 300.0000 | 1 | 1 |
| Tyrosine-protein kinase SYK | Homo sapiens (human) | Kd | 17.5000 | 4 | 8 |
| Tyrosine-protein kinase Tec | Homo sapiens (human) | Kd | 17.5000 | 4 | 8 |
| Tyrosine-protein kinase TXK | Homo sapiens (human) | Kd | 7.8000 | 3 | 5 |
| Tyrosine-protein kinase Yes | Homo sapiens (human) | Kd | 9.0398 | 5 | 9 |
| Tyrosine-protein kinase ZAP-70 | Homo sapiens (human) | Kd | 10.0000 | 3 | 5 |
| U5 small nuclear ribonucleoprotein 200 kDa helicase | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| UMP-CMP kinase | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Uncharacterized aarF domain-containing protein kinase 5 | Homo sapiens (human) | Kd | 30.0000 | 1 | 2 |
| Uncharacterized protein FLJ45252 | Homo sapiens (human) | Kd | 22.6078 | 1 | 4 |
| Uncharacterized serine/threonine-protein kinase SBK3 | Homo sapiens (human) | Kd | 4.6000 | 2 | 3 |
| Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | Kd | 4.0011 | 3 | 5 |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | Kd | 2.5044 | 6 | 8 |
| Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | Kd | 2.8886 | 5 | 7 |
| Very long-chain specific acyl-CoA dehydrogenase, mitochondrial | Homo sapiens (human) | Kd | 30.0000 | 1 | 3 |
| Wee1-like protein kinase | Homo sapiens (human) | Kd | 14.1625 | 4 | 8 |
| Wee1-like protein kinase 2 | Homo sapiens (human) | Kd | 10.0000 | 2 | 3 |
| Zinc finger protein mex-5 | Caenorhabditis elegans | EC50 | 57.3065 | 1 | 2 |